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Summary 
Mycobacterium tuberculosis, the causative agent of tuberculosis disease, contains five copies of the ESAT-6 
gene cluster, each encoding a dedicated ESX protein secretion system which has been defined as a novel 
Type-VII secretion system. The ESX have been implicated in virulence and survival of M. tuberculosis, and 
as such present a promising target for novel treatment interventions. This study has investigated the 
evolution, regulation, functions and substrates of the ESX secretion systems. 
The evolutionary history of the ESX secretion systems was established using in silico and phylogenetic 
analyses of the sequenced mycobacteria, closely related actinomycetes and WXG-FtsK clusters from other 
bacteria. The ESX-4 gene cluster appears to have evolved with the start of the evolution of the 
mycomembrane, followed by the duplication of ESX-3, which marks the evolution of the genus 
Mycobacterium. The ESX-1 duplication occurred next, followed by ESX-2 and ESX-5 which occur only in the 
slow growing mycobacteria. Five additional ESX gene clusters were newly identified and named ESX-P1 to -
P5. These additional ESX clusters occur, or are predicted to occur, on plasmid DNA, and appear to be 
progenitors of the genomic ESX-1 to -5 gene clusters, possibly indicating a plasmid-mediated mechanism of 
ESX duplication and evolution. 
The promoters expressing the M. tuberculosis ESX-1 to ESX-5 secretion systems were investigated using a 
promoter probe assay, and characterised using in silico analyses. Promoters were identified for ESX-1, -2, -3 
and -5. 
The functions of the mycobacterial ESX secretion systems were investigated using whole proteomic, 
secretomic and metabolomic analyses of the fast growing, non-pathogenic M. smegmatis, which contains 
three of the ESX secretion systems, ESX-1, 3, and 4. ESX knockout strains of M. smegmatis were generated 
and used in comparative analyses with wild-type M. smegmatis. ESX-1 was highly expressed in wild-type M. 
smegmatis, however no specific pathways showed considerable variation when ESX-1 was deleted. Deletion 
of ESX-3 resulted in substantial variation to multiple cellular pathways, including amino acid, carbohydrate 
and fatty acid metabolism and oxidative stress. These and other differences indicate possible perturbed 
polyamine metabolism in the absence of ESX-3. Although no ESX-4 protein components were detected in 
wild type M. smegmatis, the ESX-4 knockout displayed substantial proteomic variation. Reduced levels of 
ESX-3 component proteins in the ESX-4 knockout suggest that ESX-4 influences ESX-3 expression. Other 
variation linked ESX-4 to cell division and molybdenum metabolism. 
Secretomic analyses of wild-type and ESX knockout M. smegmatis strains were used to search for novel 
substrates of the M. smegmatis ESX secretion systems. No prototype ESX substrates were identified in the 
culture filtrates, however 10 possible substrates of the ESX-1, -3 and -4 secretion systems, containing the 
general ESX secretion signal, YxxxD/E, were identified. The functions of some of these proteins correlate 
with the ESX functions identified in the proteomic and metabolomic analyses. 
This study sets the groundwork for future work in understanding the functional roles and expression patterns 
of these ESX secretion systems and in using global proteomic and metabolomic analyses to understand 
cellular changes in response to specific signals or genomic changes.  
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Opsomming 
Mycobacterium tuberculosis, die veroorsakende agent van tuberkulose, bevat vyf kopieë van die ESAT-6 
geengroep, wat elk 'n toegewyde ESX proteïen sekresiesisteem, omskryf as 'n nuwe Tipe-VII 
sekresiestelsel, kodeer.  Die ESX sekresiesisteme is betrokke by virulensie en oorlewing van M. 
tuberculosis, en is dus belowende teikens vir nuwe behandelings. Hierdie studie het die evolusie, regulasie, 
funksies en substrate van die ESX sekresiesisteme ondersoek. 
Die evolusionêre geskiedenis van die ESX sekresiesisteme is bepaal met behulp van in silico en 
filogenetiese analises van die volgordebepaalde mikobakterieë, nouverwante actinomisete en WXG-FtsK 
groepe van ander bakterieë. Die ESX-4 geengroep het saam met die evolusie van die mikomembraan 
ontwikkel, gevolg deur die duplisering van ESX-3, wat die evolusie van die genus Mycobacterium merk. Die 
ESX-1 duplisering het volgende plaasgevind, gevolg deur ESX-2 en ESX-5, wat slegs in die stadig-
groeiende mikobakterieë voorkom. Vyf addisionele ESX geengroepe is nuut geïdentifiseer in hierdie studie 
en is ESX-P1 tot -P5 genoem. Hierdie addisionale ESX groepe is op, of word voorspel om op, plasmied DNS 
voor te kom, en mag voorlopers van die genomiese ESX-1 tot -5 geengroepe wees, wat moontlik dui op 'n 
plasmied-gemedieërde meganisme van ESX duplisering en evolusie. 
Die promoters wat verantwoordelik is vir die uitdrukking van die M. tuberculosis ESX-1 tot ESX-5 
sekresiesisteme is ondersoek deur middel van 'n promoter aktiwiteitstoets, en gekarakteriseer deur in silico 
analises. Promoters is geidentifiseer vir ESX-1, -2, -3 en -5. 
Die funksies van die mikobakteriële ESX sekresiesisteme is ondersoek deur proteomiese, sekretomiese en 
metabolomiese analises van die vinnig-groeiende, nie-patogeniese mikobakterium M. smegmatis, wat ESX-
1, -3 en -4 sekresiesisteme besit. ESX uitslaanmutante van M. smegmatis is gegenereer en gebruik in die 
vergelykende analises met die wilde-tipe M. smegmatis. ESX-1 is hoogs uitgedruk in wilde-tipe M. 
smegmatis, maar geen spesifieke metabolise weë het aansienlike variasie getoon wanneer ESX-1 verwyder 
is. Delesie van ESX-3 het gelei tot aansienlike variasie in verskeie sellulêre weë, insluitend aminosuur-, 
koolhidraat- en vetsuur-metabolisme en oksidatiewe stres. Hierdie en ander verskille dui op moontlike 
versteurde poli-amien metabolisme in die afwesigheid van ESX-3. Hoewel geen ESX-4 proteïenkomponente 
opgespoor is in wilde-tipe M. smegmatis nie, vertoon die ESX-4 uitslaanmutant aansienlike proteomiese 
variasie. Laer vlakke van ESX-3 proteïne dui daarop dat ESX-4 die uitdrukking van ESX-3 beinvloed. Baie 
van die proteomiese variasie kan geassosieer word met verlaagde ESX-3 uitdrukking, maar ander variasie 
mag ESX-4 koppel met seldeling en molibdeen metabolisme. 
Sekretomiese analises van wilde-tipe en ESX uitslaanmutant M. smegmatis stamme is gebruik om nuwe 
substrate van die M. smegmatis ESX sekresiesisteme te identifiseer. Geen prototipe ESX substrate is 
geïdentifiseer in die kultuurfiltraat, maar 10 moontlike substrate van die ESX-1, -3 en -4 sekresiesisteme, met 
die algemene ESX sekresiesein, YxxxD/E, is geïdentifiseer. Die funksies van sommige van hierdie proteïene 
korreleer met die funksies geïdentifiseer in die proteomiese en metabolomiese analises. 
Hierdie studie stel die grondslag vir toekomstige werk in die begrip van die funksionele rol en 
uitdrukkingspatrone van die ESX sekresiesisteme en in die gebruik van globale proteomiese en 
metabolomiese analises om sellulêre veranderinge in reaksie op spesifieke seine of genomiese 
veranderinge te verstaan. 
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The mycobacterial Type VII ESX secretion systems 
1. Introduction 
Bacteria rely on the secretion of proteins for survival. In gram negative bacteria, which are typically 
enveloped by two membranes, this may involve the incorporation of proteins into the inner plasma 
membrane, secretion into the periplasm, insertion into the outer membrane or export through both 
membranes into the extracellular environment.
1
 Protein secretion in gram positive bacteria is generally 
considered to be simpler, as these bacteria have only a single membrane layer.
2
 Secreted proteins are 
involved in numerous essential functions, including organelle biogenesis, nutrient acquisition, 
virulence and efflux of drugs and toxins. 
2. Bacterial secretion mechanisms 
There are two secretion pathways present in both gram positive and gram negative bacteria, the 
general secretion system, or Sec system, and the Twin-arginine transporter, or Tat pathway. The Sec 
secretion system is found in all bacteria and is responsible for the export of unfolded proteins with 
specific N-terminal signal sequences across the plasma membrane.
3-5
 The Tat pathway transports 
folded proteins, recognised by an N-terminal signal sequence and a double arginine motif, across the 
plasma membrane.
6
 Additional gram positive secretion mechanisms include the polypeptide 
translocating ABC transporters and the type IV prepilin-like pathway which export specific proteins.7 
Six additional secretion systems (Type I to VI) exist in gram negative bacteria to transport proteins 
across the inner and outer membranes via unique one- and two-step mechanisms, which may utilise 
the Sec and Tat secretion machineries for transport across the inner membrane.
8-14
 
3. Protein secretion in mycobacteria 
The genus Mycobacterium, consisting of over 156 species and 13 subspecies,
15
 contains both non-
pathogenic saprophytic and pathogenic organisms, the most renowned being M. tuberculosis, which 
infects and kills millions of people annually.
16
 Mycobacteria belong to the class Actinobacteria, within 
which it is placed in a distinct group, the Mycolata. The Mycolata are gram positive bacteria which 
possess an inner and outer membrane, the latter of which is composed of large hydroxylated 
branched-chain fatty acids, called mycolic acids.
17-19
 The mycobacterial cell envelope (Figure 1) is 
composed of the inner plasma membrane consisting of a phospholipid bilayer, the outer 
mycomembrane, and a complex matrix of peptidoglycan and arabinogalactan, the cell wall, which 
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spans the periplasmic space and is covalently linked to the mycomembrane. The mycomembrane also 
contains various free lipid components, and forms a hydrophobic barrier between the cell and its 
extracellular milieu. A polysaccharide capsule surrounds the cell.
20, 21
  
 
 
Figure 1. The Mycobacterial cell envelope structure. The mycobacterial cell is surrounded by four 
layers, the phospholipid bilayer plasma membrane, the cell wall of arabinogalactan and peptidoglycan 
which is covalently linked to the mycolic acids in the mycomembrane, which also incorporates various 
lipids and glycolipids, and a polysaccharide capsule.
20, 21
 
 
The complex mycobacterial envelope forms a valuable defence mechanism against toxic compounds, 
drugs and the host immune system. It is, however, also an obstruction to the secretion and uptake of 
proteins and other molecules. Mycobacteria possess two Sec secretion machineries (SecA1
22
 and 
SecA2
23
) and a Tat secretion pathway.
24, 25
 However, these protein secretion systems only transport 
proteins across the inner plasma membrane, and not across the mycomembrane. Furthermore, the 
secretion systems responsible for protein transport across the outer membrane of most gram-negative 
bacteria (Type-I to -VI) are notably absent in mycobacteria, which are generally considered to be gram 
positive bacteria. A novel Type-VII secretion system has, however, been identified, and is proposed to 
be responsible for the secretion of substrate proteins which lack traditional secretion signals across 
the inner and outer membranes. This secretion system is encoded by the ESAT-6 (or ESX) gene 
cluster and is named the ESX secretion system.
26-32
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4. The ESAT-6 gene cluster 
The ESAT-6 gene cluster was identified during comparative genomic analyses between the 
attenuated vaccine strain M. bovis BCG and virulent M. tuberculosis and M. bovis. During this analysis 
a single region, the region of difference 1 (RD1), was found to be absent from all strains of M. bovis 
BCG.
33-35
 This region encompasses nine genes annotated Rv3871 to Rv3879c, including the T-cell 
antigens ESAT-6 (6kDa early-secreted antigenic target) and CFP-10 (10kDa culture filtrate protein) 
which are secreted, but lack traditional Sec and Tat secretion signals.
27, 36
 Sequencing of the M. 
tuberculosis genome identified a cluster of genes across the RD1 of which there are 5 copies in the 
genome.
26, 27
 These clusters include, in addition to genes encoding the ESAT-6- and CFP-10-like 
(Esx) proteins, PE and PPE family proteins, cytoplasmic ATPases (EccA), membrane ATPases 
(EccC), transmembrane (EccB and EccE) and integral membrane proteins (EccD), subtilisin-like 
serine proteases (mycosins, MycP) and other proteins (including some ESX secretion-associated 
proteins, Esp), and have been named the ESAT-6 or ESX gene clusters 1 to 5 (Figure 2, Table 1). 
These ESX gene clusters have been identified in species throughout the genus Mycobacterium, and 
have been proposed to have evolved in the order ESX-4 (Rv3450c - Rv3444c), ESX-1 (Rv3868 - 
Rv3883c), ESX-3 (Rv0282 - Rv0292), ESX-2 (Rv3895c - Rv3884c) and then ESX-5 (Rv1782 - 
Rv1798), with ESX-4 occurring in various Mycolata outside of the genus Mycobacterium.
27
 
Several components of these ESX gene clusters have been shown to be required for the secretion of 
their related Esx, PE and PPE proteins, and it has been proposed that the ESX gene cluster 
components form dedicated secretion systems responsible for the secretion of these, and other 
proteins. 
5. The mycobacterial ESX secretion systems 
The secretion machineries encoded by the five M. tuberculosis ESX gene clusters have been named 
the ESX-1 to -5 secretion systems, and have recently been proposed to be a novel Type VII secretion 
system.
30, 31
 This machinery is hypothesised to be responsible for the transport of proteins across the 
plasma membrane and uniquely, across the complex mycomembrane of the Mycolata.  Although the 
precise structure and secretion mechanism of these secretion systems have not been clearly defined, 
the roles of specific proteins have been shown or predicted based on experimental and in silico 
studies and used to propose a model for ESX secretion (Figure 3).  
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Figure 2. The ESX gene clusters of M. tuberculosis. The M. tuberculosis ESX gene clusters contain the ESX conserved component genes 
(eccA-E), mycosin genes (mycP), ESX secretion associated genes (esp) as well as the pe, ppe and esx genes. 
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Table 1. The components of the five ESAT-6 gene clusters of M. tuberculosis.  
ESX 
component 
 Description Presence of genes in the ESAT-6 gene cluster regions 
1 2 3 4 5 
EspG ABC transporter family signature Rv3866 (espG1) Rv3889c (espG2) Rv0289 (espG3)  Rv1794  
EccA AAA+ class ATPases, CBXX/CFQX family, SpoVK, 1x 
ATP/GTP-binding site 
Rv3868 (eccA1) Rv3884c (eccA2) Rv0282 (eccA3)  Rv1798 (eccA5) 
EccB Amino terminal transmembrane protein, possible 
ATP/GTP-binding motif 
Rv3869 (eccB1) Rv3895c (eccB2) Rv0283 (eccB3) Rv3450c (eccB4) Rv1782 (eccB5) 
EccC DNA segregation ATPase, ftsK chromosome partitioning 
protein, SpoIIIE, YukA, 3x ATP/GTP-binding sites, 2x 
amino-terminal transmembrane protein 
Rv3870 (eccCa1) 
-Rv3871 (eccCb1) 
 
Rv3894c (eccC2) Rv0284 (eccC3) Rv3447c (eccC4) Rv1783 (eccCa5) 
-Rv1784 (eccCb5) 
PE PE Rv3872 (pe35) Rv3893c (pe36) Rv0285 (pe5)  Rv1788 (pe18) 
Rv1791 (pe19) 
PPE PPE Rv3873 (ppe68) Rv3892c (ppe69) Rv0286 (ppe4)  Rv1787 (ppe25) 
Rv1789 (ppe26) 
Rv1790 (ppe27) 
Esx  CFP-10, Esx family protein Rv3874 (esxB) Rv3891c (esxD) Rv0287 (esxG) Rv3445c (esxU) Rv1792 (esxM) 
Esx ESAT-6, Esx family protein Rv3875 (esxA) Rv3890c (esxC) Rv0288 (esxH) Rv3444c (esxT) Rv1793 (esxN) 
EspI ATPases involved in chromosome partitioning, 1x 
ATP/GTP-binding motif 
Rv3876 (espI) Rv3888c     
EccD Integral inner membrane protein, binding-protein-
dependent transport systems inner membrane 
component signature, putative transporter protein 
Rv3877 (eccD1) Rv3887c (eccD2) Rv0290 (eccD3) Rv3448 (eccD4) Rv1795 (eccD5) 
MycP Mycosin, subtilisin-like cell wall-associated serine 
protease 
Rv3883c (mycP1) Rv3886c (mycP2) Rv0291 (mycP3) Rv3449 (mycP4) Rv1796 (mycP5) 
EccE 2x amino-terminal transmembrane protein Rv3882c (eccE1) Rv3885c (eccE2) Rv0292 (eccE3)   Rv1797 (eccE5) 
Ecc: esx conserved component; Esp: ESX secretion-associated protein; MycP: mycosin protease. 
 The prototype substrate of the ESX secretion system is the pair of Esx proteins encoded in each gene 
cluster. There are eleven pairs of esx genes (esxA-esxW) in the M. tuberculosis genome, six of which 
occur outside of the ESX gene clusters, but which are duplicated from an ESX gene cluster.
26, 37, 38
 
The Esx proteins are small proteins of approximately 100 amino acids, which although not highly 
conserved in sequence, each contain a WXG amino acid motif and have a helix-turn-helix structure.
37, 
39-42
 Each Esx protein pair interacts to form heterodimers or heterotetramers,
40-42
 which are secreted 
as a complex after which they may dissociate to perform their function.
43
 The Esx pairs encoded in, 
and duplicated from, each ESX gene cluster are secreted by the associated secretion system. 
The ESX-1, -2, -3 and 5 gene clusters each contain at least one pe-ppe gene pair, encoded directly 
upstream of the esx genes.
27
 There are also pe and ppe genes associated with four of the esx 
duplications, as well as several additional duplications throughout the M. tuberculosis genome, 
amounting to 99 pe and 69 ppe genes, comprising 10% of its coding DNA.
37, 38
 The PE proteins 
contain a conserved 110 amino acid N-terminal domain, with a characteristic proline-glutamic acid 
(PE) motif at positions 8 and 9,
37, 44, 45
 while the PPE proteins have a proline-proline-glutamic acid 
(PPE) motif from positions 7 to 9 in a unique conserved N-terminal domain of approximately 180 
amino acids.
37, 44
  Both protein families possess highly variable C-terminal domains which are used to 
classify them into subfamilies.
45
 The functions of the PE and PPE proteins have not been clarified, 
although some have been shown to influence colony morphology, cellular architecture, cell-cell 
interactions and antigenic variation, and specific proteins have been shown to be fibronectin-binding 
and siderophore proteins or involved in phagosome-lysosome fusion, macrophage vacuole 
acidification, granuloma persistence, replication in macrophages and virulence and essential for in 
vitro or in vivo growth.
37, 45-55
 Several PE and PPE proteins have been localised to the plasma 
membrane, outer membrane, cell wall and culture supernatant and shown to be secreted by the ESX 
secretion systems.
56-65
 Various PE-PPE protein pairs have been shown to form 1:1 complexes, with a 
four-helix structure, and to interact with Esx and other ESX-encoded proteins.
66-70
  
In addition to the Esx and PE-PPE proteins, various other ESX secretion-associated proteins (Esp), 
some of which are secreted by the ESX secretion systems, have been identified. The EspC and EspA 
proteins and the EspB and EspK proteins are secreted and are also predicted to interact to form four-
helix bundles, similar to the Esx and PE/PPE complexes, suggesting that this structure may be a 
characteristic of ESX secretion substrates.
71
 Recently a general mycobacterial Type VII secretion 
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signal has been identified on the C-terminal of several ESX secreted substrates, including PE25 
(PE25/PPE41, ESX-5), LipY (ESX-5), PE35 (PE35/PPE68, ESX-1), CFP-10 (ESAT-6/CFP-10, esxBA, 
ESX-1) and EspB (EspB/EspK, ESX-1). This YxxxD/E motif is essential for the secretion of these 
substrates, but does not specify the ESX secretion system responsible for the secretion of the specific 
substrate.
72
  
The ESX gene clusters encode three different ATPases. The eccC gene occurs in all five ESX gene 
clusters and encodes an N-terminal transmembrane ATPase which is thought to provide energy for 
translocation of the substrate proteins.
26, 27, 39
 EccC interacts with the C-terminus of EsxB to 
translocate the EsxBA complex.
73, 74
 EccA is a hexameric protein which undergoes “open-close” 
movements on ATP binding and hydrolysis, to allow interactions with, and energy transfer to other 
proteins.
75, 76
 EccA interacts with EspC, an additional substrate of ESX-1, to enable secretion of 
EspF/EspC.
73
 The third ATPase is only encoded in ESX-1 and ESX-2, and is annotated EspI. It 
appears that interactions with multiple ATPases are required for effective ESX secretion. 
Several additional membrane proteins are encoded in the ESX gene clusters. The eccD gene encodes 
an integral membrane protein with 11 or 12 transmembrane domains, and is predicted to form the 
pore through which the proteins are translocated through the plasma membrane.
26, 27, 30
 MycP is a 
subtilisin-like serine protease which is anchored in the plasma membrane and extends into the cell 
wall.
77
 A single substrate of MycP1, EccB, has been identified,
78
 but it has been predicted that MycP 
may be responsible for the cleavage of EccD in order to open the channel and enable secretion.
71
 Two 
additional transmembrane proteins, EccB and EccE are encoded in various ESX gene clusters and 
are required for ESX secretion.
26, 27, 29
 Although their roles have not been clarified, these proteins are 
predicted to form part of the secretion complex. The protein(s) which are responsible for translocation 
across the mycomembrane have yet to be identified. 
ESX-4 contains only EccB, EccC, EccD and MycP, in addition to the Esx protein pair, suggesting that 
these may be the core components of the ESX secretion system which are required for secretion of 
the Esx substrates, while additional components may assist in the translocation of additional 
substrates including the PE/PPE and Esp secreted proteins, and contribute to the regulation of ESX 
secretion. The ESX-1 secretion system, its functions, substrates and secretion mechanism have been 
most comprehensively studied, although more recently ESX-3 and ESX-5 have been the topics of 
extensive research, while ESX-4 and ESX-2 remain largely unstudied. 
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Figure 3. A model of the ESX secretion machinery. The ESX substrates Esx/Esx, PE/PPE and 
Esp/Esp interact with their partners to form tetra-helical complexes, which interact with the ATPases 
EccC and EccA via the C-termini of one partner, to provide the energy for translocation through the 
membrane pore EccD. MycP may assist in translocation by cleaving EccD pore or by interacting with 
secreted subtrates. The secreted substrates are translocated through an unknown component through 
the mycomembrane where they may remain associated with the membrane or are released into the 
extracellular milleu, where they may dissociate from their partners to perform their functions. 
Interaction and cosecretion of the substrates is required for optimal secretion. The functions of EccB 
and EccE are unknown, but they are believed to form part of the secretory complex.
30, 39, 40, 43, 57, 63, 67, 
70, 71, 73, 74
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5.1. ESX-1 
The ESX-1 gene cluster was first identified as traversing the primary attenuating deletion, Region of 
Difference 1 (RD1), from the M. bovis BCG vaccine strain.
33-35
 The gene cluster is also absent in other 
relatively avirulent species, including M. microti and the “dassie bacillus”, but present in virulent M. 
bovis and M. africanum.
79-81
 Deletion of ESX-1 from M. tuberculosis was furthermore shown to 
attenuate the organism,
82-84
 leading to the deduction that ESX-1 plays an important role in 
mycobacterial pathogenicity. The esxA and esxB genes encoded within this region encode two potent 
T-cell antigens, ESAT-6 (6kDa early secreted antigenic target) and CFP-10 (10kDa culture filtrate 
protein) which have been identified in the culture supernatant of M. tuberculosis.
36
 ESAT-6 and CFP-
10 do not contain traditional secretion signals and their secretion is dependent on the rest of the ESX-
1 components,
29, 32, 82, 84, 85
 leading to the proposed function of ESX-1 as a protein secretion system.  
Several additional proteins have been shown, or proposed, to be secreted by ESX-1 in M. 
tuberculosis, some of which are retained on the cell surface. These include PE35, PPE68, EspJ, 
EspK, EspL and EspB, which are encoded within ESX-1, EspE, EspF, EspG and EspH, encoded 
directly upstream of ESX-1 as well as EspC, EspA and EspD which are encoded in an operon 
elsewhere in the genome, and the transcriptional regulator EspR.
57, 73, 86-94
 These various secreted 
proteins interact with each other in various combinations, and with different ATPases, including the 
EccA1 and EccC1 proteins, via their C-termini, to provide the energy for translocation.
70, 73, 74, 87
 Various 
substrates are co-dependent for secretion and full virulence is dependent on expression and secretion 
of the full contingent of ESX-1 substrates.
57, 73, 87, 88, 93
 Other ESX-1 substrates may play a role in 
stabilising intracellular levels of other proteins
86, 91
 or may influence virulence independently of the 
secretion of other substrates.
93
 EspR is involved in transcriptional regulation of the espACD operon,
90, 
94
 thereby regulating ESX-1 dependent virulence, and is also secreted by ESX-1 maintaining a 
negative feedback loop regulating ESX-1 secretory activity. EspR also binds to 165 other loci in the M. 
tuberculosis genome suggesting that it may coordinate ESX-1 secretion with other cellular functions.
95
  
The role of ESX-1 in mycobacterial virulence has been studied extensively. ESX-1 dependent 
secretion of ESAT-6 has been shown to inhibit T-cell responses and phagosome maturation.
96, 97
 
Secreted ESAT-6 associates with the membrane of vacuoles in order to destabilise and create pores 
in the membrane, enabling the escape of the mycobacteria into the macrophage cytosol.
43, 98-100
 
Perforation of the phagosome membrane also allows the transfer of mycobacterial DNA to the 
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macrophage cytosol, which activates the cytosolic surveillance pathway and contributes to the 
increased interferon-γ production observed during tuberculosis infection.
101, 102
 ESX-1 dependent 
phagosome perforation also results in caspase-1 activation and induces the secretion of interleukin-1β 
and interleukin-18, 
103, 104
 and activates the inflammasome, exacerbating inflammation and promoting 
tuberculosis disease.
92
  
In the non-pathogenic M. smegmatis, ESX-1 has been implicated in conjugal DNA transfer, where it 
negatively regulates DNA transfer from the donor strain,
105
 but is essential for DNA uptake by the 
recipient strain.
106
 ESX-1 is localised at the non-septal pole in M. smegmatis, M. marinum and M. 
tuberculosis, with specific conserved proteins implicated in trafficking of the secretion system to the 
pole.
107, 108
 EccA1 has also been linked to mycolic acid synthesis,
109
 linking ESX-1 secretion, virulence 
and mycolic acid synthesis to the non-divisive pole where rapid cell wall synthesis occurs. The M. 
tuberculosis and M. smegmatis ESX-1 gene clusters have repeatedly been shown to be functionally 
equivalent, 
105, 107, 110
 although conjugal DNA transfer does not occur in M. tuberculosis and M. 
smegmatis is avirulent. This suggests that ESX-1 has evolved additional functions in the slow-growing 
pathogenic mycobacteria, whilst retaining conserved mechanisms. The divergent functions of these 
ESX-1 secretion systems might be attributed to the additional secretion substrates in M. tuberculosis 
which are not present in M. smegmatis.  
5.2. ESX-2 
ESX-2 is encoded adjacent to ESX-1, but on the complementary strand.
27
 This gene cluster is 
dispensable for the in vitro and in vivo growth of M. tuberculosis and deletions of some components 
have been found in clinical isolates of M. tuberculosis.
54, 111
 The ESX-2 secretion system has not been 
investigated and its functions and substrates remain unknown, but its expression has recently been 
shown to be induced by WhiB5 
112
 and the ESX-1 associated regulator EspR,
95
 suggesting that its 
expression and function may be coordinated with those of other ESX secretion systems. 
5.3. ESX-3  
ESX-3 is essential for the in vitro survival of M. tuberculosis, although it is dispensable in the fast-
growing saprophyte M. smegmatis.
54, 113
 Expression of ESX-3 in M. tuberculosis is regulated by the 
iron dependent regulator (IdeR) and the zinc uptake regulator (Zur) in response to iron and zinc 
concentrations, respectively.
50, 114
 In M. smegmatis, however, regulation of ESX-3 is only influenced by 
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iron concentration.
115
 High levels of iron and zinc down-regulate expression of this secretion system 
and ESX-3-mediated protein export is increased during iron-starvation, leading to the hypothesis that 
ESX-3 is involved in divalent-cation, specifically iron and zinc, homeostasis.
116
  
A conditional ESX-3 deletion mutant of M. tuberculosis was shown to survive in vitro in culture medium 
containing high concentrations of iron and zinc, suggesting that ESX-3 is somehow involved in the 
acquisition of these metal cations.
113
 Furthermore the ESX-3 mutant could grow in the culture filtrate or 
boiled supernatant of wild-type M. tuberculosis, suggesting that ESX-3 secretes some factor(s) which 
enable iron acquisition. ESX-3 was shown to be involved in the mycobactin-mediated iron-acquisition 
pathway, somehow influencing the uptake of iron from exported mycobactins.
113
 M. tuberculosis has 
only the mycobactin pathway for iron acquisition, whereas M. smegmatis uses an additional pathway, 
the exochelin system, as its primary iron acquisition mechanism. The involvement of ESX-3 in 
mycobactin-mediated iron acquisition, and the redundancy of this system in M. smegmatis, likely 
differentiates the essentiality of this region in the two organisms.  
ESX-3 has also been associated with immunogenicity. EsxH, previously labelled TB10.4, was found in 
the culture supernatants of M. tuberculosis and found to be highly antigenic.
117
 Iron is sequestered by 
the host during infection, exposing the bacterium to iron starvation, and this may result in increased 
ESX-3 expression and the associated secretion of EsxH, during infection, resulting in the antigenicity 
of the protein. However, ESX-3 has also been implicated in the evasion of the innate immune system 
by M. smegmatis, and the M. tuberculosis ESX-3 was shown to stimulate bacterial immunity, 
suggesting that ESX-3 also promotes mycobacterial virulence.
118
   
The acquisition of iron and evasion of the immune system are essential for pathogen survival in the 
host, and the apparent involvement of ESX-3 in both of these pathways highlights it as an important 
mediator of pathogenicity in M. tuberculosis. 
5.4. ESX-4 
ESX-4 is the most ancestral of the ESX secretion systems, and is present in several species outside of 
the genus Mycobacterium.
27
 The smallest of the ESX gene clusters, ESX-4 contains only the eccB4, 
eccC4, eccD4 and mycP4 genes together with the esxU-EsxT gene pair. This may indicate that these 
are the core ESX machinery components which are required for the secretion of the Esx heterodimer. 
An additional gene, Rv3446c, is also conserved within this gene cluster, although its function has not 
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been determined and it has not been shown to be secreted. A recent study failed to observe secretion 
of EsxU in M. smegmatis and speculated that ESX-4 is either not transcribed or non-functional in M. 
smegmatis.
119
 EsxT and EsxU have never been detected in M. tuberculosis culture supernatants, 
supporting this hypothesis.
120
 Although ESX-4 is non-essential for in vitro and in vivo survival, M. 
leprae is the only mycobacterium which has lost ESX-4, despite deletions of most other ESX gene 
clusters. The maintenance and conservation of ESX-4 throughout the genus Mycobacterium and in 
other actinomycetes suggests that this region must play a role in the biology of the organism.
27, 30, 54
 
Expression of EccC4 was shown to be upregulated when FtsI, a protein involved in septum formation 
was inhibited,
121
 possibly linking ESX-4 to cell division. Transcription of esxU and esxT is regulated by 
the alternative sigma factor SigM and the global transcriptional regulator WhiB5, which is implicated in 
maintenance of metabolism during starvation and in reactivation of M. tuberculosis.
112, 122, 123
 This 
suggests that the expression and function of ESX-4 may be limited to specific conditions or periods 
during the growth cycle.  
5.5. ESX-5 
ESX-5 is the most recently evolved ESX secretion system and has only been identified in the slow-
growing mycobacteria.
27
 M. tuberculosis ESX-5 contains 3 PPE and 2 PE genes, and the PE/PPE 
gene families have been shown to have expanded from ESX-5 into the rest of the genome.
38
 ESX-5 
has predominantly been studied in the fish pathogen, M. marinum, where it has been shown to be 
responsible for the export of various PPE, PE, PPE-MPTR and PE-PGRS proteins, as well as LipY, 
which are cell surface and secreted proteins.
58-60
 The secretion and presentation of surface antigens 
by ESX-5 modulates the host macrophage response, reducing the secretion of pro-inflammatory and 
toll-like receptor signalling-dependent innate immune cytokines.
59, 124
 ESX-5 also induces 
inflammasome activation and interleukin-1β secretion, and contributes to caspase-independent cell 
death after translocation of the mycobacteria to the host cytosol.
99, 125
   
A recent study in M. tuberculosis confirmed the role of ESX-5 in the secretion of the EsxM-EsxN and 
the other TB9.9 Esx proteins (which were duplicated from ESX-5), as well as several M. tuberculosis 
PE and PPE proteins.
61
 This supports the theory that ESX-5 is responsible for the secretion of the 
majority of PE and PPE proteins, specifically the PE-PGRS and PPE-MPTR proteins, which expanded 
from the ESX-5 gene cluster.
38
 EccD5, EccA5 and the ESX-5 encoded PE and PPE proteins were 
shown to be required for secretion of EsxN and various PE and PPE proteins.
61
 An EccD5 knock-out 
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strain of M. tuberculosis was hypersensitive to detergents and hydrophilic antibiotics, implicating ESX-
5 in the formation of a stable cell wall. Furthermore various ESX-5 components were shown to be 
essential for intracellular growth in macrophages and for virulence in SCID mice.
61
 
ESX-5 plays an important role in modulating the human macrophage response during various critical 
stages during infection, by secreting PE and PPE proteins, thereby altering the immune response to 
evade the immune system and maintain a persistent infection.  
6. Conclusion 
The mycobacteria have several features which assist in their survival in general, and in escaping the 
host immune system, to enable their success as pathogens. It appears that at least the ESX-1 and 
ESX-5 secretion systems perform important roles in pathogenesis; however their precise biological 
functions remain unknown. ESX-3 is essential for the survival of M. tuberculosis and other pathogenic 
mycobacteria, and is involved in zinc and iron homeostasis, although the mechanism whereby it 
functions is unclear. Furthermore the functions of ESX-2 and ESX-4 remain completely unknown. The 
presence of various of these ESX gene clusters in the fast-growing and non-pathogenic mycobacteria 
suggests that they perform important biological functions, from which the virulence related functions 
have evolved. Although M. tuberculosis has been studied extensively, little is understood of the 
mechanisms of pathogenicity of the organism. A better understanding of these secretion systems, 
which are essential for the virulence and survival of M. tuberculosis, may lead to novel developments 
in the treatment and prevention of tuberculosis disease. 
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7. Study Design 
7.1. Aim 
The aim of this study is to investigate the evolution, regulation and functions of the mycobacterial Type 
VII ESX secretion systems (T7SSs) and their substrates.  
7.2. Objectives 
1. To investigate the evolutionary history of the Type VII ESX secretion systems (T7SSs) by 
determining the presence of these systems in different mycobacterial and other actinobacterial 
species using in silico and phylogenetic analyses.  
2. To determine the regulation of the ESX secretion systems by identifying promoters responsible for 
the expression of each of the M. tuberculosis ESX gene clusters using a β-galactosidase promoter-
probe assay.  
3. To investigate the functions of the ESX secretion systems using comparative metabolomics and 
whole cell lysate and culture supernatant proteomic analyses of M. smegmatis wild-type and ESX 
knock-out strains.  
4. To identify novel substrates of the ESX secretion systems using comparative proteomic analyses of 
the culture supernatants of M. smegmatis wild-type and ESX knock-out strains.   
 MATERIALS AND METHODS 
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1. Bacterial strains and culture conditions 
1.1. Bacterial strains 
E. coli JM109, M. smegmatis mc
2
155
126
 and M. bovis BCG Pasteur 1173P2 (Table 1) were used in 
this study.  
1.2. Media and culture conditions  
Standard culture media are described in Table 2. Antibiotics and supplements are described in Table 
3. 
E. coli was cultured in liquid Luria-Bertani broth (LB) with shaking, and on LB agar plates, overnight at 
37°C. Solid and liquid media were supplemented with antibiotics; ampicillin (50 µg/ml) and kanamycin 
(50 µg/ml); and solid media additionally with 5-bromo-4-chloro-3-indolyl-β-galactoside (X-gal) and 
isopropyl-β-D-thiogalactopyranoside (IPTG); as appropriate. 
M. smegmatis was routinely grown in Middlebrook 7H9 Broth with shaking, and on BBL
TM
 Seven H11 
Agar Base plates, at 37°C for 2-3 days unless otherwise described. Kanamycin (25 µg/ml), sucrose 
(5%) and X-gal were added as appropriate. 
M. bovis BCG was routinely grown in Middlebrook 7H9 Broth with shaking, and on BBL
TM
 Seven H11 
Agar Base plates, at 37°C for 2-3 weeks unless otherwise described. Kanamycin (25 µg/ml), was 
added as appropriate. 
Bacterial strains used in this study were stored in 40% glycerol at -80°C. 
1.3.  Ziehl-Neelsen Staining 
All mycobacterial cultures were screened for contamination using Ziehl-Neelsen (ZN) staining 
according to standard protocol.
127
 Briefly, aliquots of mycobacterial cultures were heat-fixed to 
microscope slides. Slides were flooded with ZN Carbol Fuchsin (BD), heated intermittently with a 
flame until steaming, and allowed to stand for 5 minutes. Slides were rinsed with water, decolourised 
with 5% acid-alcohol solution for 2 minutes and rinsed with water. Slides were then counterstained 
with Methylene Blue (BD) for 1-2 minutes, rinsed with water and allowed to air dry. 
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Table 1. Bacterial Strains 
Strain Genotype Features Reference/Source 
E. coli JM109 
recA1, endA1, gyrA96, thi, hsdR17, supE44, relA1, 
Δ(lac-proAB)/F' [traD36, proAB+, lacIq, lacZΔM15 
Chloramphenicol resistance  
Methylation: dam+, dcm+ 
Blue-white selection + 
Laboratory strain 
M. smegmatis mc²155 ept-1 
Efficient plasmid transformation 
mutant of M. smegmatis mc²6 
Mycobacterial model organism 
126 
 
 
M. bovis BCG Pasteur 1173P2 ΔRD1 Attenuated strain of M. bovis  Institut Pasteur 
 
Table 2. Culture media 
Medium Composition Source 
Luria-Bertani broth (LB) 1% Tryptone, 0.5% Sodium chloride, 0.5% Yeast extract   
Luria-Bertani agar (LB agar) 
1% Tryptone, 0.5% Sodium chloride, 0.5% Yeast extract, 1.2% 
bacteriological agar 
 
SOB 
2% Tryptone, 0.5% Sodium chloride, 0.5% Yeast extract, 2.5 mM 
Potassium chloride,  
 
SOC 
SOC supplemented with 20 mM glucose and 10 mM Magnesium 
chloride after autoclaving 
 
Middlebrook 7H9 Broth (7H9) 
0.47% Middlebrook 7H9 Broth powder, supplemented with 0.2% 
glycerol, 0.05% Tween-80 and 10% ADC after autoclaving 
BD 
BBL
TM
 Seven H11 Agar Base (7H11) 
1.9% BBL
TM
 Seven H11 Agar Base powder, supplemented with 0.5% 
glycerol, 0.05% Tween-80 and 10% ADC after autoclaving 
BD 
Kirchener’s broth 
0.5% asparagine, 0.3% Na2HPO4, 0.4% KH2PO4, 0.25% Tri-sodium 
citrate, 1.07 g.liter-1 MgSO4, 2% glycerol, 0.05% Tween-80 
 
ADC 
5% bovine serum albumin fraction V (Roche), 2% glucose (Kimix), 1000 
U/ml catalase (Sigma), filter sterilised 
 
All media was prepared in deionised water and autoclaved at 121°C for 20 minutes. Concentrations of all dry components are given as % m/v, and 
liquids as % v/v.  
 Table 3. Antibiotics and supplements 
 
Stock 
concentration 
Solvent Sterilisation Storage Supplier Working concentration 
      E. coli 
M. smegmatis/ 
M. bovis BCG 
Ampicillin (amp) 50 mg/ml Deionised water filtered -20°C Roche 50 µg/ml n/a 
Kanamycin* (kan) 50 mg/ml  0.9% NaCl solution filtered 4°C Sigma 50 µg/ml 25 µg/ml 
Tetracycline (tet) 5 mg/ml Ethanol  -20°C Sigma 50 µg/ml n/a 
        
5-bromo-4-chloro-3-indolyl-β-
galactoside (X-gal) 
20 mg/ml N,N'-dimethyl formamide  
-20°C,  
in foil 
Roche 
100 µl spread on 90 mm 
plate 
Isopropyl-β-D-
thiogalactopyranoside  (IPTG) 
0.1 M Deionised water filtered -20°C Biosolve 
100 µl spread on 90 mm 
plate 
Potassium Chloride (KCl) 1 M Deionised water 
autoclaved, 
121°C, 20min 
RT Merck   
Magnesium Chloride* (MgCl2) 1 M Deionised water filtered RT Sigma   
Glucose  1 M Deionised water filtered -20°C Merck   
Polyoxyethylene-sorbitan 
monooleate (Tween 80) 
20% v/v Deionised water filtered 4°C Sigma  0.2% v/v 
Sucrose 50% v/v Deionised water filtered 4°C Merck  5% v/v 
ADC  Deionised water filtered 4°C   10% 
*Supplements and antibiotics purchased in solution  
 
 Slides were read using a light microscope under the 100X (oil immersion) lens. Uncontaminated 
mycobacterial cultures contained only acid fast bacilli (pink rods). 
1.4. Preparation of electrocompetent cells 
1.4.1. Electrocompetent E. coli  
E. coli JM109 cells were inoculated into 50 ml LB containing tetracycline (50 µg/ml) and shaken 
overnight at 37ºC. Overnight cultures were inoculated into fresh antibiotic-containing medium, at a 
dilution of 1:100, and grown to OD600 = 0.7 at 37ºC, with shaking. Cultures were placed on ice and all 
further steps performed under ice-cold conditions. Cells were harvested by centrifugation at 4000 xg 
for 10 minutes at 4ºC. The cell pellet was resuspended in an equal culture-volume of ice-cold 10% 
glycerol and centrifuged at 4000 xg for 10 minutes at 4ºC. The wash step was repeated and the cells 
pooled in a 50 ml falcon tube and centrifuged at 4000 xg for 10 minutes at 4ºC. The cells were 
resuspended in ice-cold 10% glycerol using a volume of 2 ml per liter of culture. Aliquots of 100 µl 
were prepared, frozen in liquid nitrogen and stored at -80ºC. 
1.4.2. Electrocompetent M. smegmatis and M. bovis BCG 
M. smegmatis mc
2
155 and M. bovis BCG cells were inoculated into Middlebrook 7H9 medium and 
grown to OD600 = 0.5, at 37ºC with shaking. Cultures were incubated on ice for 1 hour and all further 
steps performed under ice-cold conditions. Cells were pelleted by centrifugation at 3000 xg for 10 
minutes at 4ºC, resuspended in ice-cold 10% glycerol equal to the culture volume and pelleted. The 
wash step was repeated and the cells resuspended in ice-cold 10% glycerol using a volume of 2 ml 
per 100 ml of culture. Electrocompetent M. smegmatis and M. bovis BCG were freshly prepared 
before use. 
2. DNA manipulation 
2.1.  PCR amplification 
Primers were designed using Primer Premier 5.0 (PREMIER Biosoft International) and obtained from 
Integrated DNA Technologies (IDT). Appropriate restriction endonuclease cutting sites were 
incorporated as necessary to facilitate cloning procedures. FastStart Taq DNA Polymerase (Roche) 
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and HotStarTaq (Qiagen) were used for PCR amplification using the GC-rich and Q-buffers 
respectively, as described by the manufacturers. Elongation times were calculated at 1 minute per 1 
kb. Thirty-five cycles were used unless otherwise stated. 
2.2.   Restriction Digestion 
Plasmid DNA was digested using restriction endonucleases as per manufacturer’s instructions, using 
the appropriate buffers. Two to five micrograms of plasmid DNA was digested using 10 U of enzyme in 
a total volume of 10-20 µl for 2-5 hours at 37°C. All restriction endonucleases were obtained from New 
England Biolabs (NEB), Roche, Promega or Fermentas. 
2.3.  Agarose gel electrophoresis 
PCR products and restriction digestions were separated by electrophoresis at 80-100 V on 1.0 to 1.5% 
agarose gels in TAE buffer (40 mM Tris, 20 mM Acetic acid, 1 mM Ethylenediamine tetraacetic acid 
(EDTA)) with ethidium bromide and visualized using UV light. The GeneRuler
TM
 100 bp DNA Ladder 
Plus, ready-to-use (Fermentas) was used to determine band size. When necessary the resultant 
bands were excised from the gel and purified.  
2.4.  DNA clean-up 
The Wizard
®
 SV Gel and PCR Clean-up System (Promega) was used to purify DNA embedded in 
agarose gel slices and directly from a PCR or restriction endonuclease reaction. 
2.5.  DNA quantification 
DNA was quantified using the NanoDrop
®
 ND1000 Spectrophotometer. 
2.6.  DNA sequencing 
Automated sequencing was done by the Central Analytical Facility (CAF) at Stellenbosch University, 
using the ABI 3130XL Genetic Analyzer (Applied Biosystems) in combination with the corresponding 
DNA primers.   
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2.7.  Cloning vectors 
All inserts were cloned into the commercial T-vector, pGem-T-Easy (Promega), and subcloned into the 
relevant vectors described in Table 4. 
Table 4. Vectors  
Vector Description Reference/Source 
pGem-T Easy E. coli cloning T-vector, amp
R
, lacZ, oriE Promega 
pBluescript II KS Cloning vector, amp
R
, lacZ, oriE Stratagene 
pJem15 
Promoter probe vector used for creating transcriptional 
fusions with lacZ, kan
R
, oriE, oriM 
A kind gift from J. Rauzier128 
p2NIL 
E. coli cloning vector, mycobacterial suicide vector, oriE, 
kan
R
 
A kind gift from E. Machowski
129
 
pGOAL17 
Plasmid with lacZ and sacB genes in PacI cassette, oriE, 
amp
R
 
A kind gift from E. Machowski
129
 
amp
R
 - ampicillin resistance; lacZ - β-galactosidase gene; oriE - origin of replication in E. coli; kan
R
 - 
kanamycin resistance; oriM - origin of replication in mycobacteria; sacB - levansucrose activity 
2.8.  Dephosphorylation 
Linearized vectors were dephosphorylated using Shrimp Alkaline Phosphatase (SAP, Roche) to 
prevent self-ligation of the digested plasmids. One unit of SAP was added to 1 µg digested vector 
DNA with the appropriate buffers, according to the manufacturer’s instructions. The reaction was 
incubated for 10 minutes at 37°C, followed by deactivation for 15 minutes at 65°C.  
2.9.  Ligations 
PCR and restriction digest products were ligated into appropriate vectors using T4 DNA Ligase 
(Promega), according to manufacturer’s instructions. Inserts were ligated into 100 ng of vector at an 
insert:vector molar ratio of 3:1 using 3 U of T4 DNA Ligase, and incubated at 4°C overnight.  Ligation 
reactions were deactivated at 70°C for 10 minutes prior to electrotransformation. 
2.10. Transformations 
All transformations of E. coli, M. smegmatis and M. bovis BCG were by electroporation of 
electrocompetent cells, using the Gene Pulser
TM
 (Bio-Rad) in 0.2 cm Gene Pulser
®
 Cuvettes (Bio-
Rad).  
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E. coli was transformed at 2.5 kV, 25 µF, 125 µFd, 200 Ω using 2 ul of a 10 µl ligation reaction, or 1 µg 
of plasmid DNA, in 45 µl of electrocompetent cells. One milliliter of SOC was added to the transformed 
cells which were recovered for 30-60 minutes at 37°C before plating on appropriate solid media.  
One microgram of purified plasmid DNA was transformed into 200 µl of electrocompetent M. 
smegmatis or M. bovis BCG at 2.5 kV, 25 µF, 125 µFd, 1000 Ω followed by the addition of 1 ml 7H9 
medium and expression for 3 or 4 hours, respectively, at 37°C before plating on appropriate solid 
medium. 
2.11. Colony PCR 
All transformants were confirmed by colony PCR using 1 µl of culture in a 12.5 ul PCR reaction as 
described under PCR amplification. 
2.12. Miniprep plasmid isolation 
Plasmid DNA was isolated from E. coli using the Wizard
®
 Plus SV Minipreps DNA Purification System 
(Promega), according to manufacturer’s instructions, and eluted in 50 µl nuclease-free water 
(Promega). 
2.13. Cloning 
Inserts were amplified by PCR using specific PCR primers. The PCR products were separated by 
electrophoresis, purified and ligated into pGem-T-Easy according to the manufacturer’s instructions. 
The ligation mixture was transformed into competent E. coli and selected for on appropriate LB agar. 
Colonies were picked and inoculated into LB media. Colony PCRs were done to confirm the insert and 
the construct was isolated. The resultant constructs were sequenced using Sp6 and T7 primers to 
confirm the sequence of the inserts. 
The constructs were digested using the primer-specific restriction endonucleases and the inserts 
separated by electrophoresis, cut from the gel and purified. The purified inserts were ligated into the 
pre-digested expression or suicide vectors, as appropriate, and transformed into E. coli. Transformed 
colonies were picked, colony PCR done and the constructs isolated and sequenced to verify the 
sequence of relevant inserts.  
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3.  Protein techniques 
3.1.  Culture fractionation 
Mycobacterial cultures were separated into cell pellet and culture supernatant by centrifugation at 
2500 xg for 10 minutes at 4°C. All subsequent steps were performed on ice.  
3.1.1. Whole cell lysate (WCL) sample preparation 
The cell pellet was washed twice, and resuspended in the appropriate volume of lysis buffer. A volume 
of 0.1 mm silica beads equal to the volume of the cell pellet was added and the cells were 
mechanically lysed in a BIO 101/Savant FastPrep FP120, 6 times for 20 seconds at 4.0 m.s
-1
, with 1 
minute intervals on ice. Cell debris was pelleted by centrifugation at 13000 xg, and the supernatant 
retained as the whole cell lysate fraction (WCL). When appropriate, protease inhibitors (Calbiochem 
Protease Inhibitor Cocktail set III, Merck) and DNase I (NEB) were added prior to disruption and WCL 
fractions were filtered using a 0.22 µm syringe filter (Millipore) to remove unlysed cells and to sterilise 
samples. WCL samples were stored at  -20°C or -80°C. 
3.1.2. Culture filtrate (CF) sample preparation  
The culture supernatant was sequentially filtered through 0.45 µm and 0.22 µm syringe filters 
(Millipore) to remove any remaining cells, to produce the culture filtrate fraction. CF samples were 
stored at -20°C or -80°C. 
3.2.  Protein quantification 
The protein concentrations of samples were determined spectrophotometrically using the Bio-Rad 
Protein Assay with either the 1 x Quick Start™ Bradford Dye Reagent or the RC DC™ Protein Assay. 
The Quick Start™ Bovine Serum Albumin Standard Set (BSA concentration range 0.125 mg/ml – 2 
mg/ml) was used to generate a standard curve. 
The assay using the 1 x Quick Start™ Bradford Dye Reagent was done according to standard 
microtiter plate procedure, as described by the manufacturer. Protein samples were measured in 
undiluted, 1:10 and 1:100 dilutions, in duplicate. Standards were measured in triplicate. Ten microliters 
of each sample and standard were pipetted into separate microtiter wells. Two hundred microliters of 
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Dye Reagent was added to each well, and mixed. The samples were incubated at room temperature 
for 5 minutes. Absorbance was measured at 595 nm (read within 1 hour). 
The RC DC™ Protein Assay was done according to manufacturer’s instructions; using undiluted and 
5x diluted protein samples, as appropriate. Proteins were precipitated with 125 µl of the RC Reagents 
I and II, redisolved in 127 µl DC Reagent A’, and the concentrations read at 595nm after a 15 minute 
incubation with 1 ml DC Reagent B (read within 1 hour). 
Standard curves were plotted from the BSA standard absorbance readings, and sample 
concentrations determined from the standard curve. 
3.3. SDS-PAGE 
3.3.1. Sample preparation 
Laemmli Buffer was added to each protein sample to a final concentration of 60 mM Tris-Cl pH 6.8, 
2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.01% bromophenol blue. The samples were mixed 
and incubated at 95°C for 5 minutes.   
3.3.2. Precast gradient gel SDS-PAGE 
Criterion
TM
 XT Precast Gels (4-12% Bis-Tris, 1.0 mm, 12 well, 45 µl, BIO-RAD) were used for high 
resolution separation of complex protein samples in XT MOPS running buffer (BIO-RAD). Samples 
were electrophoresed at 150 V until the front reached the bottom of the gel. PageRuler
TM
 Prestained 
Protein Ladder (Thermo Scientific) was run alongside the samples as an indication of size and 
separation. 
3.3.3. Protein gel staining 
Protein gels were stained with Imperial
TM 
Protein Stain (Thermo Scientific), for 2 hours with gentle 
shaking. Gels were destained overnight in deionised water, with gently shaking.  
3.3.4. Dot Blotting 
Protein samples were spotted on Hybond-P PVDF membrane and allowed to dry. The membrane was 
blocked in blocking buffer (Table 5) for 1 hour at room temperature, with gentle shaking. The blocked 
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membrane was rinsed twice in Tris-buffered saline with Tweeen-20 (TBS-T, Table 5) and washed 3 
times for 10 minutes in TBS-T with shaking. Five milliliters of primary antibody, at the appropriate 
dilution, was added to the membrane and shaken at room temperature for 1 hour. The membrane was 
rinsed twice in TBS-T, and washed 3 times for 10 minutes in TBS-T with shaking. The membrane was 
then probed with 5 ml secondary antibody (at the appropriate dilution) for 1 hour at room temperature, 
washed as before and placed in a sealable plastic bag. The membrane was incubated in ECL 
detection fluid (ECL Plus Western Blotting Detection System, AEC Amersham™) according to 
manufacturers instructions. The detection fluid was removed, the membrane attached to a piece of 
Whatmann paper and placed in a cassette. Signal was detected for 1 minute to 1 hour with 
autoradiographic film. 
Table 5. Dot blotting buffers 
Buffer Composition Diluent Storage 
TBS-T 20 mM Tris (pH 7.6) Water RT 
 137 mM NaCl   
  0.1% Tween-20     
Blocking buffer 10% m/v fat free milk powder TBS-T RT 
 1% m/v Bovine serum albumin   
  10 mM Azide     
 
 
4. In silico and phylogenetic analyses 
4.1. DNA and protein sequences 
All protein and DNA sequence information was obtained from publicly available finished and 
unfinished genome sequencing information. The species and their associated URL’s, sequencing 
source and level of completion are given in Table 6.  
4.2. Comparative genomic analyses of the ESX gene clusters 
M. tuberculosis ESX protein sequences of interest were used as templates to identify orthologous ESX 
protein and gene sequences. Blast similarity searches, blastn, tblastn and blastp,
130
 were done using 
NCBI Blast and the genome sequence databases listed in Table 6. Where possible adjacent genomic 
regions were searched for additional ESX genes to determine clustering and arrangement of genes; 
for unfinished genomes in contig format this was not always possible and gene cluster arrangement 
was assumed based on sequence similarity and anticipated arrangement. Large intergenic regions 
were searched for gene insertions using blastx analyses.
131
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Table 6. Mycobacterial and closely related actinomycete genome sequencing information 
Species Website Sequencing centre 
 M. abscessus CIP 104536T http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi Genoscope 
 M. africanum GM041182 
http://www.sanger.ac.uk/cgi-
bin/blast/submitblast/mycobacterium 
Wellcome Trust Sanger Insititute 
 M. avium 104 http://cmr.jcvi.org/cgi-bin/CMR/GenomePage.cgi?org=gma TIGR 
 M. avium paratuberculosis K-10 http://cmr.jcvi.org/cgi-bin/CMR/GenomePage.cgi?org=ntma03 University of Minnesota 
 M. bovis AF2122/97 http://genolist.pasteur.fr/BoviList/ Sanger Institut/Pasteur Institut 
 M. bovis BCG Pasteur 1173P2 http://genolist.pasteur.fr/BCGList/ Pasteur Institut 
 M. canetti CIPT140010059 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi Wellcome Trust Sanger Insititute 
 M. chubuense http://blast.ncbi.nlm.nih.gov/Blast.cgi? DOE Joint Genome Institute 
*M. colombiense CECT3035 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi NCBI 
 M. gilvum PYR-GCK http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi US DOE Joint Genome Institute 
 M. intracellulare http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
Department of Microbiology and 
Immunology, Seoul National 
University 
*M. kansasii 12479 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi McGill University 
 M. leprae TN http://genolist.pasteur.fr/Leproma/ Sanger Institut/Pasteur Institut 
 M. marinum M http://genolist.pasteur.fr/MarinoList/ Wellcome Trust Sanger Institute 
*M. massiliense CCUG48898 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi Chungnam National University 
*M. microti 19422 
http://www.sanger.ac.uk/cgi-
bin/blast/submitblast/mycobacterium  
Sanger Institut  
*M. parascrofulaceum BAA-614 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi Baylor College of Medicine 
*M. phlei RIVM601170 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi KAUST 
*M. rhodesiae NBB3 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi JGI 
 M. smegmatis mc2155 http://cmr.jcvi.org/cgi-bin/CMR/GenomePage.cgi?org=gms TIGR 
 M. sp. JDM601 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
Shanghai Jiao Tong University 
School of Medicine 
 M. sp. JLS http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi US DOE Joint Genome Institute 
 M. sp. KMS http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi DOE Joint Genome Institute 
 M. sp. MCS http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi DOE Joint Genome Institute 
 M. sp. MOTT36Y http://blast.ncbi.nlm.nih.gov/Blast.cgi? 
Seoul National University College 
of Medicine 
 M. sp. Spyr 1 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi US DOE Joint Genome Institute 
 M. thermoresistibile 19527 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi NCBI 
 M. tuberculosis H37Rv http://genolist.pasteur.fr/TubercuList/ Sanger Institut/Pasteur Institut 
*M. tusciae JS617 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
DOE Joint Genome Institute;  
JGI-PSF 
 M. ulcerans Agy99 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi Pasteur Institut 
 M. vanbaalenii PYR-1 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi DOE Joint Genome Institute 
*M. xenopi RIVM700367 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
Center for Biotechnology, Bielefeld 
University 
 N. farcinica IFM 10152 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
Department of Bioactive Molecules, 
National Institute of Infectious 
Diseases 
 R. opacus B4 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
National Institute of Technology 
and Evaluation 
 R. erythropolis PR4 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
National Institute of Technology 
and Evaluation 
 R. equi 103S http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
International Rhodococcus equi 
Genome Consortium 
 G. bronchialis DSM43247 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
US DOE Joint Genome Institute 
(JGI-PGF) 
 C. diphtheriae NCTC 13129 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi Sanger Institut 
 C. pseudotuberculosis http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
Center for Biotechnology, Bielefeld 
University 
 B. subtilis str. 168 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
NCBI, Baylor College of Medicine, 
Human Genome Sequencing 
Center, Baylor College of Medicine 
 L. monocytogenes L312 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi 
NCBI, ERA-NET / Spatelis, Institute 
for Microbiology and Genetics, 
Georg-August University 
Goettingen, Justus-Liebig-
University Giessen 
 S. aureus USA300 http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi NISC 
*Sequencing projects are incomplete. 
 4.3. Phylogenetic analyses of the ESX gene clusters 
Annotated protein sequences were obtained from the protein sequence databases. The protein 
sequences of conserved components of each ESX gene cluster (EccA, EccB, EccC, EccD, EccE, 
PE(s), PPE(s), Esx (CFP-10-like), ESX (ESAT-6-like), EspG, EspI, MycP, Rv3446c, EspJ, EspK, 
EspL, EspB, Cyp143 and Ferredoxin) were combined and multiple sequence alignments of all ESX 
gene cluster combined protein sequences were done with Clustal W 2.0 
132,133
 using the Bioedit 
Sequence Alignment Editor version 7.1.3.0.
134
 Similarly, multiple sequence alignments of a single 
sequence, composed of all of the combined ESX gene cluster protein sequences (ESX-4, -3, -1, -2, -5 
and any additional ESX gene clusters), from each species were done. The PAUP 4.0b10 neighbor-
joining algorithm was used for phylogenetic analyses using the combined protein multiple sequence 
alignments.
135
 One thousand subsets were generated for bootstrapping resampling of the data. 
Confidence intervals of greater than 50% for the internal topology of the trees were considered 
significant. The C. diphtheria and L. monocytogenes protein sequences were used as outgroups. 
Consensus trees were calculated using the majority rule formula and phylograms were generated 
using Treeview 1.6.6.
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5. Promoter assays 
5.1.  Selection of intergenic regions 
Intergenic regions of the M. tuberculosis ESAT-6 gene cluster regions 1 to 5 were selected in silico 
from the M. tuberculosis H37Rv genome sequence based on size. Intergenic regions of less than 
40bp were excluded from the study due to a lower probability of containing a promoter sequence. 
5.2.  DNA manipulation 
The pJEM15 ESX intergenic region-containing promoter probe constructs were obtained from 
previous studies (Table 7). The intergenic regions were amplified using HotStarTaq (Qiagen) and 
cloned into the mycobacterial-E.coli promoter-probe shuttle vector, pJEM15,
128
 a gift from J. Rauzier 
Institut Pasteur, Paris, France, to create transcriptional fusions of the intergenic regions with a 
promoterless lacZ operon.  All constructs were confirmed by DNA sequencing.  
 Table 7. pJEM15 promoter probe constructs, and relevant primers, used in the identification of the ESX gene cluster promoters. 
 
 
  
Construct 
Name of 
primer 
Primer sequence (5' - 3') 
Primer 
length 
Tm 
(ºC) 
Intergenic region covered 
Product 
length 
Construct generated by 
ESX-4 
pJem34478 
Rv34478f GGATCCACCAGGATGTCCGCAGTCG 25 bp 64.9 From 41bp inside Rv3447c to 
Rv3448 
154 bp 
M. Newton-Foot 
Rv34478r GGTACCTCTCCCCCTTTATTCTCGGAT 27 bp 60.8 
pJem34487 
Rv34487f GGATCCTCCCGGATCAGACGTAGGC 25 bp 64 From 21bp inside Rv3448 to 
Rv3447c 
160 bp 
Rv34487r GGTACCGCTGGGCGACGGTATGCAG 25 bp 67.1 
pJem34510 
Rv34510f GGATCCATGTCAGCAGGCGGATGG 24 bp 63.9 From 31bp inside Rv3451 to 
Rv3450c 
180 bp 
Rv34510r GGTACCTGGCTCTCCCACGGTGGC 24 bp 67.4 
ESX-3 
pJem8182 
T028182f GTTCGCCCGCAACACCCT 18 bp 60 From 40 bp inside Rv0281 to 18 
bp inside Rv0282 
281 bp 
N.C. Gey van Pittius 
T028182r TTCACCTACGCCCGCCAT 18 bp 58 
pJem8687 
T028687f GACCGCAACCAAAGAACGC 19 bp 60 From 184 bp inside Rv0286 to 
40 bp inside Rv0287 
273 bp 
T028687r GAGGCCACCAACTGTGGGATA 21 bp 66 
pJem8990 
T028990f TGGGTCTCCACCTTCAGCC 19 bp 62 From 135 bp inside Rv0289 to 
68 bp inside Rv0290 
249 bp 
T028990r GCCATCTCGGTCAACCTGCT 20 bp 64 
ESX-1 
pJem 6364 
386364f TCGAAGCACTGATCCGTCAGATCAA 25 bp 74 From 28bp inside Rv3863 to 
Rv3864 
272 bp 
J. Botha 
386364r TTTATGTGTTTCCTTACGCTCGCCG 25 bp 74 
pJem6465 
386465f GACAAGAAGGAAGACGAGGAAGGCG 25 bp 78 From 101 bp inside Rv3864 to 
Rv3865 
190 bp 
386465r TGGGTTGAACCCTCCTCTACGTTTA 25 bp 74 
pJem7172 
387172f GTTAAGATTATTTCATTGCCGG 22 bp 60 From 4bp inside Rv3871 to 2bp 
inside Rv3872 
149 bp 
387172r ATTTGCCTACTTCTTCCCTCC 21 bp 62 
pJem7374 
T387374f GCAGGAGCGTGAAGAAGAC 19 bp 60 From 55 bp inside Rv3873 to   
94 bp inside Rv3874 
241 bp N.C. Gey van Pittius 
T387374r CCTGGTCGATCTGGGTTTT 19 bp 58 
pJerm7576 
387576f TCACTGGGATGTTCGCATAGGGC 23 bp 72 From 19bp inside Rv3875 to 
Rv3876 
134 bp 
J. Botha 
387576r TGACAACCTCTCAGAGTGCGCTCAA 25 bp 76 
pJem8483 
388483f GTTTGGTAGCAGCCGCATAT 20 bp 60 From 8bp inside Rv3884c to 
Rv3883c 
231 bp 
388483r CTCCCAGAACACTCCATTCGTT 22 bp 66 
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Table 7. continued 
  Construct 
Name of 
primer 
Primer sequence (5' - 3') 
Primer 
length 
Tm 
(ºC) 
Intergenic region covered 
Product 
length 
Construct generated 
by 
ESX-2 
pJem38854 
Rv38854f GGATCCCCGCTATGTCAGCCTTGA 24 bp 62.6 From 46bp inside Rv3885c to 
22bp inside Rv3884c 
137 bp 
M. Newton-Foot 
Rv38854r GGTACCTCGTGTCCACCATTCTCG 24 bp 60.9 
pJem38898 
Rv38898f GGATCCCCGGCGTGTGGTGTGAAT 24 bp 65.5 From 16bp inside Rv3889c to 
22bp inside Rv3888c 
131 bp 
Rv38898r GGTACCGGTCATTCCACGGGTTCG 24 bp 63.5 
pJem389089 
Rv389089f GGATCCCCATCGCGGGCTTGTTCT 24 bp 65.4 From 20bp inside Rv3890c to 
22bp inside Rv3889c 
137 bp 
Rv389089r GGTACCCATCGACCGTCGTCGTCA 24 bp 64.1 
pJemPAN 
Panf CGCGACGGTGCGTGTTGT 18 bp 60 From 16bp inside Rv3892c to 
34bp inside Rv3891c 
178 bp J. Botha 
Panr CATCTGCGGTGTTACCTGAA 18 bp 60 
pJem38932 
Rv38932f GGATCCTTGCCGAACACGCCAGTC 24 bp 64.1 From 41bp inside Rv3893c to 
Rv3892c 
119 bp 
M. Newton-Foot 
Rv38932r GGTACCGCCTACTTACCCTTGCAGC 25 bp 63.1 
pJem39843 
Rv38943f GGATCCAGGGGATTTTGGTGGGGTAT 26 bp 62.3 From 44bp inside Rv3894c to 
Rv3893c 
310 bp 
Rv38943r GGTACCGTTCGCCCCTCCGATTGCTT 26 bp 66.3 
pJem38976 
Rv38976f GGATCCAGGTTAAGGAATAGTCGCCCTG 28 bp 61.8 From 7bp inside Rv3897c to 
23bp inside Rv3896c 
186 bp 
Rv38976r GGTACCCCAATCCTGTGCCATGTGC 25 bp 64 
ESX-5 
pJem178182 
Rv1781-82f GGATCCTCGGGCAAGTTCGACCAG 24 bp 58 From 100bp inside Rv1781 to 
100bp inside Rv1782 
265 bp 
R.G. van der Merwe 
Rv1781-82r GGTACCGCCACGCTAGATCACCT 23 bp  54 
pJem178384 
Rv1783-84f GGATCCCAGCGGGTTGCCCACATT 24 bp 
 
58 From 100bp inside Rv1783 to 
100bp inside Rv1784 
71 bp 
Rv1783-84r GGTACCATGGTGTCGGTCCGGCTA 24 bp  58 
pJem178687 
Rv1786-87f GGATCCGAAATGGCGCTCATCCT 23 bp 52 From 100bp inside Rv1786 to 
100bp inside Rv1787 
270 bp 
Rv1786-87r GGTACCCAACCAGTCCTCCCTCTC 24 bp 58 
pJem178788 
Rv1787-88f GGATCCCGCTAGGGTCGCGGATC 23 bp 58 From 100bp inside Rv1787 to 
100bp inside Rv1788 
79 bp 
Rv1787-88r GGTACCCATGCGATCTCCTGCTTA 24 bp 54 
pJem178990 
Rv1789-90f GGATCCATGGCTCGCCCACCCTTC 24 bp 60 From 100bp inside Rv1789 to 
100bp inside Rv1790 
454 bp 
Rv1789-90r GGTACCGTCCATTCCGAACCCTTT 24 bp 54 
pJem179091 
Rv1790-91f GGATCCGTCTCCGTCGGCGGGATA 24 bp 54 From 100bp inside Rv1790 to 
100bp inside Rv1791 
427 bp 
Rv1790-91r GGTACCGACATGCTGTCTTCCTCT 24 bp 54 
pJem179192 
Rv1791-92f GGATCCGAGGCGGCCAACGCAG 22 bp 56 From 100bp inside Rv1791 to 
100bp inside Rv1792 
144 bp 
Rv1791-92r GGTACCCATGTTGCCTGTCTCCTTA 25 bp 58 
pJem179394 
Rv1793-94f GGATCCACAGCGCCGTCGGCTCCA 24 bp 62 From 100bp inside Rv1793 to 
100bp inside Rv1794 
88 bp 
Rv1793-94r GGTACCGATCCATCGCTACCTCAGC 25 bp 60 
pJem179495 
Rv1794-95f GGATCCAGTGGAAAACACACAGCA 24 bp 52 From 100bp inside Rv1794 to 
100bp inside Rv1795 
272 bp 
Rv1794-95r GGTACCCATCGTCCTGTACCCCCT 24 bp 58 
 The amplicons of the ESX intergenic regions were cloned into pJEM15 via one of two methods. The 
primers, intergenic regions cloned and construct details are given in Table 7. Intergenic regions from 
ESX-3, ESX-1 and the PAN promoter from ESX-2 were cloned via a 3-step cloning method. Briefly, the 
selected intergenic regions were amplified and cloned into pGEM-T Easy (Promega). The inserts were 
digested out of pGEM-T Easy at the vector specific EcoRI restriction sites and subcloned into the 
EcoRI site in pBluescript II KS (Stratagene). The BamHI / KpnI fragments were excised from 
pBluescript II KS and cloned into the corresponding sites in the mycobacterial-E.coli promoter-probe 
shuttle vector pJEM15. The intergenic regions from ESX-4, ESX-2 (excluding the PAN promoter) and 
ESX-5 were cloned via a 2-step protocol which omitted pBluescript II KS by introducing a BamHI and 
KpnI into the specific PCR primers. Inserts were excised from pGEM-T Easy using BamHI and KpnI 
and subcloned directly into compatible sites in pJEM15. 
5.3.  β-galactosidase activity 
M. smegmatis and M. bovis BCG were electrotransformed with the intergenic region-containing 
pJEM15 constructs, and selected on Difco Seven H11 Agar base containing kanamycin (25 µg/ml). 
Single colonies were picked and grown in Middlebrook 7H9 medium with kanamycin, washed and 
inoculated into 10 ml Kirchener’s broth and grown to mid log phase (OD600 = 0.6-0.8). The cells were 
pelleted and lysed in 500 µl PBS, as described in section 3.1.1. Protein concentrations were 
determined using the 1 x Quick Start™ Bradford Dye Reagent (section 3.2). β-galactosidase activity 
was quantitatively assayed in liquid medium according to the method described by Pardee et. al. 
(1959)
137
 and Timm et. al. (1994)
128
, adapted for microtitre plates. Equal quantities of protein (1 g) 
were diluted to 50 ul in PBS and incubated with o-nitrophenyl--D-galactoside (ONPG) in 2X Assay 
Buffer (200 mM Sodium phosphate, pH7.3; 2 mM MgCl2, 100 mM β-mercaptoethanol, 1.33 mg/ml 
ONPG) at 37°C for 30 minutes. The reaction was stopped by adding 150 ul of 1 M sodium 
bicarbonate. -galactosidase activity was measured spectrophotometrically at 420nm. One unit of -
galactosidase is defined as producing 1 Mole o-nitrophenol per minute from o-nitrophenyl--D-
galactoside at 28C, pH 7.0. (1 Mole/ml o-nitrophenol has an optical density at 420 nm of 0.0075). β-
galactosidase units were calculated as 200 x OD420 /mg of protein/minute, where OD420 was corrected 
by subtracting 1.65 x OD550. The assays were performed triplicate and duplicate in M. smegmatis and 
M. bovis BCG, respectively. 
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5.4.  Identification of promoter sequence motifs 
The Berkeley Drosophila Genome Project (BDGP) Neural Network Promoter Prediction Search 
(http://www.fruitfly.org/seq_tools/promoter.html
138
) and the Softberry BPROM Promoter Predictor 
(http://linux1.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb) were used 
to screen the DNA sequences of the intergenic regions which showed promoter activity for possible 
promoter elements. Multiple sequence alignments of promoter-containing intergenic regions were 
done with the program ClustalW 2.0 on the Clustal W WWW server at the European Bioinformatics 
Institute website, http://www.ebi.ac.uk/Tools/msa/clustalw2/,
133
 to identify sequence motifs which are 
conserved across different mycobacterial species.  
5.5.  Divalent metal cation regulation of the ESX-3 promoter 
For the investigation of ESX-3 promoter regulation by divalent metal cations, the M. smegmatis ESX-3 
promoter region was amplified from genomic DNA (f primer: GGATCCGACGCTGAACGAGTG and r 
primer: GGTACCCTGACCACATCGCGG; Tm = 62) and cloned into the BamHI and KpnI restriction 
sites in pJem15 to produce pJemESX-3sm, using the two-step process described above. The M. 
tuberculosis and M. smegmatis ESX-3 pJem promoter constructs, pJem8182 and pJemESX-3sm, were 
transformed into M. smegmatis and pJem8182 additionally into M. bovis BCG. Cultures were grown in 
Kirchener’s medium which was treated with Chelex-100 (Biorad) overnight,
50
 to chelate any divalent 
metal cations, filtered and supplemented with MgS04 (1g/L). The culture medium was supplemented 
with individual metal cations: ZnSO4 (100µM), Ferric ammonium sulphate (100µM), ZnSO4 and Ferric 
ammonium sulphate (100µM ea), CoCl2 (7.5µM), NiCl2 (35µM), CuCl2 (50uM), Pb(CH3COO)2 (10µM) 
and MnSO4 (0.75µM).
139
 Cultures were grown to OD600 = 0.6, whole cell lysates were prepared and β-
galactosidase activity assayed as described above. 
6. Knock-out construction 
An ESX knock-out library was created in M. smegmatis using homologous recombination
140
 to delete 
each ESX gene cluster present in this mycobacterium, either individually or in combination, as 
described in Table 8.  
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6.1. Culture conditions 
For knock-out construction, M. smegmatis was grown in liquid LB with shaking, and on LB agar plates, 
for 4-5 days at 37°C (LB was used instead of Middlebrook media, as the sugars in Middlebrook 7H9 
medium are toxic to single crossover knock-out cultures containing the counterselectable marker sacB 
gene).  Liquid LB medium was supplemented with 0.1% Tween-80, and kanamycin (25 µg/ml, Sigma) 
when required. Solid LB medium was supplemented with kanamycin (25 µg/ml, Sigma), X-gal (Roche) 
and 5% sucrose, as required. 
6.2.  DNA manipulation 
Briefly, 500-1000 bp of DNA directly upstream of (Upsmeg) and downstream (Downsmeg) of each 
ESX gene cluster was amplified from M. smegmatis mc
2
155 genomic DNA using primers containing 
specific restriction sites (Table 9). The Upsmeg and Downsmeg fragment pairs were simultaneously 
cloned into the appropriate restriction sites of the p2NIL suicide vector via three-way cloning, to create 
p2NIL_UpDownSmeg. The lacZ-sacB marker gene cassette was digested out of pGOAL17 using PacI 
and inserted into the PacI site of p2NIL_UpDownSmeg to create the suicide vectors p2NIL_ESX-4 
KO, p2NIL_ESX-3 KO, p2NIL_ESX-1 KO.  
6.3.  Generation of ESX knock-out strains 
The knock-out constructs were transformed into M. smegmatis mc
2
155. Single recombinants were 
selected on kanamycin and X-gal, and passaged to allow a second recombination event to occur, 
double recombinants were counterselected on sucrose. Wild type and ESX knock-out M. smegmatis 
were differentiated by PCR using primers specific for either the wild type or knock-out strain (Table 
10). The M. smegmatis ESX knockouts were confirmed by sequencing across the deleted region.  This 
process was repeated using the single knock-out strains as parental strains to create double and triple 
M. smegmatis ESX knock-out strains.  
 
 Table 8. M. smegmatis ESX knock-outs 
Parent 
strain 
Deletion(s) Specific region(s) deleted Name used 
Knockout construct  
made by 
Knockout  
generated by 
M. smegmatis wild-type  WTms   
M. smegmatis ΔESX-4  MSMEG_1534-MSMEG_1539 ΔESX-4ms  M. Smit (MSc) M. Smit (MSc) 
M. smegmatis ΔESX-3 MSMEG_0615-MSMEG_0626 ΔESX-3ms M. Newton-Foot (MSc) M. Newton-Foot (MSc) 
M. smegmatis ΔESX-1 MSMEG_0057-MSMEG_0083 ΔESX-1ms N. Steyn (Hons) N. Steyn (Hons) 
M. smegmatis ΔESX-3; ΔESX-4 
MSMEG_0615-MSMEG_0626 
ΔESX-3ΔESX-4ms  
This study 
MSMEG_1534-MSMEG_1539 
M. smegmatis ΔESX-1; ΔESX-4 
MSMEG_0056-MSMEG_0083 
ΔESX-1ΔESX-4ms  This study 
MSMEG_1534-MSMEG_1539 
M. smegmatis ΔESX-1; ΔESX-3 
MSMEG_0056-MSMEG_0083 
ΔESX-1ΔESX-3ms  This study 
MSMEG_0615-MSMEG_0626 
M. smegmatis ΔESX-1; ΔESX-3; ΔESX-4 
MSMEG_0056-MSMEG_0083 
ΔESX-1ΔESX-3ΔESX-4ms  This study MSMEG_0615-MSMEG_0626 
MSMEG_1534-MSMEG_1539 
 
Table 9. Primers used to generate the M. smegmatis knock-out constructs 
Knock-out 
construct 
Primer name Primer sequence 
Length 
(bp) 
Tm (°C) 
Restriction 
site 
WT Product 
size 
(bp) 
p2NIL_ESX-4 
KO 
UpstreamR4 f GGGGGTCGACGACGAGGAAGAGGCG 25 62 SalI 57bp upstream of 
MSMEG_1534 
778 
UpstreamR4 r GGGGTTCGAACCGTGCTGTGAACGAAACCC 30 60 SfuI 
DownstreamR4 f GGGGTTCGAACGGACTGACTCGTTGGAGCG 30 64 SfuI 100bp downstream of 
MSMEG_1539 
747 
DownstreamR4 r GGGGAAGCTTCCGCGCAGTCGCCCGT 26 62 HindIII 
p2NIL_ESX-3 
KO 
R3 Upsmeg f GGGGTACCGGAGCATCCGCTGCAGACC 27 64 KpnI 28bp upstream of 
MSMEG_0615 
828 
R3 Upsmeg r GGGGAGATCTCTCTCCCTTATGTATGCC 28 54 BglII 
R3 Downsmeg f GGGGAGATCTCGATCCCAGTGCTCCCACA 29 62 BglII 58bp downstream of 
MSMEG_0626 
830 
R3 Downsmeg r GGGGAAGCTTCCCGAGCGATCCTTTCC 27 56 HindIII 
p2NIL_ESX-1 
KO 
UpReg1smeg f GGTACCAGTCGAACCTGGGCAAGCG 25 62 KpnI 219 bp upstream of 
MSMEG_0056 
824 
UpReg1smeg r AGATCTTCGGCGTATTCGCAGCACC 25 62 BglII 
DownReg1smeg f AGATCTCCCCAACAAGAATTGATCCG 26 60 BglII 29bp upstream of 
MSMEG_0083 
845 
DownReg1smeg r AAGCTTTTGTTCAGCGAGCCCGAG 24 58 HindIII 
Restriction enzyme sites are underlined 
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Table 10. M. smegmatis ESX knock-out verification primers. 
ESX 
deletion 
Validation 
PCR 
Primer 
name 
Primer sequence 
Length 
(bp) 
Tm 
(°C) 
Product 
size (bp) 
Product description 
ESX-4 
R4 F1 
R4 F1 f GAGATCGCGATGGCCATCGCC 21 
65 694 
Amplifies from within Upsmeg R4 into 
MSMEG_1534 (only amplifies in WT and SCO) R4 F1 r CGCGTAACCGGTTGCCGTGCC 21 
R4 F2 
R4 F2 f CCAACGCCTGGGGCGTCTGAT 21 
65 647 
Amplifies from within Downsmeg R4 into 
MSMEG_1539 (only amplifies in WT and SCO) R4 F2 r CTGCACGGCAACCTGTCGCAG 21 
R4 F1F2 
R4 F1 f GAGATCGCGATGGCCATCGCC 21 
65 
1159 Amplifies across Upsmeg R4 and Downsmeg 
R4(only amplifies in ΔESX-4ms and SCO) R4 F2 r CTGCACGGCAACCTGTCGCAG 21 
 
ESX-3 
R3 F1 
R3 F1 f GCAGTGGTTCTCCGAGCGTGG 21 
60 798 
Amplifies from within Upsmeg R3 into 
MSMEG_0615 (only amplifies in WT and SCO) R3 F1 r ACGACGTCCGACCAGCGTTGG 21 
R3 F2 
R3 F2 f CGCTGAACCCGTTGTCGACCG 21 
60 550 
Amplifies from within Downsmeg R4 into 
MSMEG_0626 (only amplifies in WT and SCO) R3 F2 r GTTCGGTGATGGACCATCTGG 21 
R3 KO 
R3 KO f TCCTTCTTTGCGCTGGTCTT 20 
60 822 
Amplifies across Upsmeg R3 and Downsmeg R3 
(only amplifies in ΔESX-3ms and SCO) R3 KO r TGTCGCTGCCGTGGTTCT 18 
ESX-1 
R1 F1 
R1 F1 f GAGGTGCTCGACAGCGAGGC 20 
60 880 
Amplifies from within Upsmeg R1 into 
MSMEG_0056 (only amplifies in WT and SCO) R1 F1 r TCGCCAGCGGAATCAGTGCC 20 
R1 F2 
R1 F2 f GTTCGGATCGTTGGGATCCTGA 22 
60 920 
Amplifies from within Downsmeg R1 into 
MSMEG_0083 (only amplifies in WT and SCO) R1 F2 r GGTGTACCCGTATCCCTTTCCA 22 
R4 F1F2 
R1 F1 f GAGGTGCTCGACAGCGAGGC 22 
60 876 
Amplifies across Upsmeg R1 and Downsmeg R1 
(only amplifies in ΔESX-1ms and SCO) R1 F2 r GGTGTACCCGTATCCCTTTCCA 22 
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7. Metabolomics 
7.1.  Bacterial Strains 
The M. smegmatis mc
2
155 wild-type (WTms), ESX-4ms and ESX-3ms strains were used for 
metabolomic analyses.  
7.2.  Culture conditions 
WTms, ESX-4ms and ESX-3ms were cultured in 100 ml complete Middlebrook 7H9 medium with 
shaking, at 37 ºC to mid log (OD600 = 0.6-0.8). Samples were prepared for extraction as previously 
described by Jaki et al., (2006).
141
 In short, the cells were washed twice with phosphate buffered 
saline (PBS), collected via centrifugation, snap frozen in liquid nitrogen, lyophilized and stored at  
-80ºC until extraction and GC/MS metabolomic analysis. Twelve individually cultured samples were 
prepared for each strain for the ESX-3 metabolome study and six for the ESX-4 metabolome study. 
 
7.3. GC-MS whole metabolome analysis 
GC-MS whole metabolome analysis was done in collaboration with Prof. Loots at the Centre for 
Human Metabonomics, North-West University, South Africa. The metabolite extraction, GC-MS 
analysis, data processing and statistical analyses described in sections 7.3.1 to 7.3.4 were performed 
by Mr Reinart J. Meissner-Roloff in Prof. Loots’ group. 
7.3.1. Extraction method 
Five milligrams of each lyophilized M. smegmatis sample was weighed into a microcentrifuge tube and 
extracted as previously described.
142
 All reagents are described in Table 11. Briefly, 50 µl of phenyl 
butyric acid (0.104 µg/ml) was added as an internal standard, followed by chloroform, methanol and 
water, in the ratio 2.5:7.5:2.5. The sample was briefly vortexed and extracted using a vibration mill with 
a carbide tungsten bead (Retsch) for 5 minutes at 30 Hz.s-1. The sample was centrifuged for 5 min at 
12 000 rpm and the supernatant transferred to a GC-MS sample vial and dried under a stream of 
nitrogen at room temperature. Samples were derivitised using 50 µl methoxyamine hydrochloride 
(containing 15 mg/ml pyridine) at 50 ºC for 90 minutes, followed by 50 µl  MSTFA with 1% TMCS at 50 
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ºC for 60 minutes.
143
 The samples were transferred to a 0.1 ml insert in a GC-MS sample vial and 
capped prior to GC-MS analysis.   
Table 11. Reagents used for metabolomics analyses 
Reagent Abbreviation Source 
methoxamine hydrochloride 
 
Sigma Aldrich 
n-methyl-n-(trimethylsilyl) trifluoroacetamide  MSTFA Sigma Aldrich 
trimethylchlorosilane TMCS Sigma Aldrich 
pyridine 
 
Sigma Aldrich 
3-phenylbutyric acid 
 
Burdick and Jackson 
chloroform 
 
Burdick and Jackson 
methanol 
 
Burdick and Jackson 
hexane   Burdick and Jackson 
 
7.3.2. GC-MS analysis 
An Agilent 7890A gas chromatograph coupled to an Agilent 5975B mass selective detector, equipped 
with a 7683B injector and 7683 autosampler, was used to analyze the extracted samples. A VF1-MS 
capillary column (30m x 250µm i.d., 0.25 µm film thickness) was used to achieve separation in the GC.  
The extracts were analyzed by injecting 1 µl of sample in splitless mode. The injector temperature was 
held at a constant 250 ºC for the total run time and the GC oven temperature was initially held at 50 ºC 
for 1 min after injection, followed by an increase in temperature of 10 ºC/min, until a temperature of 
240 ºC was reached. This was followed by an increase of 20 ºC/min to a final temperature of 300 ºC, 
at which it was maintained for 7 min. The carrier gas used was helium and the flow rate was kept at a 
constant 1.2 ml/min.  The MS detection was set to scan mode from m/z 50-559. 
7.3.3. GC-MS data processing 
GC-MS chromatograms were deconvoluted using the freely available AMDIS32-V2.65 (Automated 
Mass Spectral Deconvolution System) software, where automatic curve resolution was applied to the 
chromatograms. Raw GC-MS data was analyzed at a threshold of 0.01% of the total signal. 
Compound peaks were aligned across all samples analysed as previously described.
144
 A data matrix 
was compiled containing the relative concentrations of all the aligned compound peaks present in 
each individual sample of each group (in order to normalise the data using the internal standard). This 
data matrix was used in the multi- and univariate statistical data analyses in order to identify the 
markers characterising the groups. 
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7.3.4. Statistical data analysis 
Due to the complexity of the GC-MS data, data pretreatment using a non-parametric transformation
145
 
was necessary prior to statistical analysis to provide a balanced representation of all the metabolites 
present. The pretreated data was then processed using multivariate statistical analyses, in the form of 
a principle component analysis (PCA) and a partial least squares discriminate analysis (PLS-DA).  
PCA is considered an unsupervised learning method and is often used to summarise the data as 
principle components (PCs) and determine if natural separation between the sample groups exists, by 
plotting the principal component scores. The modeling power of each variable in the PCA was also 
determined and used to rank the variables in order of relevance. PLS-DA is a supervised pattern 
recognition method. The PLS-DA model can be used to predict the group membership of an unseen 
sample based on its metabolic profile. The VIP value of each variable (i.e., those metabolites that are 
important in the PLS-DA projection) was calculated and used to rank the metabolites. For each 
selected metabolite, a non-parametric Mann-Whitney U test was performed to access the univariate 
importance of the metabolite and a value of < 0.05 was considered significant. Effect sizes were also 
calculated for all selected metabolites.
146
 Effect sizes provide information concerning the practical 
relevance of a statistically relevant result. An effect size of >0.5 is considered to be highly relevant, 
>0.3 potentially relevant and <0.1 irrelevant. All statistical analyses were performed using SPSS 
version 18, and the R statistical package version 2.13.   
8. Proteomics 
8.1.  Bacterial Strains 
The M. smegmatis mc
2
155 WTms, ESX-1ms, ESX-3ms and ESX-4ms strains were used for all 
proteomic analyses.  
8.2.  Sample preparation 
8.2.1. Whole cell lysate (WCL) sample preparation 
For whole cell lysate proteomic analyses, M. smegmatis strains were grown, in duplicate, in 50 ml 
Middlebrook 7H9 medium, in the absence of bovine serum albumin (bovine serum albumin was 
omitted from the ADC), with shaking, at 37°C to mid log (OD600= 0.6-0.8). Cells were disrupted, as 
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described in section 3.1.1, in 600 µl Tris lysis buffer (5 mM Tris, pH 7.6, 0.005% Tween-80) with 
protease inhibitors and 10 µl DNase, filtered and stored at -80°C. Protein concentrations were 
determined using the Biorad RC DC™ Protein Assay.  
8.2.2. Culture filtrate (CF) sample preparation 
For culture filtrate proteomic analyses, M. smegmatis strains were grown in Middlebrook 7H9 medium, 
without bovine serum albumin and catalase to mid log (OD600 = 0.6-0.8), washed in the same 7H9 
medium, without Tween-80, and reinoculated, in duplicate, in 200 ml Middlebrook 7H9 medium, 
without bovine serum albumin, catalase and Tween-80, to OD600 = 0.005. Cultures were grown with 
shaking, at 37°C to early log phase (OD600= 0.3). Tween-80 was omitted to reduce leakage of 
intracellular proteins due to the effect of the detergent on the cell membrane structure. Catalase and 
BSA were omitted as the high concentrations of these proteins would mask the presence of the 
extracellular proteins. Culture filtrate fractions were prepared as described in section 3.1.2 and 
concentrated using Amicon Ultra Centrifugal Filters (Ultracel - 3K, Millipore) with a 3kDa molecular 
weight cut off. Concentrated samples were desalted with PBS (1000x dilution). Protein concentrations 
were determined using the Biorad RC DC™ Protein Assay and appropriate amounts of protein were 
lyophilised and resuspended in 30µl Laemmli buffer. 
To determine the amount of cell lysis which occurred during culturing and centrifugation, serial 
dilutions of WCL and culture filtrate sample prepared from the same culture were dot blotted using a 
mouse IgG2a monoclonal anti-GroEL2 antibody (Colorado State University, 1:50) and an HRP-
conjugated goat anti-mouse IgG polyclonal antibody (Santa Cruz Biotechnology, 1:5000). Lysed cells 
were determined to be between 10
-3 
to 10
-4
% of the cells in the culture. 
8.3.  Sample fractionation 
All protein samples were fractionated on Criterion
TM
 XT 4-12% Precast Gels. Sixty micrograms of each 
WCL sample and 50 µg of each CF sample were fractionated in duplicate (each strain was analysed in 
technical duplicates of in biological duplicates, i.e. 4 replicates). Each lane (sample relicate) was cut 
into 10 or 6 fractions for WCL and CF, respectively. 
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8.4. MS sample preparation 
All reagents used for MS sample preparation are described in Table 12. 
Table 12. MS sample preparation buffers 
Abbreviation Compound Source 
Working  
concentration 
Diluent 
ABC 
Ammonium  
bicarbonate 
Sigma 
50 mM  LCMS Cromasolv water (Sigma) 
25 mM LCMS Cromasolv water (Sigma) 
     
ACN Acetonitrile Sigma 
50% LCMS Cromasolv water (Sigma) 
70% LCMS Cromasolv water (Sigma) 
100% 
 
     DTT DL-Dithiothreitol Sigma 10 mM 25 mM ABC 
     IAA Iodoacetamide Sigma 55 mM 25 mM ABC 
     FA Formic acid Sigma 0.10% 70% ACN 
     
 
Trypsin Promega 
20 µg dissolved in 200 ul resuspension buffer  
       (aliquot and store at -80C) 
dilute 20 ul resuspended trypsin with 180 ul 50mM ABC 
activate diluted trypsin at 30C for 15 minutes before use 
 
8.4.1. Drying of gel pieces 
Each gel lane was excised and cut into fractions using a clean scalpel. Each gel fraction was cut into 
small pieces. The gel pieces were washed 3 times with 300 µl of water, for 10 minutes. Thereafter, the 
gel pieces were washed alternately with 300 µl of 50% ACN and 300 µl of 50 mM ABC, for 10 minutes 
each, until the blue colour was reduced. Three hundred microliters of 100% ACN was added to each 
fraction for about 10 minutes, until the gel pieces turned white. The ACN was removed and the gel 
pieces dried in a Concentratorplus (Eppendorf). Dried gel pieces can be stored at -20°C for 2 months. 
8.4.2. Reduction, acetylation and trypsin digestion 
One hundred and twenty microlitres of 10 mM DTT was added to the dried gel pieces and incubated 
for 1 hour at 56°C. The gel pieces were washed with 200 µl of 50 mM ABC and 200 µl 50% ACN for 1 
minute each, followed by incubation with 120 µl 55 mM IAA for 60 minutes, in the dark. Gel pieces 
were washed with 300 µl of 50 mM ABC for 10 minutes and 300µl of 50% ACN for 20 minutes, and 
dried in the Concentratorplus (Eppendorf). Eighty microliters of activated trypsin was added to each 
gel fraction, and incubated at 37°C for 17 hours. 
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8.4.3. Peptide extraction 
Eighty microlitres of 70% ACN, 0.1% FA was added to each fraction, for 30 minutes and the 
supernatant was removed to a clean microcentrifuge tube. This was repeated and 100% ACN was 
added to remove any additional peptide-containing water from the gel pieces. The peptides were dried 
in the Concentratorplus (Eppendorf) and stored at -20°C. 
8.4.4. Stage tip cleanup 
When an additional C18 stage tip cleanup step was included, the combined peptide-containing 
supernatant was reduced to 30 µl in the Concentratorplus (Eppendorf) and 20 µl of 5% formic acid 
was added to each sample. Stage tips were prepared by punching out disks of Empore
TM
 Octadecyl 
C18 Extraction disks (SUPELCO Analytical) and wedging them into a P200 pipette tip. The column 
was activated with 50 µl methanol and washed with 50 µl 5% formic acid, using a 2.5 ml COMBITIP 
PLUS (Eppendorf). The sample was run through the stage tip twice, and washed with 50 µl 5% formic 
acid. Sample peptides were eluted from the tip with 50 µl 80% ACN, 5% formic acid and dried in the 
Concentratorplus (Eppendorf).  
8.5.  LC-MS/MS analysis 
LC-MS/MS analysis was done on the LTQ Orbitrap Velos (Thermo Scientific) in collaboration with Dr 
S. Smit at the MS Proteomics unit of CAF, Stellenbosch University, who performed the LC-MS/MS 
analysis, initial data acquisition, differential expression and statistical analyses.  
Dried peptides were dissolved in 5% acetonitrile in 0.1% formic acid and 10 µl injections were made 
for nano-LC chromatography. All  experiments were  performed on  a Thermo  Scientific  EASY-nLC II 
connected to a LTQ Orbitrap Velos mass spectrometer (Thermo Scientific, Bremen, Germany) 
equipped with a nano-electrospray source. For liquid chromatography, separation was performed on a 
EASY-Column (2 cm, ID 100µm, 5 µm, C18) pre-column followed by a EASY-column (10 cm, ID 75 
µm, 3 µm, C18) column with a flow rate of 300 nl/min. The gradient used was from 5-17 % B in 5 min, 
17-35% B in 90 min, 35-60% B in 10 min, 60-80% B in 5 min and kept at 80% B for 10 min. Solvent A 
was 100% water in 0.1 % formic acid, and solvent B was 100% acetonitrile in 0.1% formic acid. 
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The mass spectrometer was operated in data-dependent mode to automatically switch between  
Orbitrap-MS and LTQ-MS/MS acquisition. Data was acquired using the Xcaliber software package. 
The precursor ion scan MS spectra (m/z 400 – 2000) were acquired in the Orbitrap with resolution R = 
60000 with the number of accumulated ions being 1 x 10
6
. The 20 most intense ions were isolated and 
fragmented in linear ion trap (number of accumulated ions 1.5 x 10
4
) using collision induced 
dissociation. The lock mass option (polydimethylcyclosiloxane; m/z 445.120025) enabled accurate 
mass measurement in both the MS and MS/MS modes. In data-dependent LC-MS/MS experiments, 
dynamic exclusion was used with 60 s exclusion duration. Mass spectrometry conditions were 1.8 kV, 
capillary temperature of 250 °C, with no sheath and auxiliary gas flow. The ion selection threshold was 
500 counts for MS/MS and an activation Q-value of 0.25 and activation time of 10 ms were also 
applied for MS/MS. 
8.6. Data Analysis 
Thermo Proteome Discoverer 1.3 (Thermo Scientific, Bremen, Germany) was used to identify proteins 
via automated database searching (Mascot, Matrix Science, London, UK, and Sequest) of all tandem 
mass spectra against the M. smegmatis database obtained from TBDB (TB Database).
147
 
Carbamidomethyl cysteine was set as fixed modification, and oxidized methionine, N-acetylation, 
deamidation (NQ), Gln to pyro-Glu and Glu to pyro-Glu was used as variable modifications. The 
precursor mass tolerance was set to 20 ppm, and fragment mass tolerance set to 0.8 Da. Two missed 
tryptic cleavages were allowed. Proteins were considered positively identified when they were 
identified with at least 1 tryptic peptide per protein. Proteins were searched and quantified using the 
Andromeda function from Maxquant 1.2.2.5.
148
 Relative protein concentrations were determined and a 
minimum two fold difference in protein abundance was considered significant. The T-test with a 
significance level of 0.05 was used to determine the statistical relevance of differential protein 
abundances. Protein functions and pathways were determined using Smegmalist
149
 
(http://mycobrowser.epfl.ch/smegmalist.html) and KEGG (Kyoto Encyclopedia of Genes and 
Genomes, http://www.kegg.jp/kegg/). 
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RESULTS AND DISCUSSION 
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1. The evolution of the mycobacterial Type VII ESX secretion systems 
1.1. Introduction 
The ESX gene clusters are found within all members of the genus Mycobacterium and have also been 
identified in the genomes of closely related actinomycetes outside of the genus.
27
 Furthermore, 
clustered WXG (or Esx-like) and FtsK/SpoIIIE proteins have been identified in gram-positive 
monoderm genera such as Bacillus, Listeria and Saccharomyces.
39
 Here we investigate the presence 
and absence of the ESX gene clusters in the genomes of the sequenced mycobacteria and other 
closely related actinomycetes, in comparison to identified WXG-FtsK clusters of other species, in order 
to determine the evolutionary history of the Type-VII ESX secretion systems. 
1.2. Results 
1.2.1. The ESX gene clusters of sequenced mycobacteria and other actinomycetes 
Whole genome sequences of thirty-two mycobacterial species and seven additional actinomycetes 
were analysed in this study (Materials and Methods, Table 6). The protein sequences of the M. 
tuberculosis H37Rv ESX-1, 2, 3, 4 and 5 secretion system components were used to identify orthologs 
in the other species. Intergenic regions were searched to identify any additional gene insertions and 
the arrangement of each ESX gene cluster was determined and is represented in Figure 1.1. Each of 
the 39 species studied contains between 1 and 7 ESX gene clusters. The ESX gene clusters were 
named ESX-1 to ESX-5 based on protein sequence similarity and gene arrangement similarity to the 
clusters in M. tuberculosis H37Rv. Clusters which could not be classified as one of the five ESX gene 
clusters were named based on the plasmid or contig on which they occur. Three additional WXG-FtsK 
clusters, identified from the literature,
39, 150
 from three separate species, Staphylococcus aureus, 
Listeria monocytogenes, Bacillus subtilis, are also included in Figure 1.1. 
Orthologs of the ESX-4 gene cluster were identified in seven non-mycobacterial actinomycetes of the 
genera Corynebacterium, Rhodococcus and Nocardia. An additional ESX gene cluster which includes 
orthologs of eccA, eccE, espG, espI, pe and ppe genes, in addition to the ESX-4 components, was 
identified in N. farcinica, and named ESX-3AN (ancestral ESX-3). The arrangement of the genes in this 
cluster does not resemble that of any of the M. tuberculosis ESX gene clusters. M. abscessus, the 
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most ancestral mycobacterium studied, and M. massiliense contain ESX-4 and ESX-3, while all the 
other sequenced fast-growing mycobacteria, M. thermoresistibile, M. smegmatis, M. vanbaalenii, M. 
gilvum, M. sp. Spyr1, M. rhodesiae, M. phlei , M. sp JLS, M. sp. KMS and M. sp MCS, contain copies 
of ESX-4, ESX-3 and ESX-1, with the exception of M. chubuense which appears to have undergone 
deletions of ESX-3 and most of ESX-1. All of the studied slow-growing mycobacteria contain a copy of 
ESX-5, while some species appear to have lost their copies of ESX-1 (M. avium, M. avium 
paratuberculosis, M. colombiense, M. intracellulare, M. parascrofulaceum, M. ulcerans, M. xenopi, M. 
sp. MOTT36Y and M. sp. JDM601) and ESX-2 (M. leprae, M. marinum and M. ulcerans). M. leprae, 
with its reduced genome, has retained only ESX-3, ESX-1 and ESX-5. Partial deletions of ESX-1, 
previously described as RD1, occur in M. bovis BCG and M. microti. 
33, 34, 79-81
 
Additional ESX gene clusters were identified on plasmids within M. gilvum (pMFLV01), M. sp. KMS 
(pMKMS01 and pMKMS02), M. sp. MCS (Plasmid01) and M. chubuense (pMYCCH.01 and 
pMYCCH.02). pMKMS02 and M. sp. MCS Plasmid01 are the same plasmid occurring in both species, 
while the two ESX gene clusters on the two M. chubuense plasmids have the same gene 
arrangement. The four ESX gene clusters represented on these plasmids were named ESX-P1 (on 
pMFLV01), ESX-P2 (on pMKMS01), ESX-P3 (on pMKMS02 and M. sp. MCS Plasmid01) and ESX-P4 
(on pMYCCH.01 and pMYCCH.02), where “P” indicates the plasmid localisation of the ESX. ESX-P1 
to -P4 contain all of the core ESX components, including espG and espI. The ESX-P1 also 
incorporates EspH, while EccA is absent from ESX-P2 (Figure 1.1). The arrangement and composition 
of these gene clusters most closely resemble ESX-3 and ESX-1. 
The incomplete genome sequences of M. parascrofulaceum and M. tusciae each contain 7 copies of 
the ESX gene cluster, four of which most closely resemble ESX-2 (Figure 1.1). The arrangement and 
sequences of specific protein components of the clusters vary, supporting their classification as 
independent gene clusters. Based on gene arrangement and sequence similarity, the M. tusciae ESX 
gene cluster on contig 212 was classified ESX-2AN (ancestral ESX-2), those on contigs 196 and 209 
as ESX-P2 and on contig 224 as ESX-P3. The M. parascrofulaceum ESX on contig 312/318 was 
defined as ESX-2, while those on contigs 115, 17 and 109 were classified as ESX-P2, ESX-P4 and 
ESX-P5 respectively. The M. parascrofulaceum and M. tusciae sequencing projects are incomplete,  
 46 
 
Figure 1.1. The ESX gene clusters of sequenced mycobacteria and related actinomycetes. The 
WXG-FtsK gene clusters of S. aureus, L. monocytogenes and B. subtilis are as described in the 
literature. Gene families are represented as coloured arrows as indicated in the legend. ESX gene 
clusters identified, or predicted to be, on plasmids are named ESX-P1 to -P5. Pseudogenes are 
indicated as striped arrows. Insertions are indicated. Large insertions or genome rearrangements 
resulting in genes occurring elsewhere in the genome from the rest of the gene cluster are indicated 
as transpositions. Genes which are not annotated but for which translated nucleotide results were 
obtained using tblastn are indicated. The genome sequence of M. microti has not been annotated; 
therefore no gene names are given.  
Gene families 
 
 
S. aureus 
 
L. monocytogenes 
 
B. subtilis 
C. diphtheriae 
 
C. pseudotuberculosis 
 
G. bronchialis 
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Figure 1.1. continued  
R. equi 
R. erythropolis 
R. opacus 
 
N. farcinica 
M. abscessus 
 
M. massiliense 
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Figure 1.1. continued 
 
M. thermoresistibile 
 
M. smegmatis 
M. rhodesiae 
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Figure 1.1. continued  
M. sp. JLS 
 
M. phlei 
M. vanbaalenii 
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Figure 1.1. continued  
M. gilvum 
 
M. sp. KMS 
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Figure 1.1. continued  
 
M. sp. MCS 
M. chubuense 
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Figure 1.1. continued  
M. sp. Spyr1 
 
M. tusciae 
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Figure 1.1. continued 
M. kansasii 
M. tuberculosis 
  
 54 
 
Figure 1.1. continued 
M. africanum  
M. bovis 
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Figure 1.1. continued 
M. canetti 
M. bovis BCG 
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Figure 1.1. continued 
M. microti 
 
M. xenopi 
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Figure 1.1. continued 
M. sp. JDM601 
M. avium 
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Figure 1.1. continued 
M. avium paratuberculosis 
M. intracellulare 
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Figure 1.1. continued  
M. colombiense 
M. parascrofulaceum 
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Figure 1.1. continued 
 
M. sp. MOTT36Y 
M. ulcerans
M. marinum 
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Figure 1.1. continued 
M. leprae 
 
therefore it is not possible to determine whether the ESX gene clusters are plasmid or chromosomally 
located. Due to the similarity between some of these ESX and the ESX-P clusters, we predict that 
these ESX are plasmid located, or originate directly from plasmids. In addition to these four ESX-2-like 
gene clusters, the M. parascrofulaceum genome contains ESX-4, 3 and 5, while M. tusciae contains 
ESX-4, 3 and 1. 
1.2.2. The phylogeny of the ESX gene clusters 
To investigate the phylogeny of the ESX gene cluster, protein sequences of the components of each 
gene cluster (Supplementary Tables S1.1. to S1.9. EccA, EccB, EccC, EccD, EccE, PE, PPE, Esx 
(CFP-10), Esx (ESAT-6), EspG, EspH, MycP, Rv3446c, EspI, EspJ, EspK, EspL, EspB, Cyp143 and 
ferredoxin) were concatenated into a single amino acid sequence and aligned using ClustalW 2.0. A 
neighbour-joining tree was generated using PAUP and Treeview, using the C. diphtheria ESX gene 
cluster combined protein sequence as the outgroup (data not shown). Incorporation of the WXG-FtsK 
cluster protein sequences from S. aureus, L. monocytogenes and B. subtilis using the S. aureus 
sequence as the outgroup generated a similar phylogeny depicting evolution of the ESX gene cluster 
from a WXG-FtsK cluster progenitor (Figure 1.2). 
The 5 ESX gene clusters from the different species cluster together, as anticipated. Interestingly, the 
N. farcinica ESX-3AN gene cluster groups with the ESX-4 gene clusters, most similar to the  
G. bronchialis ESX-4 gene cluster, and not with any of the other mycobacterial ESX gene clusters.  
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Figure 1.2 indicates that a duplication of ESX-4 has evolved to produce the other ESX gene clusters 
via divergent evolution which produced the ESX-3 and ESX-1 gene clusters, and the ESX-2 and ESX-
5 gene clusters. The ESX-P1 to ESX-P5 gene clusters form outgroups to all four ESX gene cluster 
duplications subsequent to ESX-4. ESX-P3 associates with ESX-3 and ESX-P1 with ESX-1; ESX-P2 
associates with ESX-2, while ESX-P4 forms an outgroup to the ESX-2/ESX-P2 cluster; and ESX-P5 
clusters with ESX-5. ESX-2AN from M. tusciae predates the entire ESX-2/ESX-5 cluster, supporting its 
definition as the ancestor of ESX-2. 
1.2.3. The phylogeny of the mycobacteria based on ESX evolution 
A phylogenetic analysis of the mycobacteria and related actinomycetes based on their ESX gene 
clusters was done using the combined protein sequences of all of the ESX gene clusters of each 
species (Figure 1.3.). M. chubuense was omitted from these analyses as the unusual combination of 
ESX clusters resulting from the deletion of ESX-3 and parts of ESX-1, in the presence of the two ESX-
P2 plasmid ESX clusters, distorted the phylogeny. The Mycolata have evolved from a single ancestor 
into two groups, those which contain only ESX-4 (A), with the exception of N. farcinica which contains 
ESX-3AN, which appears to have evolved divergently of the mycobacterial ESX-3 (Figure 1.2); and the 
Mycobacteria, which have additional ESX gene clusters in addition to ESX-4 (B). The duplication 
event which resulted in ESX-3 marks the evolution of the mycobacteria. All mycobacteria contain at 
least ESX-4 and ESX-3. M. abscessus and M. massiliense are the most ancestral mycobacteria, 
containing only these two ESX gene clusters (C). The duplication which resulted in ESX-1 separates 
the rest of the mycobacteria (D), which are further divided into 2 groups. The group which contain only 
ESX-4, -3 and -1 includes the rest of the fast-growers (E) while the duplication of ESX-2 and ESX-5 
marks the evolution of the slow-growing mycobacteria (F). The slow-growers can be subgrouped 
further into those which have subsequently lost ESX-1 (G) and those which did not undergo this ESX-
1 deletion event (H). The M. avium complex species (I) can be distinguished from the rest of the 
species which have lost ESX-1 by the transposition of EccB and EccC from ESX-2. Of the species 
which have retained ESX-1, M. marinum and M. ulcerans have undergone a deletion of ESX-2 (J), 
and M. ulcerans has further lost ESX-1 (K). M. leprae, which has undergone extensive gene reduction, 
has retained only ESX-3, -1 and -5 (L), while M. kansasii and the M. tuberculosis complex species 
have retained all five ESX gene clusters (M). The RD1 deletions have removed parts of ESX-1 from 
M. microti and M. bovis BCG (N).   
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Figure 1.3. The phylogeny of the sequenced mycobacteria and closely related actinomyetes 
based on the evolution of the ESX gene clusters. The tree was drawn using alignments of the 
combined protein sequences of all the ESX gene cluster regions in each species, using S. aureus as 
the outgroup. Letters A-N represent ESX duplication and deletion events, as described in the text. The 
species which contain plasmid located ESX-P gene clusters are circled in blue. 
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1.3. Discussion 
The ESX gene clusters each encode a dedicated protein secretion system, the ESX secretion 
systems, which are responsible for the secretion of at least the Esx, Esp, PE and PPE proteins. It has 
been proposed that these ESX secretion systems be classified as a novel Type-VII secretion system, 
defined by its ability to transport proteins across the outer mycomembrane peptidoglycan-
arabinogalactan-mycolic acid matrix.
30
 Although secreted protein substrates of the ESX secretion 
systems have been identified in culture filtrates, the mechanism whereby they are secreted and the 
components responsible for translocation across the mycomembrane have not been elucidated. This 
has generated some controversy as some suggest that identification of a mycomembrane 
translocation mechanism and components are essential for the classification of a novel type of 
secretion system. Indeed, it has been suggested that ESX secretion systems occur outside of the 
Mycolata (species containing a mycomembrane-like outer membrane, including Corynebacteria, 
Rhodococci, Nocardia and Mycobacteria) and are therefore not typically involved in trans-
mycomembrane secretion.
151
 Esx-like (WXG100) proteins have been identified in a number of other 
Actinobacteria, Firmicutes and Chloroflexi which are typically monoderm bacteria. However, only a 
protein with FtsK/SpoIIIE domains (EccC-like) is frequently associated with the WXG100 proteins 
throughout the Firmicutes and non-mycolata Actinobacteria.
151
 This suggests that although the 
FtsK/SpoIIIE-like protein may be involved in translocation of the WXG100 proteins across a monoderm 
plasma membrane, the additional components of the ESX secretion systems, encoded in the ESX 
gene clusters, may enable the secretion of additional substrates and facilitate translocation across the 
mycomembrane as a Type VII secretion system.   
In this chapter we have explored the evolution of the mycobacterial Type-VII ESX gene clusters from 
the WXG-FtsK cluster in S. aureus, L. monocytogenes and B. subtilis, via the ancestral region in the 
Corynebacteria, Nocardia and Rhodococci to the 5 ESX gene clusters in M. tuberculosis, and the 
distribution of these gene clusters in the other mycobacteria. We have identified an additional ESX 
gene cluster in N. farcinica (ESX-3AN), which appears to be an ancestral ESX-3 which has evolved 
divergently of the mycobacterial ESX-3, as it clusters phylogenetically with the ESX-4 gene clusters. 
The ESX-3, -1, -2 and -5 gene clusters have evolved from a duplication of the ancestral ESX-4 cluster. 
The presence and absence of the ESX gene clusters in the various mycobacteria defines the order of 
duplication of the ESX gene clusters as ESX-4, ESX-3, ESX-1 and then ESX-2 and ESX-5.
30
  
 66 
 
The presence of ESX-3 marks the evolution of the mycobacteria, with M. abscessus and M. 
massiliense possessing only ESX-4 and ESX-3; while the rest of the fast growers also contain ESX-1. 
The progenitor of the slow-growers contained both ESX-2 and ESX-5, although various deletions of 
ESX regions have subsequently occurred in some species. One exception to this is M. tusciae, which 
is a slow-growing mycobacterium, which is phylogenetically grouped with the fast-growers. This 
classification is consistent with 16S rDNA sequencing results which showed that M. tusciae is most 
closely related to the fast-growing mycobacteria M. farcinogenes, M. komossense and M. aichiense.
152
 
This species contains several ESX gene clusters which appear to be precursors of the ESX-2 and 
ESX-5 gene clusters, which are associated with a slow-growing phenotype, and may contribute to its 
conflicting phenotype. 
Interestingly, we identified a number of ESX-containing plasmids in the fast-growing mycobacteria M. 
ssp. KMS and MCS, M. gilvum and M. chubuense, and seven ESX gene clusters in each of M. tusciae 
and M. parascrofulaceum. The plasmid ESX gene clusters as well as 3 and 4 of the M. 
parascrofulaceum and M. tusciae ESX gene clusters, respectively, form outgroups to the ESX-3, ESX-
1, ESX-2 and ESX-5 gene clusters, and appear to be precursors thereof. The ESX gene clusters on 
pMKMS02, M sp. MCS Plasmid01 and the M. tusciae contig 212 appear to be precursors of ESX-3 
(ESX-P3) and pMFLV01 of ESX-1 (ESX-P1). The ESX gene clusters on pMKMS01, pMYCCH.01, 
pMYCCH.02, M. tusciae contigs 209 and 196 and M. parascrofulaceum contig 115 are precursors of 
ESX-2 (ESX-P2), while M. parascrofulaceum contig 17 ESX is a predecessor of all of these (ESX-P4). 
M. parascrofulaceum contig 109 ESX is a precursor of ESX-5 (ESX-P5), and M. tusciae contig 212 
ESX predates all ESX-2 and ESX-5 gene clusters and their direct precursors (ESX-2AN).   
The M. parascrofulaceum and M. tusciae genome sequences have not been completed, and as such 
it remains unclear whether the additional ESX duplications are genomic or plasmid encoded. The 
close phylogenetic relationships between some M. tusciae and M. parascrofulaceum ESX gene 
clusters and the plasmid ESX gene clusters from M. spp. KMS and MCS, M. gilvum and M. 
chubuense suggests that at least some of these gene clusters may be, or have been, located on 
plasmids. If this is the case, it points to plasmid-mediated duplication and evolution of the ESX gene 
clusters. 
We propose an evolutionary pathway for the ESX gene clusters whereby they evolved from the 
original WXG-FtsK cluster into a complete ESX-4 gene cluster together with the evolution of the 
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mycomembrane in order to facilitate transport of proteins across it. ESX-4 incorporates genes 
encoding a mycosin protease (mycP), a transmembrane protein (eccB) and the predicted 
transmembrane pore (eccD). These proteins may be involved in a more complex secretion 
mechanism to transport proteins into and across the unique and complex outer membrane. MycP may 
be involved in the cleavage of proteins or other cell structures to enable the insertion of the EccD pore 
protein into the mycomembrane, through which proteins can be translocated, or in the release of 
secreted substrates from the secretion machinery. EccB may be involved in protein-protein 
interactions or stabilisation of the secretion complex.  
We hypothesise that ESX-4 was subsequently incorporated into plasmid DNA and evolved to form 
ESX-P3, which was inserted into the genome as ESX-3, and marks the evolution of the mycobacteria. 
ESX-P1 evolved divergently from ESX-P3 and was inserted into the genome subsequent to the 
evolution of M. abscessus and M. massiliense. ESX-P3 further diverged to form ESX-2AN, which 
evolved to form the ESX-2 pre-precursor ESX-P4 and the ESX-5 precursor ESX-P5. The ESX-P4 
evolved further to form ESX-P2 which was inserted into the genome and evolved to the current ESX-2. 
ESX-P5 was also incorporated into the genome and evolved as the current ESX-5. The incorporation 
of ESX-2 and ESX-5 into the mycobacterial genome marks the evolution of the slow-growing 
mycobacteria. The evolutionary pathway of ESX evolution is represented in Figure 1.4. Due to the 
extrachromosomal nature of the plasmids, bacteria are able to retain multiple plasmids containing 
different ESX clusters, enabling multiple evolutionary paths to occur simultaneously. Additionally, 
these plasmids may be lost from the bacteria before or after their incorporation into the chromosome; 
although plasmid DNA which confers a fitness advantage may be preferentially retained or 
incorporated.  
The presence of multiple ESX-2- and ESX-5-like ESX gene clusters, in the absence of ESX-2 and 
ESX-5, in M. tusciae, suggests that this species may be an evolutionary bridge between the fast- and 
slow growers. The conflicting genotypic and phenotypic classification regarding its growth rate 
provides further support for this, and may furthermore implicate the duplication of the ESX gene 
 68 
 
 
 
 
 
Figure 1.4. The evolutionary pathway of ESX evolution. The five M. tuberculosis ESX gene clusters evolved in the order 4, 3, 1, 2 and 5 via several 
plasmid located intermediaries, as described in the text. Black arrows represent duplication events and/or evolution of the ESX gene cluster. The genomic 
ESX are indicated in blue; plasmid located ESX are indicated in green.  
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clusters in the reduced growth rate of the slow-growing mycobacteria. ESX-5 is the only ESX gene cluster 
which is present in all of the slow-growers but absent in all of the fast-growers, and although deletion of this 
region does not directly increase the growth rate of M. marinum or M. tuberculosis, 
61, 125
 investigation of its 
potential association with growth rate may provide important understanding of the evolution of the often 
pathogenic slow-growing mycobacteria. 
1.4. Conclusion 
The duplication and evolution of the ESX gene clusters and their secretion systems have clearly impacted on 
the evolution, diversity and success of the mycobacteria. Although the function(s) of ESX-4 have yet to be 
determined, the presence and maintenance of this gene cluster throughout the mycobacteria and related 
actinomycetes suggests that it plays an important, though non-essential, role in bacterial metabolism. ESX-3 
has co-evolved with the mycobacteria, and although essential for in vitro growth of M. tuberculosis, it is not 
essential in the fast-growing M. smegmatis,
54
 and has been completely lost from the genome of M. 
chubuense. Genetic reduction during evolution of the slow-growers may have eliminated the redundancy of 
ESX-3 in the fast-growers. ESX-1 has been implicated in virulence, and its deletion in attenuation of the 
pathogenic mycobacteria.
82-84
 However, this gene cluster is present throughout most of the mycobacteria, 
including non-pathogenic and saphrophytic fast-growing organisms, suggesting that the primary function of 
this gene cluster is not virulence, and that the virulence-function has evolved more recently in pathogenic 
organisms. The function(s) of ESX-2 have also not been elucidated, and although its duplication correlates 
evolutionarily with both the slow-growing and pathogenic phenotype, it has been lost from some of these 
bacteria. Only ESX-5 has been retained throughout the slow-growing and pathogenic mycobacteria. ESX-5 
has been implicated in immune evasion and may be the ESX gene cluster most involved in pathogenicity 
and the slow growing phenotype.
124
 The presence of additional copies of ESX gene clusters in various 
species and on plasmids has pointed to a novel plasmid-mediated mechanism of genome evolution, via 
duplication and insertion of ESX gene clusters, in mycobacteria. 
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Supplementary Tables S1.1. to S1.9. The components of the ESX gene clusters of the sequenced 
mycobacteria and related actinomycetes. PS - annotated pseudogene; NA - gene is not annotated but 
orthologous sequence identified using tblastn; M. microti was omitted as the genome sequence has not been 
annotated 
 
Table S1.1. The components of the ESX gene clusters of S. aureus, L. monocytogenes, B. subtilis,  
C. diphtheria, C. pseudotuberculosis and G. bronchialis 
  
S. aureus L. monocytogenes B. subtilis C. diphtheriae C. pseudotuberculosis G. bronchialis 
ESX-4 EccB 
   
DIP0552 cpfrc_00395 Gbro_3295 
 
MycP 
   
DIP0554 cpfrc_00397 Gbro_1681 
 
EccD 
   
DIP0555 cpfrc_00398 Gbro_1682 
 
EccC 
SAV0287/ 
SAV0288 
lmo0061 
CAB04782/ 
CAB04781 
DIP0556 cpfrc_00399 Gbro_1683 
 
Rv3446c 
   
DIP0557 cpfrc_00400 Gbro_1684 
 
EsxU SAV0290 lmo0063 
 
DIP0558 cpfrc_00401 Gbro_ 3643 
 
EsxT SAV0282 lmo0056 CAB04773 DIP0559 cpfrc_00402 Gbro_3644 
  
SAV0287-
SAV0288 
is a single 
gene 
  
Insertion 
DIP0553 
Insertion cpfrc_00396 
2 transposition 
events 
ESX-3 
 
ABSENT  ABSENT   ABSENT  ABSENT  ABSENT  ABSENT 
ESX-1 
 
ABSENT  ABSENT   ABSENT  ABSENT  ABSENT  ABSENT 
ESX-2 
 
ABSENT  ABSENT   ABSENT  ABSENT  ABSENT  ABSENT 
ESX-5 
 
ABSENT  ABSENT   ABSENT  ABSENT  ABSENT  ABSENT 
 
Table S1.2. The components of the ESX gene clusters of E. equi, E. erythropolis, R. opacus,  
N. farcinica, M. abscessus and M. massiliense 
    R. equi R. erythropolis R. opacus N. farcinica M. abscessus M. massiliense 
ESX-4 EccB REQ_35500 RER_18880 ROP_62200 Nfa_8470 MAB_3759c MMAS_36350 
 
MycP REQ_34490 RER_18890 ROP_62210 Nfa_8490 MAB_3758 MMAS_36340 
 
EccD REQ_34480 RER_18900 ROP_62220 Nfa_8500 MAB_3757 MMAS_36330 
 
EccC REQ_34470 
RER_18910/ 
RER19000 
ROP_62230 Nfa_8510 MAB_3756c MMAS_36320 
 
Rv3446c REQ_34460 RER_19010 ROP_62240 Nfa_8520 MAB_3755c MMAS_36310 
 
EsxU REQ_34450 RER_19020 ROP_62250 Nfa_8530 MAB_3754c MMAS_36300 
 
EsxT REQ_35440 RER_19030 ROP_62260 Nfa_8540 MAB_3753c MMAS_36290 
   
8 ORF insertion in 
EccC, includes 
recombinase  
Insertion 
Nfa_8480  
MMAS_36360 is 
EccE 
ESX-3 EccA 
 ABSENT ABSENT  ABSENT 
Nfa_8260 MAB_2234c MMAS_20690 
 
EccB Nfa_8250 MAB_2233c MMAS_20680 
 
EccC Nfa_8290 MAB_2232c MMAS_20670 
 
PE5 Nfa_8180 MAB_2231c MMAS_20660 
 
PPE4 Nfa_8200 MAB_2230c MMAS_20650 
 
EsxG Nfa_8220 MAB_2229c MMAS_20640 
 
EsxH Nfa_8230 MAB_2228c MMAS_20630 
 
EspG Nfa_8210 MAB_2227c MMAS_20620 
 
EccD Nfa_8270 MAB_2226c MMAS_20610 
 
MycP Nfa_8280 MAB_2225c MMAS_20600 
 
EccE Nfa_8240 MAB_2224c MMAS_20590 
     
Nfa_8310 is 
EspI;  
2 Insertions 
Nfa_8190, 
Nfa_8300 
ESX-3AN 
  
ESX-1  ABSENT  ABSENT   ABSENT  ABSENT  ABSENT  ABSENT 
ESX-2  ABSENT  ABSENT   ABSENT  ABSENT  ABSENT  ABSENT 
ESX-5 
 
ABSENT  ABSENT   ABSENT  ABSENT  ABSENT  ABSENT 
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Table S1.3. The components of the ESX gene clusters of M. thermoresistibile, M. smegmatis,  
M. rhodesiae, M. sp. JLS, M. phlei and M. vanbaalenii. 
   
M. thermoresistibile M. smegmatis M. rhodesiae M. sp. JLS M. phlei M. vanbaalenii 
ESX-4 EccB KEK_22836 MSMEG_1534 MycrhNDRAFT_1287 Mjls_1150 MPHLEI_05352 Mvan_1444 
 
MycP KEK_22841 MSMEG_1533 MycrhNDRAFT_1288 Mjls_1151 MPHLEI_05357 Mvan_1445 
 
EccD KEK_22846 MSMEG_1535 MycrhNDRAFT_1289 Mjls_1152 MPHLEI_05362 Mvan_1446 
 
EccC 
KEK_22851/ 
KEK_22856 
MSMEG_1536 MycrhNDRAFT_1291 Mjls_1153 MPHLEI_05367 
Mvan_1447/ 
Mvan_1462 
 
Rv3446c KEK_22861 MSMEG_1537 MycrhNDRAFT_1292 Mjls_1154 MPHLEI_05372 Mvan_1463 
 
EsxU KEK_22866 MSMEG_1538 MycrhNDRAFT_1293 Mjls_1155 MPHLEI_05377 Mvan_1464 
 
EsxT 
 
MSMEG_1539 MycrhNDRAFT_1294 Mjls_1156 MPHLEI_05382 Mvan_1465 
    
insertion 1ORF 
MycrhNDRAFT_1290   
Insertion in 
EccC, splits 
gene in 2; 14 
ORFs including 
recombinase 
ESX-3 EccA KEK_04557 MSMEG_0615 MycrhNDRAFT_0493 Mjls_0359 MPHLEI_07122 Mvan_0411 
 
EccB KEK_04552 MSMEG_0616 MycrhNDRAFT_0494 Mjls_0360 MPHLEI_07127 Mvan_0412 
 
EccC KEK_04547 MSMEG_0617 MycrhNDRAFT_0495 Mjls_0361 MPHLEI_07132 Mvan_0413 
 
PE5 KEK_04542 MSMEG_0618 MycrhNDRAFT_0496 Mjls_0362 MPHLEI_07137 Mvan_0414 
 
PPE4 
KEK_04537/ 
KEK_02676 
MSMEG_0619 MycrhNDRAFT_0497 Mjls_0363 MPHLEI_07142 Mvan_0415 
 
EsxG KEK_02671 MSMEG_0620 MycrhNDRAFT_0498 Mjls_0364 MPHLEI_07147 Mvan_0417 
 
EsxH KEK_02666 MSMEG_0621 MycrhNDRAFT_0499 Mjls_0365 MPHLEI_07152 Mvan_0418 
 
EspG KEK_02661 MSMEG_0622 MycrhNDRAFT_0500 Mjls_0366 MPHLEI_07157 Mvan_0419 
 
EccD KEK_02656 MSMEG_0623 MycrhNDRAFT_0501 Mjls_0367 MPHLEI_07162 Mvan_0420 
 
MycP KEK_02651 MSMEG_0624 MycrhNDRAFT_0502 Mjls_0368 MPHLEI_07167 Mvan_0421 
 
EccE KEK_02646 MSMEG_0626 MycrhNDRAFT_0503 Mjls_0369 MPHLEI_07172 Mvan_0422 
  
  
MSMEG_0625 
is outside of 
ESX-3    
insertion 1 ORF 
Mvan_0416 
ESX-1 EspG KEK_11068 MSMEG_0057 MycrhNDRAFT_0049 Mjls_0052 MPHLEI_25571 Mvan_0070 
 
EspH 
 
MSMEG_0058 MycrhNDRAFT_0048 Mjls_0053 MPHLEI_25576 Mvan_0071 
 
EccA KEK_11078 MSMEG_0059 MycrhNDRAFT_0047 Mjls_0054 MPHLEI_25581 Mvan_0072 
 
EccB KEK_11083 MSMEG_0060 MycrhNDRAFT_0046 Mjls_0055 MPHLEI_25586 Mvan_0073 
 
EccC 
KEK_11088/ 
KEK_11093 
MSMEG_0061/ 
MSMEG_0062 
MycrhNDRAFT_0045/ 
MycrhNDRAFT_0044 
Mjls_0056/ 
Mjls_0057 
MPHLEI_25591 
Mvan_0074/ 
Mvan_0075 
 
PE35 KEK_11098 MSMEG_0063 MycrhNDRAFT_0043 Mjls_0058 MPHLEI_25596 Mvan_0076 
 
PPE68 KEK_11103 MSMEG_0064 MycrhNDRAFT_0042 Mjls_0059 MPHLEI_25601 Mvan_0077 
 
EsxB KEK_11108 MSMEG_0065 MycrhNDRAFT_0041 Mjls_0060 MPHLEI_25606 Mvan_0078 
 
EsxA KEK_11113 MSMEG_0066 MycrhNDRAFT_0040 Mjls_0061 MPHLEI_25611 Mvan_0079 
 
EspI KEK_11118 MSMEG_0067 MycrhNDRAFT_0039 Mjls_0062 MPHLEI_25616 Mvan_0080 
 
EccD KEK_11123 MSMEG_0068 MycrhNDRAFT_0038 Mjls_0063 MPHLEI_25621 Mvan_0081 
 
EspJ not annotated MSMEG_0069 
   
Mvan_0082 
 
EspK KEK_05562 MSMEG_0071 
   
Mvan_0085 
 
EspL KEK_05542 MSMEG_0081 MycrhNDRAFT_0283 Mjls_0065 MPHLEI_25966 Mvan_0089 
 
EspB not annotated MSMEG_0076 MycrhNDRAFT_0284 Mjls_0066 MPHLEI_25971 Mvan_0090 
 
EccE KEK_05527 MSMEG_0082 MycrhNDRAFT_0285 Mjls_0067 MPHLEI_25976 Mvan_0091 
 
MycP KEK_05522 MSMEG_0083 MycrhNDRAFT_0286 Mjls_0068 MPHLEI_25981 Mvan_0092 
  
 
Transposition after 
EccD; 2 insertions; 
3ORFs KEK_05557, 
KEK_05537. 
KEK_05532 
3 insertions; 9 
ORFs 
MSMEG_0070; 
MSMEG_0072-
75; 
MSMEG_0077-
80; EspB 
transposed 
and inverted 
transposition after 
EccD, deletion of 
EspJ and EspK 
insertion 
1ORF 
Mjls_0064 
  
2 insertions; 
5ORFs 
Mvan_0083-84; 
Mvan_0086-88 
ESX-2 
 
ABSENT ABSENT ABSENT ABSENT ABSENT ABSENT 
ESX-5 
 
ABSENT ABSENT ABSENT ABSENT ABSENT ABSENT 
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Table S1.4. The components of the ESX gene clusters of M. sp. MCS, M. sp. KMS, M. gilvum and  
M. chubuense.  
    M. sp. MCS M. sp. KMS M. gilvum M. chubuense 
ESX-4 EccB Mmcs_1123 Mkms_1140 Mflv_4962 Mycch_1049 
 
MycP Mmcs_1124 Mkms_1141 Mflv_4961 Mycch_1050 
 
EccD Mmcs_1125 Mkms_1142 Mflv_4960 Mycch_1051 
 
EccC Mmcs_1126 Mkms_1143 Mflv_4959 Mycch_1052 
 
Rv3446c Mmcs_1127 Mkms_1144 Mflv_4958 Mycch_1053 
 
EsxU Mmcs_1128 Mkms_1145 Mflv_4957 Mycch_1054 
 
EsxT Mmcs_1129 Mkms_1146 Mflv_4956 Mycch_1055 
   
  
  
ESX-3 EccA Mmcs_0370 Mkms_0380 Mflv_0329 
Deleted 
 
EccB Mmcs_0371 Mkms_0381 Mflv_0328 
 
EccC Mmcs_0372 Mkms_0382 Mflv_0327 
 
PE5 Mmcs_0373 Mkms_0383 Mflv_0326 
 
PPE4 Mmcs_0374 Mkms_0384 Mflv_0325 
 
EsxG Mmcs_0376 Mkms_0385 Mflv_0324 
 
EsxH Mmcs_0377 Mkms_0386 Mflv_0323 
 
EspG Mmcs_0378 Mkms_0387 Mflv_0322 
 
EccD Mmcs_0379 Mkms_0388 Mflv_0321 
 
MycP Mmcs_0380 Mkms_0389 Mflv_0320 Mycch_0833 
 
EccE Mmcs_0381 Mkms_0390 Mflv_0319 Deleted 
  
insertion; 1 ORF 
Mmcs_0375 
transposase  
  
 
  
ESX-1 EspG Mmcs_0062 Mkms_0071 Mflv_0775 Not annotated 
 
EspH Mmcs_0063 Mkms_0072 Mflv_0774 
Deleted 
 
EccA Mmcs_0064 Mkms_0073 Mflv_0773 
 
EccB Mmcs_0065 Mkms_0074 Mflv_0772 
 
EccC 
Mmcs_0066/ 
Mmcs_0067 
Mkms_0075/ 
Mkms_0076 
Mflv_0771/ 
Mflv0770 
 
PE35 Mmcs_0068 Mkms_0077 Mflv_0769 
 
PPE68 Mmcs_0069 Mkms_0078 Mflv_0768 
 
EsxB Mmcs_0070 Mkms_0079 Mflv_0767 
 
EsxA Mmcs_0071 Mkms_0080 Mflv_0766 
 
EspI Mmcs_0072 Mkms_0081 Mflv_0765 Mycch_0072 
 
EccD Mmcs_0073 Mkms_0082 Mflv_0764 Mycch_0073 
 
EspJ 
  
Mflv_0763 Mycch_0074 
 
EspK 
  
Mflv_0760 Mycch_0076 
 
EspL Mmcs_0075 Mkms_0084 Mflv_0758 Mycch_0079 
 
EspB Mmcs_0076 Mkms_0085 Mflv_0757 Mycch_0080 
 
EccE Mmcs_0077 Mkms_0086 Mflv_0756 Mycch_0081 
 
MycP Mmcs_0078 Mkms_0087 Mflv_0757 Mycch_0082 
  
Insertion 1ORF; 
Mmcs_0074 
replaces EspJ and 
EspK 
Insertion 1ORF; Mkms_0083 
replaces EspJ and EspK 
2 insertions; 3 
ORFs 
Mflv_0762-61, 
Mflv_0759 
2 insertions 2 ORFs, Mycch0075, 
Mycch_0078 and Mycch_0077 EspK-like 
pseudogene 
ESX-2   ABSENT ABSENT ABSENT ABSENT 
ESX-5   ABSENT ABSENT ABSENT ABSENT 
Plasmid 
ESX 
EccA Mmcs_5555   Mkms_5958 Mflv_5463 Mycch_5525 Mycch_6017 
EccB Mmcs_5556 Mkms_5778 Mkms_5959 Mflv_5462 Mycch_5548 Mycch_6040 
 
EccC Mmcs_5557 Mkms_5772 Mkms_5960 Mflv_5461 Mycch_5547 Mycch_6039 
 
EccD Mmcs_5564 Mkms_5780 Mkms_5967 Mflv_5455 Mycch_5539 Mycch_6031 
 
EccE Mmcs_5562 Mkms_5782 Mkms_5965 Mflv_5453 Mycch_5537 Mycch_6029 
 
pe Mmcs_5558 Mkms_5773 Mkms_5961 Mflv_5460 Mycch_5545 Mycch_6037 
 
ppe Mmcs_5559 Mkms_5774 Mkms_5962 Mflv_5459 Mycch_5544 Mycch_6036 
 
esx Mmcs_5560 Mkms_5775 Mkms_5963 Mflv_5458 Mycch_5543 Mycch_6035 
 
esx Mmcs_5561 Mkms_5776 Mkms_5964 Mflv_5457 Mycch_5542 Mycch_6034 
 
EspG Mmcs_5566 Mkms_5777 Mkms_5969 Mflv_5539 Mycch_5541 Mycch_6033 
 
EspI Mmcs_5565 Mkms_5779 Mkms_5968 Mflv_5456 Mycch_5540 Mycch_6032 
 
MycP Mmcs_5563 Mkms_5782 Mkms_5966 Mflv_5454 Mycch_5538 Mycch_6030 
 
EspH 
   
Mflv_5464 
  
 
  Plasmid01 ESX-P3 
pMKMS01 
ESX-P2 
pMKMS02 
ESX-P3 
pMFLV01;  
EspG 
transposed; 
Insertion 1 ORF 
Mycch0046 
ESX-P1 
pMYCCH.01; 
2 insertions 1 ORF 
Mycch_5546  
and 11 ORFs  
ESX-P4 
pMYCCH.02, 
 2 insertions 1 
ORF Mycch_6038 
and 11 ORFs 
ESX-P4 
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Table S1.5. The components of the ESX gene clusters of M. sp. Spyr1 and M. tusciae. 
    M. sp. Spyr1 M. tusciae 
ESX-4 EccB Mspyr1_43790 MyctuDRAFT_4371 
 
MycP Mspyr1_43780 MyctuDRAFT_4372 
 
EccD Mspyr1_43770 MyctuDRAFT_4373 
 
EccC Mspyr1_43760 MyctuDRAFT_4374 
 
Rv3446c Mspyr1_43750 MyctuDRAFT_4375 
 
EsxU Mspyr1_43740 MyctuDRAFT_4376 
 
EsxT Mspyr1_43730 MyctuDRAFT_4377 
ESX-3 EccA Mspyr1_04290 MyctuDRAFT_0854 
 
EccB Mspyr1_04300 MyctuDRAFT_0855 
 
EccC Mspyr1_04310 MyctuDRAFT_0856 
 
PE5 Mspyr1_04320 MyctuDRAFT_0857 
 
PPE4 Mspyr1_04330 MyctuDRAFT_0858 
 
EsxG Mspyr1_04340 MyctuDRAFT_0859 
 
EsxH Mspyr1_04350 MyctuDRAFT_0860 
 
EspG Mspyr1_04360 MyctuDRAFT_0861 
 
EccD Mspyr1_04370 MyctuDRAFT_0862 
 
MycP Mspyr1_04380 MyctuDRAFT_0863 
 
EccE Mspyr1_04390 MyctuDRAFT_0864 
ESX-1 EspG Mspyr1_00560 MyctuDRAFT_1521 
 
EspH Mspyr1_00570 MyctuDRAFT_1522 
 
EccA Mspyr1_00580 MyctuDRAFT_1523 
 
EccB Mspyr1_00590 MyctuDRAFT_1524 
 
EccC 
Mspyr1_00600/ 
Mspyr1_00610 
MyctuDRAFT_1525/ 
MyctuDRAFT_1526 
 
PE35 Mspyr1_00620 MyctuDRAFT_1528 
 
PPE68 Mspyr1_00630 MyctuDRAFT_1529 
 
EsxB Mspyr1_00640 MyctuDRAFT_1530 
 
EsxA Mspyr1_00650 MyctuDRAFT_1531 
 
EspI Mspyr1_00660 MyctuDRAFT_1532 
 
EccD Mspyr1_00670 MyctuDRAFT_1533 
 
EspJ Mspyr1_00680 MyctuDRAFT_1539 
 
EspK Mspyr1_00710 MyctuDRAFT_1536 
 
EspL Mspyr1_00730 MyctuDRAFT_1871 
 
EspB Mspyr1_00740 MyctuDRAFT_1870 
 
EccE Mspyr1_00750 MyctuDRAFT_1869 
 
MycP Mspyr1_00760 MyctuDRAFT_1868 
  
2 insertions; 3 
ORFs 
Mspyr1_00690-
700; 
Mspyr1_00720 
  
 Insertion 1ORF MtctuDRAFT_1527 
  
  
ESX-2 EccB 
ABSENT 
MyctuDRAFT_5541 MyctuDRAFT_2371 MyctuDRAFT_5597 MyctuDRAFT_3298 
 
EccC 
MyctuDRAFT_5540/ 
MyctuDRAFT_5539 
MyctuDRAFT_2365 MyctuDRAFT_5591 MyctuDRAFT_3299 
 
PE36 MyctuDRAFT_5538 MyctuDRAFT_2366 MyctuDRAFT_5592 MyctuDRAFT_3300 
 
PPE69 MyctuDRAFT_5537 MyctuDRAFT_2367 MyctuDRAFT_5593 MyctuDRAFT_3301 
 
EsxD MyctuDRAFT_5536 MyctuDRAFT_2368 MyctuDRAFT_5594 MyctuDRAFT_3302 
 
EsxC MyctuDRAFT_5535 MyctuDRAFT_2369 MyctuDRAFT_5595 MyctuDRAFT_3303 
 
EspG MyctuDRAFT_5534 MyctuDRAFT_2370 MyctuDRAFT_5596 MyctuDRAFT_3309 
 
EspI MyctuDRAFT_5533 MyctuDRAFT_2372 MyctuDRAFT_5598 MyctuDRAFT_3308 
 
EccD MyctuDRAFT_5532 MyctuDRAFT_2373 MyctuDRAFT_5599 MyctuDRAFT_3307 
 
MycP MyctuDRAFT_5531 MyctuDRAFT_2374 MyctuDRAFT_5600 MyctuDRAFT_3306 
 
EccE MyctuDRAFT_5530 MyctuDRAFT_2375 MyctuDRAFT_5601 MyctuDRAFT_3305 
 
EccA MyctuDRAFT_5529 MyctuDRAFT_2589 MyctuDRAFT_55615 MyctuDRAFT_3294 
    
EccA transposed EccA transposed 
Insertion 
MyctuDRAFT_3304; 
EspG-EccE inverted 
      CONTIG 212 ESX-2AN 
CONTIG 196 
ESX-P2 
CONTIG 209 
ESX-P2 
CONTIG 224 
ESX-P3 
ESX-5   ABSENT ABSENT 
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Table S1.6. The components of the ESX gene clusters of M. kansasii, M. tuberculosis, M. africanum, 
M. bovis, M. canetti, M. bovis BCG. 
    M. kansasii M. tuberculosis M. africanum M. bovis M. canetti M. bovis BCG 
ESX-4 EccB MkanA1_00645 Rv3450c MAF_34650 Mb3480c MCAN_34671 BCG3516c 
 
MycP MkanA1_00650 Rv3449 MAF_34640 Mb3479 MCAN_34661 BCG3515 
 
EccD MkanA1_00655 Rv3448 MAF_34630 Mb3478 MCAN_34651 BCG3514 
 
EccC MkanA1_00660 Rv3447c MAF_34620 Mb3477c MCAN_34641 BCG3513c 
 
Rv3446c MkanA1_00665 Rv3446c MAF_34610 Mb3476c MCAN_34631 BCG3512c 
 
EsxU MkanA1_00670 Rv3445c MAF_34600 Mb3475c MCAN_34621 BCG3511c 
 
EsxT MkanA1_00675 Rv3444c MAF_34590 Mb3474c MCAN_34611 BCG3510c 
ESX-3 EccA MkanA1_27591 Rv0282 MAF_02840 Mb0290 MCAN_02911 BCG0322 
 
EccB MkanA1_27596 Rv0283 MAF_02850 Mb0291 MCAN_02921 BCG0323 
 
EccC MkanA1_27601 Rv0284 MAF_02860 Mb0292 MCAN_02931 BCG0324 
 
PE5 MkanA1_27606 Rv0285 MAF_02870 Mb0293 MCAN_02941 BCG0325 
 
PPE4 
MkanA1_27611/ 
MkanA1_25662 
Rv0286 MAF_02880 Mb0294 MCAN_02951 BCG0326 
 
EsxG MkanA1_25667 Rv0287 MAF_02890 Mb0295 MCAN_02961 BCG0327 
 
EsxH MkanA1_25672 Rv0288 MAF_02900 Mb0296 MCAN_02971 BCG0328 
 
EspG MkanA1_25677 Rv0289 MAF_02910 Mb0297 MCAN_02981 BCG0329 
 
EccD MkanA1_25682 Rv0290 MAF_02920 Mb0298 MCAN_02991 BCG0330 
 
MycP MkanA1_25687 Rv0291 MAF_02930 Mb0299 MCAN_03001 BCG0331 
 
EccE MkanA1_25692 Rv0292 MAF_02940 Mb0300 MCAN_03011 BCG0332 
ESX-1 EspG MkanA1_03472 Rv3866 MAF_38810 Mb3896 MCAN_38881 BCG3929 
 
EspH MkanA1_03477 Rv3867 MAF_38820 Mb3897 MCAN_38891 BCG3930 
 
EccA MkanA1_03482 Rv3868 MAF_38830 Mb3898 MCAN_38901 BCG3931 
 
EccB MkanA1_03487 Rv3869 MAF_38840 Mb3899 MCAN_38911 BCG3932 
 
EccC MkanA1_03492/ 
MkanA1_03497 
Rv3870/ 
Rv3871 
MAF_38850/ 
MAF_38860 
Mb3900/ 
Mb3901 
MCAN_38921/ 
MCAN_38931 
BCG3933/ BCG3934 
 
PE35 MkanA1_03502 Rv3872 MAF_38870 Mb3902 MCAN_38941 BCG3934 
 
PPE68 MkanA1_03507 Rv3873 MAF_38880 Mb3903 MCAN_38951 
RD1 deletion 
 
 
 
EsxB MkanA1_03512 Rv3874 MAF_38890 Mb3904 MCAN_38961 
 
EsxA MkanA1_03517 Rv3875 MAF_38900 Mb3905 MCAN_38971 
 
EspI MkanA1_03527 Rv3876 MAF_38910 Mb3906 MCAN_38981 
 
EccD MkanA1_03532 Rv3877 MAF_38920 Mb3907 MCAN_38991 
 
EspJ MkanA1_03537 Rv3878 MAF_38930 Mb3908 MCAN_39001 
 
EspK MkanA1_03542 Rv3879c MAF_38940 Mb3909c MCAN_39011 BCG3935c 
 
EspL MkanA1_03547 Rv3880c MAF_38950 Mb3910c MCAN_39021 BCG3936c 
 
EspB MkanA1_03552 Rv3881c MAF_38960 Mb3911c MCAN_39031 BCG3936c 
 
EccE MkanA1_03557 Rv3882c MAF_38970 Mb3912c MCAN_39041 BCG3937c 
 
MycP MkanA1_03562 Rv3883c MAF_38980 Mb3913c MCAN_39051 BCG3938c 
  
Insertion MkanA1_03522     
ESX-2 EccB NA Rv3895c MAF_39100 Mb3925c MCAN_39171 BCG3952c 
 
EccC MkanA1_03622 Rv3894c MAF_39090 Mb3924c MCAN_39161 BCG3951c/BCG3950c 
 
PE36 MkanA1_03612 Rv3893c MAF_39080 Mb3923c MCAN_39151 BCG3949c 
 
PPE69 MkanA1_03607 Rv3892c MAF_39070 Mb3922c MCAN_39141 BCG3948c 
 
EsxD MkanA1_03602 Rv3891c MAF_39060 Mb3921c MCAN_39131 BCG3947c 
 
EsxC MkanA1_03597 Rv3890c MAF_39050 Mb3920c MCAN_39121 BCG3946c 
 
EspG MkanA1_03592 Rv3889c MAF_39040 Mb3919c MCAN_39111 BCG3945c 
 
EspI MkanA1_03587 Rv3888c 
MAF_39030 Mb3918c MCAN_39101 
BCG3944c/ 
 
EccD MkanA1_03582 Rv3887c BCG3943c 
 
MycP MkanA1_03577 Rv3886c MAF_39020 Mb3917c MCAN_39091 BCG3942c 
 
EccE MkanA1_03572 Rv3885c MAF_39010 Mb3916c MCAN_39081 BCG3941c 
 
EccA MkanA1_03567 Rv3884c MAF_39000 Mb3915c MCAN_39071 BCG3940c 
  
Insertion 
MkanA1_03617  
MAF_38990 Mb3914c MCAN_39061 BCG3939c 
ESX-5 EccB MkanA1_22060 Rv1782 MAF_18040 Mb1811 MCAN_18001 BCG1815 
 
EccC MkanA1_22065 Rv1783/Rv1784 
MAF_18050/ 
MAF_18060 
Mb1812 
MCAN_18011/ 
MCAN_18021 
BCG1816 
 
Cyp143 MkanA1_22070 Rv1785c MAF_18070 Mb1813c MCAN_18031 BCG1817 
 
Ferredoxin MkanA1_22075 Rv1786 MAF_18080 Mb1814 MCAN_18041 BCG1818 
 
PPE25 MkanA1_22080 Rv1787 MAF_18090 Mb1815 MCAN_18051 BCG1819 
 
PE18 MkanA1_22085 Rv1788 MAF_18100 Mb1816 MCAN_18061 BCG1820 
 
PPE26 MkanA1_22090 Rv1789 MAF_18110 Mb1817 MCAN_18071 BCG1821 
 
PPE27 
 
Rv1790 MAF_18120 Mb1818 MCAN_18081 BCG1822 
 
PE19 MkanA1_29706 Rv1791 MAF_18130 Mb1819 MCAN_18091 BCG1823 
 
EsxM MkanA1_27436 Rv1792 MAF_18140 Mb1820 MCAN_18101 BCG1824 
 
EsxN MkanA1_27431 Rv1793 MAF_18150 Mb1821 MCAN_18111 BCG1825 
 
EspG MkanA1_26312 Rv1794 MAF_18160 Mb1822 MCAN_18121 BCG1826 
 
EccD MkanA1_26317 Rv1795 MAF_18170 Mb1823 MCAN_18131 BCG1827 
 
MycP MkanA1_26322 Rv1796 MAF_18180 Mb1824 MCAN_18141 BCG1828 
 
EccE not annotated Rv1797 MAF_18190 Mb1825 MCAN_18151 BCG1829 
 
EccA MkanA1_26332 Rv1798 MAF_18200 Mb1826 MCAN_18161 BCG1830 
    Insertion MkanA1_26327            
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Table S1.7. The components of the ESX gene clusters of M. xenopi, M. sp. JDM601, M. avium,  
M. avium paratuberculosis, M. intracellulare and M. colombiense. 
    M. xenopi M. sp. JDM601 M. avium M. avium 
paratuberculosis 
M. intracellulare M. colombiense 
ESX-4 EccB 
  
MAV_4392 MAP_4238 MintA_04831 MCOL_23415 
 
MycP MXEN_02879 JDM601_3275 MAV_4393 MAP_4239c MintA_04836 MCOL_23420 
 
EccD MXEN_02874 JDM601_3274 MAV_4391 MAP_4240c MintA_04841 MCOL_23425 
 
EccC MXEN_02869 JDM601_3273 MAV_4390 MAP_4241 MintA_04846 MCOL_23430 
 
Rv3446c MXEN_02864 JDM601_3272 MAV_4389 MAP_4242 
MintA_04851/ 
MintA_17752 
MCOL_23435 
 
EsxU MXEN_02859 JDM601_3271 MAV_4388 MAP_4243 MintA_17757 MCOL_23440 
 
EsxT MXEN_02854 JDM601_3270 MAV_4387 MAP_4244 MintA_17762 MCOL_23445 
ESX-3 EccA MXEN_19795 JDM601_0290 MAV_4871 MAP_3778 MintA_03216 MCOL_10158 
 
EccB MXEN_19800 JDM601_0291 MAV_4870 MAP_3779 MintA_03211 MCOL_10153 
 
EccC MXEN_19805 JDM601_0292 MAV_4869 MAP_3780 MintA_03206 MCOL_10148 
 
PE5 MXEN_19810 JDM601_0293 MAV_4868 MAP_3781 MintA_03201 MCOL_10143 
 
PPE4 MXEN_19815 JDM601_0294 MAV_4867 MAP_3782 
MintA_06869/ 
MintA_16847 
MCOL_10138 
 
EsxG MXEN_19820 JDM601_0295 MAV_4866 MAP_3783 MintA_16847 MCOL_10133 
 
EsxH MXEN_19825 JDM601_0296 MAV_4865 MAP_3784 MintA_16842 MCOL_10128 
 
EspG MXEN_19830 JDM601_0297 MAV_4864 MAP_3785 MintA_16837 MCOL_10123 
 
EccD MXEN_19835 JDM601_0298 MAV_4863 MAP_3786 MintA_16832 MCOL_10118 
 
MycP MXEN_19840 JDM601_0299 MAV_4862 MAP_3787 MintA_16827 MCOL_10108 
 
EccE MXEN_19845 JDM601_0300 MAV_4860 MAP_3788 MintA_16822 MCOL_10103 
        
MAV_4861 
falls outside 
of ESX-3 
    Insertion MCOL_10113 
ESX-1   ABSENT ABSENT ABSENT ABSENT ABSENT ABSENT 
ESX-2 EccB MXEN_05555 JDM601_0058 MAV_5285 MAP_4321c MintA_05824 MCOL_25658 
 
EccC MXEN_05560 JDM601_0057 MAV_5283 
MAP4322c/ 
MAP4323c 
MintA_05829 MCOL_25663 
 
PE36 MXEN_05565 JDM601_0056 MAV_0151 MAP_0157 MintA_21719 MCOL_14655 
 
PPE69 MXEN_05570 JDM601_0055 MAV_0152 MAP_0158 
MintA_21714/ 
MintA_15042 
MCOL_14650 
 
EsxD MXEN_05575 JDM601_0054 MAV_0153 MAP_0160 MintA_15047 MCOL_14645 
 
EsxC MXEN_05580 JDM601_0053 MAV_0154 MAP_0161 MintA_15052 MCOL_14640 
 
EspG MXEN_05585 JDM601_0052 MAV_0155 MAP_0162 MintA_15057 MCOL_14635 
 
EspI MXEN_05590 JDM601_0051 MAV_0156 MAP_0163 MintA_15062 MCOL_14630 
 
EccD MXEN_05595 JDM601_0050 MAV_0157 MAP_0164 MintA_15067 MCOL_14625 
 
MycP MXEN_05600 JDM601_0049 MAV_0158 
MAP_0165 
MAP_0165 
MAP_0166 
MintA_15072/ 
MCOL_14620 
MintA_18212 
 
EccE MXEN_05605 JDM601_0048 MAV_0159 MAP_0167 MintA_18217 MCOL_14615 
 
EccA MXEN_05610 JDM601_0047 MAV_0160 MAP_0167 MintA_18222 MCOL_14610 
    
Transposition 
of EccB and 
EccC 
Transposition of 
EccB and EccC; 
EccB split into 
two genes; 
Insertion 
MAP_0159c  
Transposition of 
EccB and EccC 
Transposition of 
EccB and EccC 
ESX-5 EccB MXEN_04109 MJDM601_1892 MAV_2933 MAP_1501 MintA_10176 MCOL_20626 
 
EccC MXEN_04114 MJDM601_1893 MAV_2932 MAP_1502 MintA_10181 MCOL_20621 
 
Cyp143 MXEN_04134 
 
MAV_2931 MAP_1503c MintA_10186 MCOL_20616 
 
Ferredoxin MXEN_04139 
 
MAV_2929 MAP_1504 MintA_10191 MCOL_20611 
 
PPE25 
MXEN_04144/ 
MXEN_09344  
MAV_2928 
 
MintA_10196 MCOL_20606 
 
PE18 MXEN_09349 
 
MAV_2927 
 
MintA_10201 MCOL_20601 
 
PPE26 MXEN_09354 
 
MAV_2926 MAP_1505 MintA_10206 MCOL_20596 
 
PPE27 MXEN_09369 
 
MAV_2925 MAP_1506 
 
MCOL_20591 
 
PE19 MXEN_09364 MJDM601_1894 MAV_2923 MAP_1507 
 
MCOL_20576 
 
EsxM 
MXEN_09374/ 
MXEN_01242 
MJDM601_1895 MAV_2922 MAP_1508 MintA_21674 MCOL_20571 
 
EsxN MXEN_01237 MJDM601_1896 MAV_2921 NA MintA_21669 MCOL_20566 
 
EspG MXEN_09204 MJDM601_1897 MAV_2920 MAP_1509 MintA_10221 MCOL_20561 
 
EccD MXEN_09209 MJDM601_1898 MAV_2919 MAP_1510 MintA_10226 MCOL_20556 
 
MycP MXEN_09214 MJDM601_1899 MAV_2918 MAP_1511 
MintA_10231/ 
MintA_13857 
MCOL_20551 
 
EccE MXEN_09219 MJDM601_1900 MAV_2917 MAP_1512 MintA_13852 MCOL_20546 
 
EccA MXEN_09224 MJDM601_1901 MAV_2916 MAP_1513 MintA_13847 MCOL_20541 
    
2 insertions 4 
ORFs MXEN-
04119-04134; 
MXEN_09359 
DNA sequence 
spanning absent 
genes could not 
be identified in 
available 
contigs 
Insertion 
MAV_2930; 
additional 
PPE 
MAV_2924 
    
Duplication of 2 
PPE genes: 
MCOL_20586 and 
MCOL_20581 
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Table S1.8. The components of the ESX gene clusters of M. parascrofulaceum and M. sp. MOTT36Y. 
    M. parascrofulaceum M. sp. MOTT36Y 
ESX-4 EccB HMPREF0591_3880 W7S_21385 
 
MycP HMPREF0591_3881 W7S_21380 
 
EccD HMPREF0591_3882 W7S_21375 
 
EccC HMPREF0591_3883 W7S_21370 
 
Rv3446c HMPREF0591_3884/HMPREF0591_1773 W7S_21365 
 
EsxU HMPREF0591_1774 W7S_21360 
 
EsxT HMPREF0591_1775 W7S_21355 
ESX-3 EccA HMPREF0591_3351 W7S_23965 
 
EccB HMPREF0591_3352 W7S_23960 
 
EccC HMPREF0591_3353 W7S_23955 
 
PE5 HMPREF0591_3354 W7S_23950 
 
PPE4 HMPREF0591_3355/HMPREF0591_1873 W7S_23945 
 
EsxG HMPREF0591_1872 W7S_23940 
 
EsxH HMPREF0591_1871 W7S_23935 
 
EspG HMPREF0591_1870 W7S_23930 
 
EccD HMPREF0591_1869/HMPREF0591_3356 W7S_23925 
 
MycP HMPREF0591_3357 W7S_23920 
  EccE HMPREF0591_3358 W7S_23915 
ESX-1   ABSENT ABSENT 
ESX-2 EccB HMPREF0591_3018 HMPREF0591_1319 HMPREF0591_1425 HMPREF0591_0084 W7S_25690 
 
EccC 
HMPREF0591_3019/ 
HMPREF0591_3020 
HMPREF0591_1318 HMPREF0591_1432 
HMPREF0591_0085/ 
HMPREF0591_0086 
W7S_25685 
 
PE36 HMPREF0591_2863 HMPREF0591_1317 HMPREF0591_1431 
 
W7S_00765 
 
PPE69 HMPREF0591_2862 HMPREF0591_1316 HMPREF0591_1430 HMPREF0591_0089 W7S_00770 
 
EsxD HMPREF0591_2861 HMPREF0591_1315 HMPREF0591_1429 HMPREF0591_0090 W7S_00775 
 
EsxC HMPREF0591_2860 HMPREF0591_1314 HMPREF0591_1428 HMPREF0591_0091 W7S_00780 
 
EspG HMPREF0591_2859 HMPREF0591_1313 HMPREF0591_1427 HMPREF0591_0092 W7S_00785 
 
EspI HMPREF0591_2858 HMPREF0591_1312 HMPREF0591_1426 HMPREF0591_0093 W7S_00790 
 
EccD HMPREF0591_2857 HMPREF0591_1311 HMPREF0591_1424 HMPREF0591_0094 W7S_00795 
 
MycP 
HMPREF0591_2856/ 
HMPREF0591_1310 HMPREF0591_1423 HMPREF0591_0095 
W7S_00800 
HMPREF0591_2855 W7S_00805 
 
EccE HMPREF0591_2854 HMPREF0591_1309 HMPREF0591_1422 HMPREF0591_0096 W7S_00810 
 
EccA HMPREF0591_2853 HMPREF0591_1308 
  
Transposition of 
EccB and EccC 
  
Transposition of EccA 
and EccB; MycP split 
into 2 genes;  
CONTIG 312/318 
ESX-2 
 
CONTIG 109 
ESX-P5 
EccB inserted 
between EspI and 
EccD;   
CONTIG 115 
ESX-P2 
insertion; 2 ORFs 
HMPREF0591_0087-
88; 
 CONTIG 17 
ESX-P4 
ESX-5 EccB HMPREF0591_0777 W7S_13390 
 
EccC 
HMPREF0591_0778/HMPREF0591_0779 W7S_13385 
 
W7S_13380 
 
Cyp143 HMPREF0591_0780 W7S_13375 
 
Ferredoxin HMPREF0591_0781 
 
 
PPE25 HMPREF0591_0782 
 
 
PE18 HMPREF0591_5626 
 
 
PPE26 
 
W7S_13370 
 
PPE27 
 
W7S_13365 
 
PE19 
 
W7S_13360 
 
EsxM HMPREF0591_5624 W7S_13355 
 
EsxN HMPREF0591_0783 W7S_13350 
 
EspG HMPREF0591_0784 W7S_13345 
 
EccD HMPREF0591_0785 W7S_13340 
 
MycP HMPREF0591_0786 W7S_13335 
 
EccE HMPREF0591_0787 W7S_13330 
 
EccA HMPREF0591_0788 W7S_13325 
    region extending between PPE25 and EsxN is unclear  
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Table S1.9. The components of the ESX gene clusters of M. ulcerans, M. marinum and M. leprae. 
    M. ulcerans M. marinum M. leprae 
ESX-4 EccB Mul_0857 MMAR1099 
 
 
MycP Mul_0858 MMAR1100 
 
 
EccD Mul_0859 MMAR1101 
 
 
EccC Mul_0860 MMAR1102 
 
 
Rv3446c Mul_0861 MMAR1103 
 
 
EsxU Mul_0862 MMAR1104 
 
 
EsxT Mul_0863 MMAR1105 
 ESX-3 EccA Mul_1204 MMAR0541 ML2537c 
 
EccB Mul_1205 MMAR0542 ML2536c 
 
EccC Mul_1206 MMAR0543 ML2535c 
 
PE5 Mul_1207 MMAR0544 ML2534c 
 
PPE4 Mul_1208 MMAR0545 ML2533c (PS) 
 
EsxG Mul_1209 MMAR0546 ML2532c 
 
EsxH Mul_1210 MMAR0547 ML2531c 
 
EspG Mul_1211 MMAR0548 ML2530c 
 
EccD Mul_1212 MMAR0549 ML2529c 
 
MycP Mul_1213 MMAR0550 ML2528c 
 
EccE Mul_1214 MMAR0551 ML2527c 
ESX-1 EspG   MMAR5441 ML0057c (PS) 
 
EspH 
 
MMAR5442 ML0056c 
 
EccA 
 
MMAR5443 ML0055c 
 
EccB 
 
MMAR5444 ML0054c 
 
EccC 
 
MMAR5445/MMAR5446 ML0053c 
 
PE35 
 
MMAR5447 ML0052c 
 
PPE68 
 
MMAR5448 ML0051c 
 
EsxB 
 
MMAR5449 ML0050c 
 
EsxA 
 
MMAR5450 ML0049c 
 
EspI 
 
MMAR5451 ML0048c 
 
EccD 
 
MMAR5452 ML0047c 
 
EspJ 
 
MMAR5453 ML0046c (PS) 
 
EspK 
 
MMAR5455c ML0045 (PS) 
 
EspL 
 
MMAR5456c ML0044 
 
EspB 
 
MMAR5457c ML0043 (PS) 
 
EccE 
 
MMAR5458c ML0042 
 
MycP 
 
MMAR5459c ML0041 
  
  Insertion MMAR5454c (EspE)   
ESX-2   ABSENT ABSENT ABSENT 
ESX-5 EccB Mul_3093 MMAR2664 ML1544c 
 
EccC Mul_3092 MMAR2665 ML1543c 
 
Cyp143 Mul_3091 MMAR2666 ML1542 (PS) 
 
Ferredoxin Mul_3090 MMAR2668 ML1541c (PS) 
 
PPE25 Mul_3089 MMAR2669 
 
 
PE18 Mul_3088 MMAR2670 
 
 
PPE26 Mul_3087 MMAR2671 
 
 
PPE27 
   
 
PE19 Mul_3086 MMAR2673 
 
 
EsxM Mul_3083 MMAR2674 
 
 
EsxN Mul_3082 MMAR2675 
 
 
EspG Mul_3081 MMAR2676 ML1540c 
 
EccD Mul_3080 MMAR2677 ML1539c 
 
MycP Mul_3079 MMAR2678 ML1538c 
 
EccE Mul_3078 MMAR2679 ML1537c 
 
EccA Mul_3077 MMAR2680 ML1538c 
    
Insertion 2 ORFs 
including IS2404 
transposase 
2 insertions MMAR_2667 and 
MMAR_2672   
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2. The regulation of the mycobacterial Type VII ESX secretion systems 
2.1. Introduction 
Identification of the promoters which drive expression of the ESX secretion systems may assist in the 
identification of their regulatory mechanisms and functions. Some promoters have been identified upstream 
of, and within the ESX gene clusters. They include the PESREG3 promoters upstream of ESX-3,
50, 114, 153
 the 
Pesat-6 promoter upstream of the esxB-esxA operon (transcribing ESAT-6 and CFP-10) in ESX-1
36
 and the 
PAN promoter upstream of the esxD-esxC operon in ESX-2.
154
 However, a comprehensive search for the 
promoters driving expression of all 5 ESX gene clusters has not been done. In this study we have identified 
intergenic promoters from the M. tuberculosis ESX gene clusters using β-galactosidase promoter probe 
assays and in silico promoter prediction. 
2.2. Results 
2.2.1. ESAT-6 gene cluster organisation 
The ESAT-6 gene clusters of M. tuberculosis contain variable numbers of genes, in different arrangements. 
The positions of the genes in M. tuberculosis H37Rv were obtained from TubercuList,
155
 and the number of 
base pairs separating the genes determined. Intergenic regions of 40bp and larger were selected for 
analysis to determine the presence of promoters driving transcription of these gene cluster regions. Two 
intergenic regions were selected from ESX-4, one of which separates two genes in opposite orientations, 
and the sequence was therefore analysed in both directions. Four intergenic regions were selected from 
ESX-3, including one directly upstream of the gene cluster. Six intergenic regions were selected from ESX-1, 
seven from ESX-2, and nine from ESX-5. These include intergenic regions, regions directly upstream of 
ESX-1 and -5 and intergenic regions between additional genes further upstream of the gene clusters. The 
positions and sizes of the selected intergenic regions are indicated in Figure 2.1. 
2.2.2. Promoter identification 
To determine which intergenic regions contain promoter elements which allow transcription of the ESX gene 
clusters, the selected intergenic regions were amplified from M. tuberculosis H37Rv genomic DNA and 
cloned into the E. coli-mycobacterial promoter-probe vector pJEM15. The pJEM constructs were transformed 
into M. smegmatis, which is used as a mycobacterial host organism for promoter assays. 
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Figure 2.1. Selected intergenic regions of the M. tuberculosis ESX gene clusters. Intergenic regions greater than 40bp, which were selected for analysis, are 
indicated as arrows representing the direction in which the DNA was cloned into pJEM15. White block arrows represent genes outside of the ESX gene clusters. 
Spaces are not representative of the real distances between genes. 
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Promoter activity was assayed quantitatively on cultures grown in Kirchener’s medium using a β-
galactosidase assay. The intergenic region Rv8182 containing the ESX-3 promoter, PESREG3, the PAN 
promoter containing region from ESX-2 and the Pesat-6 promoter containing region Rv7374, from ESX-
1, were used as positive controls, while the promoterless pJEM15 vector was used as a negative 
control for promoter activity. 
Promoter activity was classified as very strong, greater than 3000 β-galactosidase units; strong, 1000 
to 3000 β-galactosidase units; moderate, 400 to 1000 β-galactosidase units and negligible, less than 
400 β-galactosidase units. Relative promoter activities obtained in M. smegmatis cultures are given in 
Figure 2.2. Very strong promoter activities were obtained for the intergenic regions Rv8182 and 
Rv178182, upstream of the ESX-3 and ESX-5 gene cluster regions, respectively. Strong promoters 
were identified in the intergenic region upstream of ESX-1 (Rv6465), upstream of the pe/ppe 
(Rv38943), esxD-C (PAN promoter) and espI (Rv38898) genes in ESX-2, and upstream of pe19 
(Rv179091) in ESX-5. Promoter activity was also identified in the intergenic regions Rv7374, upstream 
of esxA and esxB in ESX-1, upstream of Rv3896, the gene preceding ESX-2 (Rv38976) and upstream 
of Rv1795 (Rv179495) in ESX-5. No significant promoter activity was identified for ESX-4.  
The promoter activities of the intergenic regions were also determined using M. bovis BCG as a host 
organism, to account for any differences resulting from the differences in transcriptional apparatus in 
M. smegmatis, as opposed to M. tuberculosis and other M. tuberculosis complex species (Figure 2.3). 
The assays were done as described for M. smegmatis. Promoter activities of the intergenic regions 
could be assigned as very strong, strong, moderate or negligible promoter activities which correspond 
to those obtained in M. smegmatis. The exception to this was the Rv8483 intergenic region which 
occurs on the complementary strand downstream of ESX-1, and showed greater promoter activity in 
M. bovis BCG, than in M. smegmatis, and could be classified as a strong promoter in M. bovis BCG. 
The β-galactosidase activities obtained in M. bovis BCG were, however, higher than those obtained in 
M. smegmatis. 
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ESX  
cluster 
Intergenic 
region 
β-gal 
activity 
standard  
deviation 
ESX-4 
34478 35 23 
34487 332 244 
34510 5 5 
ESX-3 
8182 5941 2543 
8687 8 8 
8990 14 18 
ESX-1 
6364 171 50 
6465 1158 508 
7172 52 26 
7374 580 173 
7576 103 20 
8483 282 173 
ESX-2 
38854 223 74 
38898 1949 631 
389089 215 96 
PAN 1427 311 
38932 117 14 
38943 2639 662 
38976 849 165 
ESX-5 
178182 6774 1677 
178384 472 218 
178687 25 7 
178788 -2 8 
178990 17 4 
179091 2980 322 
179192 283 57 
179394 80 27 
179495 943 294 
 
Figure 2.2. Promoter activities of the intergenic regions of the M. tuberculosis ESX gene cluster 
regions in M. smegmatis. Results are the mean of 3 independent experiments. 
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ESX 
cluster 
Intergenic 
region 
β-gal 
activity 
standard 
deviation 
ESX-4 
34478 406 60 
34487 771 98 
34510 394 48 
ESX-3 
8182 8731 717 
8687 211 149 
8990 197 169 
ESX-1 
6364 350 77 
6465 1945 511 
7172 538 82 
7374 1056 299 
7576 344 178 
8483 2075 736 
ESX-2 
38854 653 152 
38898 3613 1651 
389089 551 25 
PAN 1094 224 
38932 411 21 
38943 818 40 
38976 1068 137 
ESX-5 
178182 14247 615 
178384 531 3 
178687 480 24 
178788 167 151 
178990 204 152 
179091 3949 49 
179192 646 94 
179394 275 118 
179495 1498 134 
 
Figure 2.3. Promoter activities of the intergenic regions of the M. tuberculosis ESX gene cluster 
regions in M. bovis BCG. Results are the mean of 2 independent experiments. 
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2.2.3. Sequence analysis 
Two online promoter prediction programs, Softberry BPROM and BDGP Neural Network Promoter Prediction 
were used to identify possible promoter motifs in the intergenic regions which possess promoter activity. 
Furthermore, as functional sequences are expected to be more conserved than non-functional regions, the 
intergenic regions which showed promoter activity were aligned with the corresponding sequences from 
other mycobacterial species to identify potential promoter motifs. Conserved sequences which resemble 
consensus mycobacterial promoter sequence motifs were identified as putative promoter sequences. 
Putative promoters and associated DNA sequences were also manually searched for any regulatory 
domains and specific sigma factor binding motifs which may highlight potential regulation of transcription of 
the gene cluster and indicate possible functions. (See Addendum A: Newton-Foot, M, Gey van Pittius, NC, 
The complex architecture of mycobacterial promoters, Tuberculosis (2012), 
http://dx.doi.org/10.1016/j.tube.2012.08.003; for a review of the mycobacterial transcriptional apparatus and 
its regulation).  
The intergenic regions which showed promoter activity are presented in Figure 2.4, in which putative 
promoter sequence motifs identified using multiple sequence alignments of the corresponding regions in 
related mycobacteria, the Softberry BPROM Promoter Prediction and BDGP Neural Network Promoter 
Prediction programs, and published promoter sequences are presented. Where promoter motifs were not 
clearly identified by promoter prediction programs and sequence alignments, promoter sequences are 
proposed based on identity to the mycobacterial and E. coli consensus promoter sequences. 
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P1 and P2 
M.tb                CACCCCGGGCTCCATAATGAAAATCATGTTCAGTAAGCT-ACACTCTGCATATCGGGCTACCAACGAAATGGAGTATCGGTCATGATCTTGCCAGCCGTGCCTAAAAGCTTGGCCGCA 
                    ||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.bovis             CACCCCGGGCTCCATAATGAAAATCATGTTCAGTAAGCT-ACACTCTGCATATCGGGCTACCAACGAAATGGAGTATCGGTCATGATCTTGCCAGCCGTGCCTAAAAGCTTGGCCGCA 
                    || |||| | |  ||||||||||| || |||  |||| | |  |  |||   
M.ap                CAACCCGAGTTG-ATAATGAAAATGATTTTCGTTAAGGTTAGGCCTTGCTGT 
 
P3 
M.smeg              TCACGGCCCAGAGCCCCCACGTGCGTCTCGACAGTTAACTTATGTAATGCTAACTTCTCG AAAGTTA 
                       | |    ||     | ||  || ||||||||||| |||||| ||||||||||||  |  |   
M.tb                GGGCCGAGTCGATTGGTCGCGGTCGCCTCGACAGTTAGCTTATGCAATGCTAACTTCGGGGCAAAGTTCAGGCGGATCGGCCGATG 
                    |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.bovis             GGGCCGAGTCGATTGGTCGCGGTCGCCTCGACAGTTAGCTTATGCAATGCTAACTTCGGGGCAAAGTTCAGGCGGATCGGCCGATG 
                                           |||||||||||||||||||||||||||||||||| ||             ||        ||       
M.ap                                       CGCCTCGACAGTTAGCTTATGCAATGCTAACTTCAGGCGGGTCAGGTTAGGGGAGACTACATACATGAAAAGACGCGGCCGTG 
 
 
GTTCGCCCGCAACACCCTGGTCAGTGCCGCCCGCGTCTGACGGCGCACCGTTCGCGCTGCCGGCACCCCG 
GGctccataatgaaaatcatgttcagtaagctacactctgcatatcgggctaCCAACGAAATGGAGTATCG 
GTCATGATCTTGCCAGCCGTGCCTAAAAGCTTGGCCGCAGGGCCGagtcgattggtcgcggtcgcctcgaca 
gttagcttatgcaatgctaacttCGGGGCAAAGTTCAGGCGGATCGGCCGATGGCGGGCGTAGGTGAA  
Figure 2.4 A. The PESREG3 ESX-3 promoters in intergenic region Rv8182. The intergenic region Rv8182 contains 3 published promoters. P1 has a Zur 
binding motif in the interhexameric region overlapping the -10 and -35 motifs,
50
 P2 contains the signature sequence motifs for the binding of SigC
153
 and P3 has 
a IdeR-box overlapping its -35 and -10 motifs.
114
 This correlates with data which shows that expression of M. tuberculosis ESX-3 is repressed in the presence of 
high concentrations of iron and zinc, and is dependent on Zur and IdeR. P3 has an extended -10 TGn motif which may be responsible for the high level of 
promoter activity in this region. The P1 promoter is not conserved in M. smegmatis, and it has been shown that ESX-3 expression is not regulated by Zur or zinc 
concentration in M. smegmatis, although the consistent promoter activities observed in M. smegmatis and M. bovis BCG demonstrate that the regulatory 
mechanisms may have been retained. The P2 promoter sequence is not conserved outside of the M. tuberculosis complex species and expression from this 
promoter may be restricted to these species. SigC is not conserved throughout all mycobacteria, and is absent in M. smegmatis, and this may be responsible for 
the lack of conservation of this sequence. SigC is involved in various stress conditions and its expression of ESX-3 may facilitate survival in the host. Promoter 
motifs predicted by BPROM are given in bold, and by BDGP in small letters. M.tb - M. tuberculosis; M.ap - M. avium paratuberculosis; M.smeg - M. smegmatis 
End of Rv0281 
Start of Rv0282 
19bp 
7bp 
26bp 
17bp 
5bp 
    Stop codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative ribosome binding site (RBS) 
    Putative extended -10 TGn motif 
    IdeR box 
    Zur binding site 
    SigC promoter 
P1 
P2 
P3 
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M.smeg          ACATTAGACCACGGT--ATTCC---CGGGTCTGCGGCCGCGCGCGGTGCGTGAGGATCCAAGG-GAATGTCGGGGAATC-GAGGGGATTCATG 
                  ||  ||| || |    |  |   | |||||| | |   ||| |  |          | ||  ||| ||          |||||  |                           
M.tb            TGATCGGAC-ACCGA--GTCGCCAGCAGGTCTGTGCCATAGCGAGTCGAAGC-CATAGCGAGTAGAAAGTTAAACGTAGAGGAGGGTTCAAC-CCATG 
                ||||||||| |||||  ||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||||| ||||| 
M.bovis         TGATCGGAC-ACCGA--GTCGCCAGCAGGTCTGTGCCATAGCGAGTCGAAGC-CATAGCGAGTAGAAAGTTAAACGTAGAGGAGGGTTCAAC-CCATG 
                |||  |||| || ||  ||||        |   ||     ||  |  |     || | ||||      |   |||  | |   | |  |||| |  || 
M.marinum       TGACAGGACTACTGAACGTCGTGCCTTCATTCTTGAAGGTGCTGGCGGGCATGCACAACGAGATAGTCGGCGAACTCAAATCGGCGACCAACGTCGTG 
                ***  **** ** **  ****        *   **     **  *  *     ** * ****      *   ***  * *   * *  ****  * **             
 
 
CTTTGATCGGACACCGAGTCGCCAGCAGGTCTGTGCCATAGCGAGTCGAAGCCATAGCGAGTAGAAAGTTAAACGTAGAGGAGGGTTCAACCCATg 
 
 
 
 
 
 
Figure 2.4 B. The putative promoter in the intergenic region Rv6465 of ESX-1. The Rv6465 intergenic region is not well conserved across non M. tuberculosis 
complex slow-growers, or the fast growing mycobacteria, and may indicate the divergent expression from this promoter in different species. The proposed promoter 
motifs were identified based on identity to consensus promoter motifs. M.tb - M. tuberculosis; M.smeg - M. smegmatis 
 
End of Rv3864 
Start of Rv3865 
19bp 13bp 
    Stop codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative ribosome binding site (RBS) 
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M.smeg          AGGATGAAGACGACGAGTGGTGAACACTCGCA----CAAGAACTTTCCGGTGCACTCG--CCGGAAGACTCGCCATGGAATTGGTGAGGACACAGGGAAATAAGGGGAAATCCA--ATG 
                 ||| ||||| ||||| |||||| | | || |    ||| |   |||| |  ||| ||  |||||||||| ||||     |||| ||||| |     | | |    | | ||||  |||   
M.tb            GGGACGAAGAGGACGACTGGTGAGCTCCCGTAATGACAACAGACTTCCCGGCCACCCGGGCCGGAAGACTTGCCAACATTTTGGCGAGGA-AGGTAAAGAGAGAAAGTAGTCCAGCATG 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| 
M.bovis         GGGACGAAGAGGACGACTGGTGAGCTCCCGTAATGACAACAGACTTCCCGGCCACCCGGGCCGGAAGACTTGCCAACATTTTGGCGAGGA-AGGTAAAGAGAGAAAGTAGTCCAGCATG 
                |||| || |||||||||||||||||  |   ||    ||||||||||||||||||||||||||||||||||||||||| ||||||||||| | | ||||||||||||||||||||||||                     
M.marinum       GGGATGACGAGGACGACTGGTGAGCGTCGTCAACACGAACAGACTTCCCGGCCACCCGGGCCGGAAGACTTGCCAACAATTTGGCGAGGA-AAG-AAAGAGAGAAAGTAGTCCAGCATG   
                 || ||| || || || |||| | |||  ||| ||||   ||||||||||  || || | | ||||||||||| ||| | |||||| |   | ||  |    |      ||| |||| 
M.leprae        ATGACGACCAGCACAACTGGTGAACACCCAAAATCACAA---ACTTCCCGGCGCCCGGGCCGGAAAGACTTGCCAGCATCT-GGCGAGTAACAGCAAGAAAGAGAGTAGAACCAACATG 
 
 
 
GAGCGTGAAGAAGACGACGAGGACGACTGGGACGAAGAGGACGACTGGTGAGCTCCCGTAATGACAACAGAC 
TTCCCGGCCACCCGGGCCGGAAGACTTGCCAACATTTTGGCGAGGAAGGTAAAGAGAGAAAGTAGTCCAGCATG 
 
Figure 2.4 C. The Pesat-6 promoter occurs in the Rv7374 intergenic region of ESX-1. The Pesat-6 promoter has previously been identified and its role in the 
expression of ESAT-6 and CFP-10 described.
36
 The multiple sequence alignment shows that these previously proposed sequence motifs (underlined) are not well 
conserved across the mycobacteria. Alternate promoter motifs predicted by BPROM (in bold) are more conserved and proposed as more likely promoter motifs in 
this region. M.tb - M. tuberculosis; M.smeg - M. smegmatis 
14bp 6bp 
End of Rv3873 
Start of Rv3883c 
14bp 
3bp 
    Stop codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative ribosome binding site (RBS) 
    Published ribosome binding site (RBS) 
    Published -35 motif 
    Published -10 motif 
     
 
 
 
 
 
 
pESAT-6 
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M.smeg   CCTGCGGCCGGGATTTTCCGGGCAGGTAAAAAAGCGTCATCGGCGTGATCGTGATGCCCATAGA 
          |       |                |||||      ||    ||| |    |   |      
M.bovis  GCGTTGTTTGCCCAGCCGTT-ACGTCTAAAATGCACACAGGTCCGTCAAGT-GGCCCAAGGT---AGCAACGCAGCT-----CAATGAATCGCAATGAATCTCAACG--AATGGAGTGTTCTGG------GAGTG 
         ||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||||   ||||||||||||     |||||||||||||||||||||||||  |||||||||||||||      ||||| 
M.tb     GCGTTGTTTGCCCAGCCGTT-ACGTCTAAAATGCACACAGGTCCGTCAAGT-GGCCCAAGGT---AGCAACGCAGCT-----CAATGAATCGCAATGAATCTCAACG--AATGGAGTGTTCTGG------GAGTG 
          ||  | || |  |   ||| | |||||||||||||||  || ||||| |  ||||||| ||   ||||   |         |||  |  ||  | ||  | | ||   | || ||     |        || ||  
M.leprae CCGCGGATTACTTAATTGTTTAAGTCTAAAATGCACACCAGTGCGTCACGCAGGCCCAATGTCCGAGCAGATCGTTCTCGAGCAACCACGCGTGACGAGCCACCACACCAGTGCAGCAGCTTAAAAACATGAATGGAATGG 
 
 
 
 
GTTTGGTAGCAGCCGCATATCGGCTAGTGCGGTAGCAAAACCGTTGAGTCCCGGCGTG 
GTCCAGGTACAGCGCCTACGCGCCCTGGTCGGCGCGGCGGACCAGCCCAGGCGTGACA 
GCGTTGTTTGCCCAGCCGTTACGTCTAAAATGCACACAGGTCCGTCAAGTGGCCCAAG 
GTAGCAACGCAGCTCAATGAATCGCAATGAATCTCAACGAATGGAGTGTTCTGGGAGTG 
Figure 2.4 D. The putative promoter in the intergenic region Rv8483 of ESX-1. The Rv8483 intergenic region is not well conserved across the mycobacteria 
and no promoter motifs were predicted for this region. However a highly conserved putative -10 hexamer was identified and a -35 motif proposed. The variation in 
sequence between the M. smegmatis and M. tuberculosis -35 regions may represent differences in the specificities of the relevant sigma factor of these two 
species, which may account for the difference in promoter activity of this intergenic region when assayed in M. smegmatis and M. bovis BCG. Promoter motifs 
predicted by BPROM are given in bold. M.tb - M. tuberculosis; M.smeg - M. smegmatis 
 
End of Rv3884c 
Start of Rv3883c 
16bp 5bp 
    Stop codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative ribosome binding site (RBS) 
     
 88 
 
 
 
 
 
 
 
 
 
 
 
 
M.tb      GCGAGGTCGGCCTTCGCGCCACGACTGAGTAGTCGGG------TCGCGTCAACGGCA-(50bp)-GGTCGGTACGGCCGAGGTGATGGCACCCGGCAACGGATGTG 
          |||||||||||||||||||||||||||||||||||||      ||||||||||||||        ||||||||||||||||||||||||||||||||||||||||| 
M.microti GCGAGGTCGGCCTTCGCGCCACGACTGAGTAGTCGGG------TCGCGTCAACGGCA-(50bp)-GGTCGGTACGGCCGAGGTGATGGCACCCGGCAACGGATGTG 
          |||||||||||||||||||||||||||||||||||||      ||||||||||||||        ||||||||||||||||||||||||||||||||||||||||| 
M.bovis   GCGAGGTCGGCCTTCGCGCCACAACTGAGTAGTCGGG------TCGCGTCAACGGCA-(50bp)-GGTCGGTACGGCCGAGGTGATGGCACCCGGCAACGGATGTG 
            |    |||| |||||| |      |    |   |       ||||||   ||| |         | | |  |  | |||       
M.avium   AGGTCTGCGGCGTTCGCGGCCAGGAGGGTGTGGGAGTACTAGCTCGAGTGTCCGGTAGAAGCCGGTGACCGATCCCCTGAGAATG 
 
 
 
 
 
AGGTTAAGGAATAGTCGCCCTGGGGCGAGGTCGGCCTTCGCGCCACGACTGAGTAGTCGGG 
TCGCGTCAACGGCAGTATGGTCGTGGCGCAGGGGCACCGGCCGCAATCGACAAGGTCGTGG 
TCTGGTCGGTACGGCCGAGGTGATGGCACCCGGCAACGGATGTGAGCACATGGCACAGGATT 
Figure 2.4 E. The putative promoter in the intergenic region Rv38976 of ESX-2. The proposed p38976 promoter was identified based on sequence identity 
within the slow-growing mycobacteria. Two conserved hexamers were identified as the -10 and -35 hexamers. M.tb - M. tuberculosis 
End of Rv3897c 
Start of Rv3896c 
19bp 
3bp 
    Stop codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative ribosome binding site (RBS) 
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M.tb         TGACCATGTCGCTGTACGGGTTCAGTGACACCCGC----------------------GCGTATCCTCCAGGCGTCGCAGATT – 125bp - CAGCGACCATCACGCATTGCAGAAGCAATCGGAGGGGCGAACATG 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.bovis      TGACCATGTCGCTGTACGGGTTCAGTGACACCCGC----------------------GCGTATCCTCCAGGCGTCGCAGATT – 125bp - CAGCGACCATCACGCATTGCAGAAGCAATCGGAGGGGCGAACATG 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.microti    TGACCATGTCGCTGTACGGGTTCAGTGACACCCGC----------------------GCGTATCCTCCAGGCGTCGCAGATT – 125bp – CAGCGACCATCACGCATTGCAGAAGCAATCGGAGGGGCGAACATG 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.africanum  TGACCATGTCGCTGTACGGGTTCAGTGACACCCGC----------------------GCGTATCCTCCAGGCGTCGCAGATT – 125bp - CAGCGACCATCACGCATTGCAGAAGCAATCGGAGGGGCGAACATG 
             |  |    |   |||    |   |||       |                        | |||                                      ||  | | ||   ||  |  | ||||||   
M.avium      TTCCGGGATTTTTGTGACAGCCGAGTCCGGAGTGGTCGTTGAGGTTTATCGCCGACTCCTTATGGGAACTCA--------------------------GGAATTTCACGTTTGGGAGCCGTTTGGAAGGCGTG 
 
 
 
 
 
AGGGGATTTTGGTGGGGTATCCGTCGGTGCCCGGCGAGCAGTAGGGCCGGATCGCAAGATAGCGCGCATGGCTACTTTCTGCCTGACCATG 
TCGCTGTACGGGTTCAGTGACACCCGCGCGTATCCTCCAGGCGTCGCAGATTTCACATCCGCCCCACACGTACCGCTGACATGCTGGAACAC 
ATGGGGCGGCGTGGACCAGTTCGACGTCGGCATCGGTGCAGACGACTGATTTGCGCATACGCGATCGGCCGACTCGCATTACACTCAGCGAC 
CATCACGCATTGCAGAAGCAATCGGAGGGGCGAACATG 
Figure 2.4 F. The putative promoter in the intergenic region Rv38943 of ESX-2. The p38943 promoter motifs were identified by BPROM (bold) although 
the specific motifs are not well conserved outside of the M. tuberculosis complex. Expression of ESX-2 may therefore involve different mechanisms in different 
species. M.tb - M. tuberculosis  
End of Rv3894c 
Start of Rv3893c 
20bp 5bp 
    Stop codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative ribosome binding site (RBS) 
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M.tuberculosis  TAGCTCG-GGCACAGGGTGAATCGACAGGTCCGCAGAGCAGCCATACACTTCGCGTCATGCCCCGATATTTGAGGGGGAACGGCTAACGGCAGTAAAGGAGAAGGGCCCGTG 
                ||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||| 
M.bovis         TAGCTCG-GGCACAGGGTGAATCGACAGGTCCGCAGAGCAGCCATACACTTCGCGTCATGCCCCGATATTTGAGGGGGAACGGCTAACGGCAGTAAAGGAGAAGGGCC-GTG 
                 | | |  ||   ||||||||||||||||| | || ||| |||||||||||||  |||||||   |        ||||  |||| |||  |||  |||||||||   |||||  
M.avium         GACCCCCTGGTGAAGGGTGAATCGACAGGTACACACAGCCGCCATACACTTCGCTTCATGCCCTTAC-------GGGGGGCGGCCAACC-CAG--AAGGAGAAT--TCCGTG               
 
                 
 
CGCGACGGTGCGTGTTGTCGATGACCGGCGGTAGATCTAGCTCGGGCACAGggtgaatcgacaggtccgcagagcagccatacact 
tcgcgtcatgccccgATATTTGAGGGGGAACGGCTAACGGCAGTAAAGGAGAAGGGCCCGTGGCAGACACAATTCAGGTAACACCGCAGATG 
 
Figure 2.4 G. The PAN promoter in ESX-2. The PAN promoter was identified between Rv3892 and Rv3891 in M. tuberculosis.
154
 The published promoter sequences 
correspond to the promoter region identified by the BDGP Neural Network Promoter Prediction program (small letters), BPROM (bold) and with conserved regions 
within the slow growing mycobacteria. This promoter sequence is very similar to the mycobacterial consensus SigA promoter sequence.  
 
End of Rv3892c 
Start of Rv3891c 
17bp 
6bp 
Stop codon for preceding gene 
Start codon for following gene 
Putative –35 motif 
Putative -10 motif (Pribnow box) 
Putative transcriptional start site 
Putative ribosome binding site (RBS) 
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M.microti   -----------------------------------TGAATGAC-ATTGTCTGGCGAATAGCAAA--CTAATGCACTCAA-AGAGCCGCTCACGCGCAGTAAACAAGGAATCTCGAATCATGTTAGCATCGCGGTCGTG 
                                               |||||||| ||||||||||||||||||||  ||||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.tb        -----------------------------------TGAATGAC-ATTGTCTGGCGAATAGCAAA--CTAATGCACTCAA-AGAGCCGCTCACGCGCAGTAAACAAGGAATCTCGAATCATGTTAGCATCGCGGTCGTG 
                                               |||||||| ||||||||||||||||||||  ||||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.bovis     -----------------------------------TGAATGAC-ATTGTCTGGCGAATAGCAAA--CTAATGCACTCAA-AGAGCCGCTCACGCGCAGTAAACAAGGAATCTCGAATCATGTTAGCATCGCGGTCGTG 
                                               ||    || |  |||  | |||||||||   ||   | |||  | |  |    | |   |  ||||||  || ||| | || | |||||||||  || ||||| 
M.avium     TGACGGTGCGGCCCCGTTATCGCGTCAAACTAACTTGGTCAACCAAAGTCCTG-GAATAGCAACGCCTGTCGTACTTGA-AAGGTTTGTGATCGG--GTAAACGCGGTATCGCAAAGCGTGTTAGCATCGCG-TCGTG 
 
 
 
CCGGCGTGTGGTGTGAATGACATTGTCTGGCGAATAGCAAACTAATGCACTCAAAGAGCCGCTCACGCGCA 
GTAAACAAGGAATCTCGAATCATGTTAGCATCGCGGTCGTGACGAACCCGTGGAATGACC 
Figure 2.4 H. The putative promoter in the intergenic region Rv38898 of ESX-2. No promoters were predicted using the online promoter tools, however an 
extended -10 TGn motif and putative -10 and -35 are predicted based on sequence identity amongst the slow growers. The presence of the TGn motif corresponds 
to the high promoter activity exhibited by this promoter in the promoter assays. An additional conserved motif which may be important for transcription, possibly 
transcription factor binding, is underlined. M.tb - M. tuberculosis 
 
End of Rv3889c 
Start of Rv3888c 
2bp 17bp 
    Stop codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative extended -10 TGn motif 
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M.leprae        GATTCCGTCGACCGGCAGGCTGACCGTATTGAAGAAGATTCGATTCAATAATGTAATCCGATGCCGAGATGGGCGAGTGTATCGCACTTTGGCCAAGGTAAATACAGGTGATTTACGGTT 
                 |  ||        |||||   ||    | ||    |   ||     | | |    |||   | ||   | ||  | |    |||      ||| ||  ||  |||        |||  |   
M.tb            AACACCACTACGTTGCAGGTCAACGAGGTAGACTGCGGAGCGG----ACAGT----TCCACAGGCGGACTCGGTCATTCGC-CGCTACCATGCCCAGTGAAG-ACA------CGACGAAT 
                |||||||||||||||||||||||||||||||||||||||||||    |||||    ||||||||||||||||||||||||| |||||||||||||||||||| |||      |||||||| 
M.bovis         AACACCACTACGTTGCAGGTCAACGAGGTAGACTGCGGAGCGG----ACAGT----TCCACAGGCGGACTCGGTCATTCGC-CGCTACCATGCCCAGTGAAG-ACA------CGACGAAT 
                 || ||      | || | | |       ||    |  ||||     |   |    |     | |   | ||||||    | |    | |   |  |    |  |       | |||  | 
M.marinum       CACGCCGGCGATTCGCCGCTAACATGCACAGGAGACACAGCGA----ATCCT----TGGGGGGTCCAGCACGGTCAGCGTCGCATGGCGACTTCTGGCCCGGTGCC------CTACGGTT 
 
 
M.leprae        ATCGATAATGAGCAGTGCATAGCTTTTAAAGCCATGTCAATATACGGGAGTTTTT---TAGACCGGAAGGTGATCTAACGTG     
                         || | | |||  |     | | ||| |||||| | | || ||| |     |||||||||||||||||| |||| 
M.tb            CCTTGGG-GGATCCGCGCAGTGGCAA-ATACCCAGGTCAATGTCCAGGTGTTCTGAG-CAGACCGGAAGGTGATCTAGCGTG 
                ||||||| |||||||||||||||||| |||||||||||||||||||||||||||||| |||||||||||||||||||||||| 
M.bovis         CCTTGGG-GGATCCGCGCAGTGGCAA-ATACCCAGGTCAATGTCCAGGTGTTCTGAG-CAGACCGGAAGGTGATCTAGCGTG 
                      |  |||| |||    |      || ||||| ||   |||||| |||||||  |||| || ||||||||||| |||| 
M.marinum       GTCAACG-TGATCAGCGTTACGCCGG-GTATCCAGGCCAGCATCCAGGCGTTCTGAAACAGAGCGAAAGGTGATCTAACGTG 
 
 
ACCAGCGAAGGCGCGAGCTCGGTCATGTCGCCCATCTTGCGTCCGGCACCCGTGTGCGGGCGAGCGCAGGAATCTG 
AGCCTTCCGTCAGCACAGCACGGTTGGCTACCGAACACCACTACGTTGCAGGTCAACGAGGTAGACTGCGGAGCGG 
ACAGTTCCACAGGCGGACTCGGTCATTCGCCGCTACCATGCCCAGTGAAGACACGACGAATCCTTGGGGGATCCGC 
GCAGTGGCAAATACCCAGGTCAATGTCCAGGTGTTCTGAGCAGACCGGAAGGTGATCTAGCGTG 
Figure 2.4 I. The putative promoter in the intergenic region Rv178182 of ESX-5.  A possible promoter was identified between Rv1781c and Rv1782 by BROM 
(bold), however this region showed low sequence identity outside of the M. tuberculosis complex species. and alternative promoter motifs, closer to the start codon 
are based on sequence identity and similarity to mycobacterial consensus promoter sequences. Promoter motifs predicted by BPROM are given in bold. 
M.tb - M. tuberculosis  
Start of Rv1781c 
Start of Rv1782 
16bp 1bp 
10bp 
    Start codon for preceding gene 
    Start codon for following gene 
    Putative –35 motif 
    Putative -10 motif (Pribnow box) 
    Putative transcriptional start site 
    Putative ribosome binding site (RBS) 
     
 
 
 
 
 
 
6 
bp 
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M.tb            ACTCTTCCGGCTGAATTCGATGCTCTGGGCGCCCGCTCGACGCCGAGTATCTCGAGTGGGCCGCAAACCCGGTCAAACGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGTGCCAA 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.bovis         ACTCTTCCGGCTGAATTCGATGCTCTGGGCGCCCGCTCGACGCCGAGTATCTCGAGTGGGCCGCAAACCCGGTCAAACGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGTGCCAA 
                 |||||| | | | |  ||          | |   || |||   |||| |   |||||||  || |      || | ||||||||||||| |||||| |||||||||||  |||||| |  
M.marinum       -CTCTTCGGCCAGCAGCCG----------CACATCCTTGACTGTGAGTTTGCTGAGTGGGAAGCTAGGTGCATCGAGCGCTGTTACTGTGTCGTTACTACAGGTGAATTCACGGTGCTAT 
 
 
M.tb            CTGGTGAACACTTGCGAACGGGTGGCATCGAAATCAACTTGTTGCGTTGCAGTGATCTACTCTCTTGCAGAGAGCCGTTGCTGGGATTAATTGGGAGAGGAAGACAGCATG 
                ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.bovis         CTGGTGAACACTTGCGAACGGGTGGCATCGAAATCAACTTGTTGCGTTGCAGTGATCTACTCTCTTGCAGAGAGCCGTTGCTGGGATTAATTGGGAGAGGAAGACAGCATG 
                |  |||||||  ||| ||| ||   | | |||  |||| ||  |     |||| ||||| ||||| |||       |  || |||  |||| | | |||||| |||||||| 
M.marinum       CGCGTGAACAAATGCAAACAGGCCCCGTAGAAGGCAACCTGGCGTCACACAGTCATCTAGTCTCT-GCACTAGATGGGCGCCGGGGATAATCGAGGGAGGAATACAGCATG 
 
 
ATTACCCGGTCTCCGTCGGCGGGATAGCTTTCGATCCGGTCTGCGCGGCCGCCGGAAATGCTGCAGATAGCGATCGACCGCGCCGGTCGGTAAA 
CGCCGCACACGGCACTATCAATGCGCACGGCGGGCGTTGATGCCAAATTGACCGTCCCGACGGGGCTTTATCTGCGGCAAGATTTCATCCCCAG 
CCCGGTCGGTGGGCCGATAAATACGCTGGTCAGCGCGACTCTTCCGGCTGAATTCGATGCTCTGGGCGCCCGCTCGACGCCGAGTATCTCGAGT 
GGGCCGCAAACCCGGTCAAACGCTGTTACTGTGGCGTTACCACAGGTGAATTTGCGGTGCCAACTGGTGAACACTTGCGAACGGGTGGCATCGA 
AATCAACTTGTTGCGTTGCAGTGATCTACTCTCTTGCAGAGAGCCGTTGCTGGGATTAATTGGGAGAGGAAGACAGCATG 
Figure 2.4 J. The putative promoter in the intergenic region Rv179091 of ESX-5. BPROM identified promoter motifs (bold) in the intergenic region between 
Rv1790 and Rv1791, however these sequences are not very conserved and another possible promoter was identified based on identity and similarity to the 
consensus promoter sequences.Additional conserved regions which may be important for transcription initiation, or the regulation thereof are underlined.  
M.tb - M. tuberculosis 
 
Start of Rv1791 
End of Rv1790 
13bp 
17bp 8bp 
4bp 
Stop codon for preceding gene 
Start codon for following gene 
Putative –35 motif 
Putative -10 motif (Pribnow box) 
Putative transcriptional start site 
Putative ribosome binding site (RBS) 
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M.tb            AGAGTATGACGCCAGGGCGTGAAACCCGAAGTACAACAACAAATTTGAGCATCAGATACAACCCAGATACGTACAGGGCAAATTGCTCTAGAATCGACTGCAATACTGCAAGGCAAGGT 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
M.bovis         AGAGTATGACGCCAGGGCGTGAAACCCGAAGTACAACAACAAATTTGAGCATCAGATACAACCCAGATACGTACAGGGCAAATTGCTCTAGAATCGACTGCAATACTGCAAGGCAAGGT 
                ||||| |||    | |    ||||      || || |||    ||| ||||| | || | |   |||     ||| |||| | ||||||||||||  | | || |||| || |||| |  
M.marinum       AGAGTTTGATAGGAAGCGACGAAATTGCGCGTGCAGCAAGCTTTTTAAGCATAAAATGCGATTGAGACGGCAACACGGCATACTGCTCTAGAATCCGCAGTAAAACTGAAAAGCAACGG 
 
 
M.tb            CAACCACAACGATTTGGTCGCGAGGCAAGGCAAATGAAATCGGAGTTAGTCGAGCCGCAGCTCCCGGTGGGCTACCGCGCCTCGGTGCCTACACCGACGG---------------AGCTC 
                ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||               ||||| 
M.bovis         CAACCACAACGATTTGGTCGCGAGGCAAGGCAAATGGAATCGGAGTTAGTCGAGCCGCAGCTCCCGGTGGGCTACCGCGCCTCGGTGCCTACACCGACGG---------------AGCTC 
                |||| ||||| |||  ||||| |||| ||||||||| ||| ||||||||||||||||||  |    | ||||||| |||| ||||||  |  ||||||||               ||| | 
M.marinum       CAACTACAACTATT-AGTCGCAAGGCGAGGCAAATGAAATTGGAGTTAGTCGAGCCGCAAATGAAAGCGGGCTACGGCGCTTCGGTGTATGTACCGACGGTGTATGTACCGACAGAGCCC 
 
 
 
M.tb            CCCGCGCCACTGAAGCCACGGTGTAACACGTTTGCCATGGCAGGGGGTACAGGACGATGA 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
M.bovis         CCCGCGCCACTGAAGCCACGGTGTAACACGTTTGCCATGGCAGGGGGTACAGGACGATGA 
                |  ||||  |||||| ||||| |||||||||| ||||  ||||||||||||| ||||||| 
M.marinum       CGGGCGCGGCTGAAGTCACGGAGTAACACGTTCGCCACAGCAGGGGGTACAGAACGATGA 
 
 
GAGTATGACGCCAGGGCGTGAAACCCGAAGTACAACAACAAATTTGAGCATCAGATACAACCCAGATACGT 
ACAGGGCAAATTGCTCTAGAATCGACTGCAATACTGCAAGGCAAGGTCAACCACAACGATTTGGTCGCGAGG 
CAAGGCAAATGAAATCGGAGTTAGTCGAGCCGCAGCTCCCGGTGGGCTACCGCGCCTCGGTGCCTACACCGA 
CGGAGCTCCCCGCGCCACTGAAGCCACGGTGTAACACGTTTGCCATGGCAGGGGGTACAGGACGATG 
Figure 2.4 K. The putative promoter in the intergenic region Rv179091 of ESX-5. BPROM identified a possible promoter sequence in the intergenic region 
between Rv1794 and Rv1795 (bold). This region is not highly conserved outside of the M. tuberculosis complex, and more conserved areas in the intergenic region 
(underlined), may contain alternate promoter motifs, although they were not identified. 
 
Start of Rv1782 
End of Rv1790 
17bp 
10bp 
Stop codon for preceding gene 
Start codon for following gene 
Putative –35 motif 
Putative -10 motif (Pribnow box) 
Putative transcriptional start site 
Putative ribosome binding site (RBS) 
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2.3. Discussion 
The five M. tuberculosis ESX gene cluster regions each contain six conserved genes as well as 
several additional genes which occur in one or more of the regions.
26, 27
 The arrangement of the 
constituent genes of each gene cluster region is different. The ESX-3 and ESX-2 gene components 
occur on a single strand and in close proximity, although the sequence and constituents vary. In the 
ESX-1 and ESX-5 gene cluster regions, most of the more conserved genes occur on a single strand, 
however gene insertions occur on the complementary strand and precipitate an inversion of two 
conserved genes in ESX-1. The protein products of each ESX gene cluster region are predicted to be 
components and substrates of dedicated protein secretion systems. This functional relationship is 
supported by the arrangement of the genes in clusters and the conservation of the clusters between 
bacterial species.
156
 Although the precise functions of these five secretion systems remain to be 
resolved, they are unable to complement each other,
30
 suggesting that their functions are distinct, and 
possibly that the conditions of their expression are different. Indeed, expression of some ESX gene 
clusters is dependent on specific environmental conditions, e.g. expression of ESX-3 is dependent on 
environmental iron and zinc concentration.
50, 114, 116
 ESX-1 and ESX-5 have, however, been shown to 
influence one another, as deletion of EsxA and EsxB from ESX-1 results in increased secretion of the 
ESX-5 substrate PPE41,
59
 and deletion of ESX-5 increases the secretion of ESX-1 substrates.
30
 This 
suggests that the functions of one ESX may influence that of another. In this chapter we have 
identified the promoter-containing intergenic regions of the M. tuberculosis ESX gene clusters as a 
first step in determining the signals which allow expression of these ESX secretion systems. The 
promoter activities of the intergenic regions of the M. tuberculosis ESX gene clusters were compared 
using a β-galactosidase assay, and promoter containing regions identified (Figure 2.5).  
No promoter activity was detected in the intergenic regions of ESX-4. It has been suggested that ESX-
4 may not be expressed, or functional, in M. tuberculosis and M. smegmatis, as the EsxU protein has 
not been detected in culture supernatants, and exogenously expressed EsxU is not secreted.
119, 120
 
However, transcription of ESX-4 and its components, esxT and esxU, has been shown to be 
dependent on WhiB5 and SigM in M. tuberculosis.
112, 122
 WhiB5 has been shown to be important for 
reactivation of M. tuberculosis after persistence and this may indicate that expression of ESX-4 occurs 
only under specific conditions. Furthermore, ESX-4 is conserved throughout the Mycobacteria and 
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Figure 2.5. The promoters driving expression of the ESX gene clusters of M. tuberculosis, investigated in this study. Intergenic regions which showed 
promoter activity in this study are indicated as black arrows.
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various other actinomycetes, suggesting that the region serves a biological function and it may only be 
expressed and functional under specific conditions and growth states, and not in normal in vitro growth. 
The other 4 ESX gene clusters all have a promoter-containing intergenic region directly upstream, or within a 
few genes upstream of the cluster, with various additional promoters within the gene clusters (Figure 2.5). A 
single promoter-containing region, PESREG3, was identified upstream of ESX-3. Three promoters have been 
identified in this intergenic region, one regulated by IdeR in response to iron concentration,
50
 one regulated 
by Zur in response to zinc concentration,
114
 and one which contains the SigC promoter consensus 
sequence.
153
 The various promoters are likely responsible for differential expression under various conditions 
to tightly regulate the levels of ESX-3 proteins in the cell.  
In ESX-1 we identified three promoter-containing intergenic regions. One of these are located upstream of 
the gene cluster, directly upstream of espF (P6465). P6465 is likely responsible for expression of the ESX-1 
genes on the forward strand. espF (Rv3865) occurs directly upstream of espG and espH and is an ESX-1 
secreted protein. Another promoter (P8483) occurs downstream of the ESX-1 gene cluster, 5’ to the mycP1 
gene, which occurs on the complementary strand, and may express the reverse-oriented portion of the ESX-
1 gene cluster. This promoter was, however, only identified in the M. bovis BCG assay, indicating that this 
promoter may require a sigma factor or other transcription factors which are specific to M. tuberculosis, or 
the slow-growing mycobacteria in general, however no promoter motifs which are specific to the slow-
growing mycobacteria could be identified in this promoter region. This may indicate the requirement of 
specific transcription factors which are only present in the slow-growing mycobacteria. Promoter activity was 
also identified upstream of the esxB-esxA operon (P7374) and this promoter has previously been shown to 
express esxB and esxA as an operon.
36
 These promoters can explain expression of the entire ESX-1 gene 
cluster, on both strands, with potential inducible, or increased, expression of esxA and esxB. 
ESX-2 contains three internal promoter-containing intergenic regions and another is situated one gene 
upstream of the gene cluster (P38976). The upstream gene, Rv3896, is a conserved hypothetical gene of 
unknown function and its co-expression with ESX-2 may imply that it is involved in ESX-2 function. The 
internal promoters occur upstream of the pe/ppe gene pair (P38943), the esxD-esxC gene pair (PAN)
154
 and the 
espI-like gene Rv3888c (P38898). The single strand layout of ESX-2 might suggest that this entire cluster is 
expressed in an operon from P38976, and that the internal promoters regulate differential expression of various 
components as they are required under different conditions.  
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A promoter-containing intergenic region also occurs directly upstream of ESX -5, with two additional internal 
intergenic regions which exhibit promoter activity. One occurs directly upstream of eccD5 and the other 
upstream of the pe19 gene directly upstream of the esxM-esxN gene pair. 
Clearly each of the ESX duplications subsequent to ESX-4 is expressed from an upstream promoter and in 
ESX-1 an additional promoter occurs upstream of the gene components on the complementary strand. An 
additional promoter occurs upstream of the esx gene pair in each of the ESX-1, -2 and -5 gene clusters, 
although in ESX-5 a pe gene is inserted between the promoter and the esx gene pair. In ESX-3 a promoter 
has been identified upstream of the esxG-esxH gene pair in M. smegmatis, although no promoter activity has 
been detected in M. tuberculosis.
115
 The promoters upstream of the esx gene pairs, and other internal 
promoters, may increase expression of specific components or substrates in response to specific 
environmental cues. 
The sequences of the various promoters, both previously identified and proposed in this study (Table 2.1), 
show little conservation between and within ESX gene clusters. This is consistent with the proposed distinct 
functions and expression profiles of the ESX secretion systems. Mycobacterial promoters are not very well 
characterised and extensive sequence variation, particularly in the -35 region of the promoter, is common, 
probably due to the large number of sigma factors and other transcription factors employed in the 
mycobacteria. (Mycobacterial promoters and their regulatory motifs are described in Addendum A: Newton-
Foot, M, Gey van Pittius, NC, The complex architecture of mycobacterial promoters, Tuberculosis (2012), 
http://dx.doi.org/10.1016/j.tube.2012.08.00) This is consistent with what is seen in the ESX gene clusters, 
where although there is a level of similarity between the -10 hexamer sequences, there is little conservation 
in the -35 hexamer sequences. The two promoter prediction programs used to identify promoter motifs in the 
intergenic regions which exhibited promoter activity, are optimised for the identification of general bacterial 
promoter motifs (the analysis was done for prokaryotes on BDGP). Due to the extensive variation and lack of 
conservation of mycobacterial promoters with other bacterial motifs, these programs were not efficient in the 
identification of motifs in the promoter-containing intergenic regions. Furthermore, with the exception of the 
previously published SigC promoter and Zur and Fur binding sites in ESX-3, no specific sigma factor or 
regulatory binding sequences could be discerned. However, two extended -10 TGn motifs occur upstream of 
ESX promoters, one upstream of ESX-3 and another upstream of EspI in ESX-2 (Table 2.1, Figure 2.4). 
Extended -10 promoters are typically very strong promoters, as observed by the very strong promoter activity  
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Table 2.1. The proposed promoter motifs of the M. tuberculosis ESX gene cluster promoters. 
REGION PROPOSED PROMOTER REFERENCE 
ESX PROMOTER -35 bp TGn -10 bp TSP bp RBS bp START CODON 
 
ESX-3 PESREG3 
GCTCCA 19 
 
TAAGCT 7 G 
 
AGGCGGA 
 
ATG 
50
 
CGAAAT 26 
 
CGTGCC 
    
ATG 
153
 
TCGACA 17 TGC TAACTT 5 CA 6 7 ATG 
114
 
             
ESX-1 
P6465 TCTGTG 19  
TAGCGA 13 CG 3 AGGAGGG 8 ATG This study 
            
P7374 
AGGACG 14 
 
TAATGA 3 CA 58 GAGAAA 10 ATG 
36
 
TTCCCG 14 
 
AAGACT 6 CA 4 GGCGAGG 26 ATG This study 
            
P8483 TTGTTT 16  
TAAAAT 5 CA 42 GGAGTG 8 GTG This study 
ESX-2 
P38976 TTCGCG 19  
TCGCGT 3 CG 66 GAGGTG 19 GTG This study 
            
P38943 TGTACG 20  
TATCCT 5 CG 163 GGAGGGG 5 ATG This study 
            
P38898 GTAAAC 19 TGT TAGCAT 2 CG 3   
GTG This study 
            
PAN TCGACA 17  
TACACT 6 CA 38 AGGAGAA 6 GTG 
154
 
ESX-5 
P178182 
TTGCAG 10 
 
TAGACT 6 CG 123 GGAAGG 9 GTG This study 
TACCCA 16 
 
TTCTGA 1 CA 4 GGAAGG 9 GTG This study 
            
P179192 
TGTTAC 17 
 
TGAATT 8 CA 97 GAGGAA 6 ATG This study 
TTGTTG 13 
 
TACTCT 4 CA 27 GAGGAA 6 ATG This study 
            
P179495 ATACAA 17  
CAAATT 10 CG 169 AGGGGG 9 ATG This study 
Mycobacterial  
consensus TTGACG/A 17±1 TGn TATRMT 5-9 A/G 
 
AGGAGG 4-7 GTG/ATG/TTG 
157
 
             M. tuberculosis  
consensus 
TTGACR 16-19 TGn TAYgAT 5-9 A/G AGGAGG 4-7 GTG/ATG/TTG 
158
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of the ESX-3 promoter (PESREG3). P38898 is also a strong promoter, although to a lesser degree, and may 
be regulated by other factors.  
2.4. Conclusion 
The five ESX gene clusters of M. tuberculosis encode functionally distinct secretion systems. We have 
identified promoter containing intergenic regions from the ESX gene cluster regions 3, 1, 2 and 5, but no 
promoter activity was detected for the ancestral region ESX-4. This study was however limited to the 
detection of intergenic promoters under in vitro growth in minimal culture medium and any promoters 
which are not active under these conditions may have been missed. Promoter activity was assayed 
using both M. smegmatis and M. bovis BCG as host organisms to account for any differences in the 
transcriptional machineries between the fast-growing saphrophytic, and slow-growing pathogenic 
mycobacteria. The results were consistent for all of the intergenic regions which were included in this 
study, with the exception of Rv8483, the region upstream of the ESX-1 components on the reverse 
strand, although no specific promoter motifs could be identified which would distinguish between these 
activities.  
The positions of the promoters in the ESX duplications appears to be fairly conserved, with promoters 
occurring upstream of each gene cluster, with internal promoters occurring at similar positions, 
particularly upstream of the esx gene pairs. The proposed promoter sequences show little sequence 
identity, which may be indicative of the differential expression patterns of the different ESX gene clusters 
and their distinct functions. Identification of these promoters will assist in the investigation of the 
expression patterns and functional roles of the ESX secretion systems. 
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3. The functions of the mycobacterial ESX secretion systems and their substrates 
3.1. Introduction 
The ESX secretion systems have been implicated in the survival and virulence of M. tuberculosis, 
however their precise biological functions have yet to be clarified. The fast-growing, non-pathogenic 
mycobacterium, M. smegmatis, is frequently used as a model organism for the investigation of M. 
tuberculosis biological systems. M. smegmatis contains three ESX gene clusters, ESX-1, ESX-3 and 
ESX-4, which are similar in arrangement and composition to their orthologs in M. tuberculosis,
27
 some of 
which have been shown to be functionally equivalent.
105, 107, 110
  
To investigate the functions and substrates of the mycobacterial ESX secretion systems a library of ESX 
knockout strains of M. smegmatis was generated using allelic exchange. Each of the ESX gene clusters 
was deleted individually to create the ESX knockout strains ESX-1ms, ESX-3ms and ESX-4ms, which 
were subsequently used to create the double and triple mutant strains ESX-1ESX-3ms, ESX-1ESX-
4ms, ESX-3ESX-4ms and ESX-1ESX-3ESX-4ms. All deletions were confirmed by selective PCR 
amplification and sequencing across the deleted region. The successful deletion of all three M. 
smegmatis ESX gene clusters indicates that all three secretion systems are non-essential for in vitro 
growth of the organism; furthermore the generation of double- and triple- ESX deletion strains indicates 
that ESX secretion in general is dispensable for M. smegmatis growth in vitro. To investigate the specific 
biological changes associated with ESX-1, ESX-3 and ESX-4, ESX-1ms, ESX-3ms and ESX-4ms were 
used in comparative metabolomic and proteomic analyses with wild type M. smegmatis. The differential 
protein and metabolite profiles of the bacteria in the presence and absence of each ESX was used to 
investigate the functions of the ESX secretion systems. 
3.1.1. Whole cell lysate proteomic analysis of the M. smegmatis ESX secretion systems. 
Proteomic analysis of the whole cell lysates of ESX-1ms, ESX-3ms, and ESX-4ms, in comparison to that 
of WTms, was used to identify differences in the protein profiles of the mutant and wild type organisms 
resulting from the presence or absence of the ESX gene cluster.  Whole cell lysate protein fractions were 
prepared from cultures grown in routine 7H9 culture medium in the absence of bovine serum albumin, 
and fractionated by SDS-PAGE to enable maximum sensitivity. LC-MS/MS analysis was done on the 
LTQ Orbitrap Velos to identify and quantify the proteins present each sample. Samples were analysed in 
technical duplicates of biological duplicates (4 replicates), using a single WTms experiment as reference 
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for all three ESXms strains. Proteins were identified using Thermo Proteome Discoverer 1.3 by 
automated database searching (Mascot and Sequest) of the tandem mass spectra against the M. 
smegmatis database at TB Database (TBDB). Proteins were searched and quantified using the 
Andromeda function from Maxquant 1.2.2.5. The peptide peak intensities were used to identify proteins 
with different abundances in the two strains. A two fold difference in protein abundance, with a 
significance level of 0.05 was considered statistically relevant. 
3.1.2. Culture filtrate proteomic analysis of the M. smegmatis ESX secretion systems. 
Proteomic analyses of the culture filtrates of ESX-1ms; ESX-3ms; ESX-4ms were done to identify novel 
substrates of the ESX secretions systems by identifying proteins which are secreted in WTms but not in 
the various knock out strains (Section 4), and to identify other proteomic changes in the culture filtrates 
resulting from the presence or absence of the ESX secretion systems. Culture filtrate fractions were 
prepared from WTms, ESX-1ms, ESX-3ms and ESX-4ms grown to early log phase (OD600   0.3) in 
Middlebrook 7H9 medium, in the absence of BSA, catalase and Tween-80, and the constituent proteins 
were identified by LC-MS/MS analysis on the LTQ Orbitrap Velos.  
Samples were analysed in technical duplicates of biological duplicates (4 replicates), using a single WTms 
experiment as reference for all three ESXms strains. Proteins were identified and relative quantification 
done as for the whole cell lysate proteome. Protein concentrations in the culture filtrate fractions may be 
influenced directly by ESX secretion, by increased expression levels and by additional biological 
processes which are influenced by the presence or absence of the ESX secretion systems. 
3.1.3. Metabolomic analysis of the M. smegmatis ESX secretion systems. 
Metabolomics is an approach which aims to examine all the metabolites in an organism, with specific 
interest in those metabolites originating from, or influenced by, altered gene expression. This approach 
was used to analyse the changes in metabolites resulting from the absence and presence of the ESX-3 
and ESX-4 gene clusters in M. smegmatis. Metabolites were extracted from M. smegmatis cultures and 
GC-MS analysis was done on an Agilent 7890A gas chromatograph coupled to an Agilent 5975B mass 
selective detector, in collaboration with Prof. Du Toit Loots at the Centre for Human Metabonomics, North 
West University, South Africa. PCA, PLS-DA and univariate statistical analyses were done on the 
metabolite data to determine whether the ESX strains group separately from wild type M. smegmatis 
and to identify metabolites which contribute most to the variation between the strains.  
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3.2. The functions of the M. smegmatis ESX-1 secretion system and its substrates 
3.2.1. Introduction 
ESX-1 has been implicated in virulence in M. tuberculosis; however this gene cluster is found throughout 
most of the fast growing mycobacteria, including M. smegmatis, and has been deleted from a number of 
the disease-causing slow growers. Several studies have shown that the M. smegmatis and M. 
tuberculosis ESX-1 secretion systems are, to at least some degree, functionally equivalent.
105, 107, 110
 This 
suggests that ESX-1 has a non-essential function which is unrelated or indirectly related to virulence. 
This study investigates the role of ESX-1 in M. smegmatis on a proteomic level by comparing a ESX-1 
deletion strain to the parental M. smegmatis strain, in order to identify possible biological functions of this 
secretion system. 
3.2.2. Results 
3.2.2.1.  Whole cell lysate proteomic analysis of ESX-1 function 
The whole cell lysate fractions of mid log phase cultures of ESX-1ms and WTms were analysed using LC-
MS/MS on the LTQ Orbitrap Velos in order to define their proteomes. In total, 2952 proteins were 
identified between the two strains (Supplementary Table S3.1). Protein abundances were compared and 
used to investigate the biological functions of the ESX-1 secretion system. Sixty-six proteins were 
differentially abundant between the two strains (Table 3.2.1), representing approximately 2.2% of the 
detected proteome. Ten proteins were only detected in ESX-1ms and 14 only in WTms, while a further 19 
and 23 proteins were detected at greater or lower levels in ESX-1ms than in WTms, respectively. 
Most of the ESX-1 protein components were detected in WTms, however only eight are given in Table 
3.2.1, as the variation in abundance of other proteins was not considered significant due to the variation 
in the levels in which they were detected, or due to their detection in only one or two of the WTms 
replicates. Four of the ESX-1 proteins were detected in ESX-1ms, all of which were detected at 
significantly reduced levels (between 5 and 240 fold less in ESX-1ms). EspG1 (MSMEG_0057) is only 
partially deleted from ESX-1ms, and the presence of truncated EspG1 accounts for the detection of this 
protein in ESX-1ms. EccA1 (MSMEG_0059) was detected in a single ESX-1ms replicate, in which only 
three of thirteen unique peptides detected in WTms were identified. MSMEG_0071/0074 was also 
detected in only a single replicate of ESX-1ms, and only three of the eight unique peptides detected in  
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Table 3.2.1. Proteins with different abundances in ESX-1ms and WTms WCLs, classified according to biological function. 
MSMEG_ Product Differential abundance* p value Biological function 
H37Rv 
ortholog 
0061 FtsK/SpoIIIE family protein, EccC1a  only WTms 0.007 ESX-1 Rv3870 
0066 early secretory antigenic target, 6 kDa, ESAT-6, EsxA  only WTms 0.012 ESX-1 Rv3875 
0076 antigen MTB48, EspB only WTms 0.023 ESX-1 Rv3881c 
0083 membrane-anchored mycosin MycP1 only WTms 0.009 ESX-1 Rv3883c 
0057 hypothetical protein, EspG1 -11.7 0.021 ESX-1 Rv3866 
0059 ATPase, AAA family protein, EccA1 -5.1 0.023 ESX-1 Rv3868 
0067 hypothetical protein, EspI1  -15.7 0.000 ESX-1 Rv3876 
0071/0075 hypothetical protein, ESX-1 encoded -242.9 0.038 ESX-1 
 3807 TetR-type regulator  only ESX-1ms 0.022 Transcriptional regulation 
 0179 transcriptional regulator, GntR family protein  2.1 0.038 Transcriptional regulation 
 0983 two-component system response regulator  2.5 0.014 Transcriptional regulation 
 1397 transcriptional regulator, TetR family protein 2.2 0.005 Transcriptional regulation Rv0681 
4953 putative transcriptional regulator  2.6 0.006 Transcriptional regulation 
 5673 transcriptional regulator  2.0 0.025 Transcriptional regulation 
 6300 transcriptional regulator, GntR family protein  3.0 0.008 Transcriptional regulation 
 1915 anti-sigma factor, family protein  -4.7 0.007 Transcriptional regulation Rv3221A 
2793 sensor-type histidine kinase PrrB  only WTms 0.013 Transcriptional regulation 
 0087 glucitol operon repressor  3.1 0.052 Transcriptional regulation 
 6096 Bvg accessory factor family protein 2.1 0.039 Transcriptional regulation 
 2437 16S rRNA processing protein RimM  3.3 0.030 Translation Rv2907c 
0832 peptide deformylase only ESX-1ms 0.033 Translation Rv0429c 
6911 ABC transporter, ATP-binding protein GluA Only WTms 0.019 Amino acid metabolism 
 3208 imidazole glycerol phosphate synthase,  glutamine amidotransferase, hisH 2.6 0.051 Amino acid metabolism Rv1602 
3173 L-asparaginase -3.1 0.036 Amino acid metabolism Rv1538c 
3207 imidazoleglycerol-phosphate dehydratase, HisB -2.1 0.004 Amino acid metabolism Rv1601 
3878 precorrin-6Y C5,15-methyltransferase, CobL only ESX-1ms 0.013 Cofactor metabolism Rv2072c 
2597 aldehyde dehydrogenase only ESX-1ms 0.030 Reduction/oxidation Rv2858c 
6874 aldehyde dehydrogenase only ESX-1ms 0.003 Reduction/oxidation 
 1157 short chain dehydrogenase  only ESX-1ms 0.000 Reduction/oxidation 
 0884 glyoxalase family protein 2.5 0.032 Reduction/oxidation 
 5862 short chain dehydrogenase  4.5 0.035 Reduction/oxidation Rv0765c 
2206 3-oxoacyl-(acyl-carrier-protein) reductase, FabG -2.5 0.036 Reduction/oxidation Rv1350 
5837 glutathione peroxidase family protein -2.0 0.011 Reduction/oxidation 
 0985 sugar transporter family protein  only ESX-1ms 0.000 Carbohydrate metabolism Rv3476c 
5676 citrate synthase  2.0 0.034 Carbohydrate metabolism Rv0889c 
5345 glycosyl hydrolases family protein 16  -3.1 0.039 Carbohydrate metabolism 
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1676 adenosine deaminase -2.1 0.001 DNA/RNA metabolism Rv3313c 
6927 MutT/nudix family protein -2.5 0.041 DNA/RNA metabolism Rv3908 
6278 metallo-beta-lactamase superfamily protein only WTms 0.028 Antibiotic 
 0819 N-carbamoyl-L-amino acid amidohydrolase only ESX-1ms 0.021 Other 
 0946 NAD dependent epimerase/dehydratase family only WTms 0.009 Other Rv0501 
2579 zinc metalloprotease only WTms 0.014 Other Rv2869c 
5516 phosphoribosylglycinamide formyltransferase  only WTms 0.024 Other Rv0956 
0203 IS1096, tnpR protein   2.7 0.014 Other 
 2201 ZbpA protein  2.5 0.052 Other Rv0130 
3430 SAM-dependent methyltransferase  2.0 0.036 Other 
 4704 acyltransferase family protein 8.2 0.006 Other Rv2483c 
0434 aminoglycoside 2'-N-acetyltransferase -2.3 0.021 Other Rv0262c 
3655 ABC transporter, permease/ATP-binding protein  -2.0 0.013 Other Rv1819c 
4475 LppP protein -3.3 0.023 Other Rv2330c 
0546 hypothetical protein only ESX-1ms 0.032 Hypothetical protein 
 5087 hypothetical protein  only ESX-1ms 0.003 Hypothetical protein Rv1205 
0840 hypothetical protein only WTms 0.016 Hypothetical protein 
 2032 hypothetical protein only WTms 0.005 Hypothetical protein 
 2679 hypothetical protein only WTms 0.008 Hypothetical protein 
 3204 hypothetical protein only WTms 0.033 Hypothetical protein Rv1598c 
2445 hypothetical protein 2.5 0.022 Hypothetical protein 
 6901 hypothetical protein 6.5 0.008 Hypothetical protein Rv0049 
2498 hypothetical protein -2.5 0.012 Hypothetical protein 
 3592 hypothetical protein  -2.3 0.038 Hypothetical protein 
 3613 hypothetical protein -7.2 0.017 Hypothetical protein 
 4219 hypothetical protein  -2.0 0.021 Hypothetical protein Rv2147c 
5816 hypothetical protein  -2.4 0.037 Hypothetical protein 
 6207 hypothetical protein  -2.3 0.026 Hypothetical protein 
 *Differential abundances represent the fold change in abundance of a protein in ESX-1ms relative to WTms. Negative values indicate a lower abundance in ESX-
1ms than WTms. Where indicated proteins were detected in only one strain. 
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WTms were identified, at dramatically reduced intensities. EspI1 (MSMEG_0067) was detected in all four 
replicates, however only four or five peptides were identified in any ESX-1ms replicate, relative to eleven 
in WTms. The detection of these peptides in ESX-1ms is incongruent with the absence of the proteins 
expressed from just within the borders of the deletion and throughout the deleted region, and might be 
attributed to peptide contamination or the presence of homologous proteins. The reduced abundances 
and numbers of peptides from these proteins detected in ESX-1ms, together with the complete absence 
of other ESX-1 proteins, however, support the deletion of ESX-1 from ESX-1ms and indicates that ESX-1 
is expressed under these in vitro conditions in WTms.  
Despite the significant expression levels of the ESX-1 proteins, and significant changes in abundance of 
various proteins, no cellular pathways appear to be considerably influenced by the deletion of ESX-1. The 
only protein grouping which shows noteworthy differences between the two strains is transcriptional 
regulation, where there is a general increase in the abundances of various transcriptional regulators. 
Other differences include proteins involved in oxidation and reduction reactions, carbohydrate and amino 
acid metabolism, and a number of unclassified and hypothetical proteins.  
3.2.2.2. Culture filtrate proteomic analysis of ESX-1 function 
Proteins were identified from the culture filtrate fractions of WTms and ESX-1ms cultures, using LC-
MS/MS analysis on the LTQ Orbitrap Velos. A total of 1783 proteins were detected in the two strains 
(Supplementary table S3.2). Protein abundances were compared and thirty-six proteins found to vary in 
abundance between the two strains (Table 3.2.2.) Thirteen were present only in ESX-1ms and 7 only in 
WT, while 9 were more abundant in ESX-1ms and a further 7 more abundant in WTms. The deviant 
proteins could be classified into much the same groups as in the WCL proteomic analysis, however a 
reduction in divergent transcription factors may indicate that enrichment for secreted proteins was 
successful.  
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Table 3.2.2. Proteins with different abundances in ESX-1ms and WTms culture filtrates, classified according to biological function. 
MSMEG_ Product Differential abundance* p value Biological function 
H37Rv 
ortholog 
0059  ATPase, AAA family protein, large subunit only WTms 0.008 ESX-1 Rv3868 
3142 HTH-type transcriptional repressor AcnR only WTms 0.000 Transcriptional regulation Rv1474c 
5512 magnesium chelatase 3.3 0.001 Transcriptional regulation Rv0958 
3778 phenylalanyl-tRNA synthetase, alpha subunit  only WTms 0.002 Translation Rv1649 
6102 dihydroneopterin aldolase, folB only ESX-1 0.049 Cofactor metabolism Rv3607c 
1603 IMP dehydrogenase family protein only ESX-1ms 0.000 Reduction/oxidation Rv3410c 
4320 alkyl hydroperoxide reductase only ESX-1ms 0.003 Reduction/oxidation Rv3328c 
5029 alkanal monooxygenase alpha chain  only ESX-1ms 0.004 Reduction/oxidation  
2529 glyoxylate reductase  only ESX-1ms 0.014 Reduction/oxidation  
6916 short chain dehydrogenase only ESX-1ms 0.048 Reduction/oxidation  
6362 quinone oxidoreductase  2.1 0.017 Reduction/oxidation Rv3777 
1573 carbohydrate kinase family protein  only WTms 0.012 Carbohydrate metabolism Rv3433c 
0313 phosphogluconate dehydratase -2.5 0.041 Carbohydrate metabolism 
 
2362 DNA ligase, NAD-dependent  -2.0 0.002 DNA/RNA metabolism Rv3014c 
6278 metallo-beta-lactamase superfamily protein only WTms 0.013 Antibiotic  
5245 universal stress protein family protein  2.0 0.049 Stress  Rv2028c/Rv3134c 
0635 putative conserved exported protein  -2.0 0.007 Secreted protein Rv0309 
6815 secreted protein -2.0 0.043 Secreted protein 
 
5746 gas vesicle protein only ESX-1ms 0.002 Other  
1852 selenide, water dikinase, SelD only ESX-1ms 0.013 Other  
0529 probable serine/threonine-protein kinase PknK  only ESX-1ms 0.024 Other Rv3080 
6906 putative hydrolase only ESX-1ms 0.027 Other Rv0045c 
1108 hydrolase, alpha/beta fold family protein  only ESX-1ms 0.049 Other Rv0554 
5243 helix-turn-helix motif  3.5 0.000 Other 
 
4200 peptidase M20  2.3 0.003 Other Rv2141c 
5136 helix-turn-helix motif  2.6 0.004 Other Rv0080 
3127 conserved protein, DUF59  2.7 0.029 Other Rv1466 
2073 CAIB/BAIF family protein 2.4 0.044 Other 
 
6179 acetyl-coenzyme A synthetase  -2.1 0.002 Other Rv3667 
3645 hypothetical protein only ESX-1ms 0.012 Hypothetical protein Rv1825 
4923 hypothetical protein only ESX-1ms 0.013 Hypothetical protein Rv1321 
3905 hypothetical protein  only ESX-1ms 0.004 Hypothetical protein Rv2117 
3016 hypothetical protein only WTms 0.014 Hypothetical protein Rv2566 
1340 hypothetical protein  2.1 0.007 Hypothetical protein Rv0635 
2739 hypothetical protein -2.2 0.006 Hypothetical protein Rv2721c 
5629 hypothetical protein  -2.0 0.047 Hypothetical protein   
*Differential abundances represent the fold change in abundance of a protein in ESX-1ms relative to WTms. Negative values indicate a lower abundance in ESX-
1ms than WTms. Where indicated proteins were detected in only one strain. 
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3.2.3. Discussion 
The proteomic analysis of ESX-1ms indicates that ESX-1 is expressed under normal culture conditions in 
M. smegmatis. A total of 15 ESX-1 proteins were detected in WTms, all of which were either not detected 
in ESX-1ms, or present at a much lower abundance. However, no cellular pathways were considerably 
impacted in the absence of ESX-1 and approximately 98% of the detected proteome showed no 
significant variation between strains. The greatest distinction between ESX-1ms and WTms is the altered 
abundances of transcription factors, most of which are more abundant in ESX-1ms. The functions of 
these transcription factors are, however unknown, making the signal(s) and response(s) difficult to 
identify, particularly as the additional proteomic variation does not highlight any pathways.  The absence 
of concerted pathway deviation on a proteomic or secretomic level in ESX-1ms suggests that ESX-1 may 
function independently of the mycobacterial cellular metabolic processes. Whole metabolomic analyses 
of ESX-1ms and WTms are currently underway to investigate the effects of the deletion of ESX-1 on the 
metabolite profile of the bacterium (In collaboration with Prof. Loots, North West University, South Africa). 
These results my corroborate these findings or highlight pathways which are influenced by the deletion of 
ESX-1. 
The proteomic and secretomic results do not correlate directly with the previously identified functions of 
ESX-1, most notably conjugal DNA transfer
105, 106
 and mycolic acid synthesis by EccA1.
109
 No significant 
changes to proteins involved in cell wall biosynthesis or in DNA binding proteins, other than the 
previously mentioned transcription factors, were seen. If ESX-1 is involved in the transfer of DNA 
between cells via conjugal DNA transfer, this may be expected not to impact on other basic cellular 
metabolic processes. EccA1 is however highly expressed in WTms under these conditions, therefore it 
could be expected that the absence of this protein in ESX-1ms would affect other proteins involved in cell 
wall and mycolic acid biosynthesis. It is possible that under these conditions M. smegmatis is not 
undergoing conjugal DNA transfer and that EccA1 is only involved in mycolic acid metabolism during this 
process, to enable the transfer of the proteins involved in conjugation through the cell wall and 
mycomembrane. EccA1 was also identified in the culture filtrate and whole cell lysate fractions of WTms. 
There are conflicting reports of the localisation of this protein in M. tuberculosis where it has been 
identified in the membrane fraction,
159
 or only in the cytosolic fraction
160
 in two separate studies. The 
presence of this protein in the culture filtrates in this study may correlate with membrane localisation, and 
subsequent release into the culture medium. The function of EccA1 in mycolic acid biosynthesis 
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corresponds to its membrane localisation. However, EccA1 has also been predicted to be involved in 
protein-protein interactions and the secretion of various substrates, suggesting an intracellular role.
73, 75
 
3.2.4. Conclusion  
The proteomic and secretomic analyses of M. smegmatis ESX-1 fail to highlight specific mechanisms or 
pathways whereby it functions. ESX-1 is highly expressed in M. smegmatis under these conditions, but 
shows very little variation on a proteomic level. Protein detection is, however, limited to those proteins 
which can be extracted successfully and in sufficient abundance using the current methodology. Amongst 
others, membrane proteins may be underrepresented and alternate extraction and enrichment methods 
may indicate increased proteomic variation in ESX-1ms. The absence of ESX-1 clearly impacts on the 
transcriptional regulome of M. smegmatis. The lack of collective response by pathways of proteins, 
however, deters identification of signal and response resulting from the deletion of ESX-1. ESX-1 has 
been shown to regulate conjugal DNA transfer in M. smegmatis and to be involved in virulence and 
mycolic acid biosynthesis in M. tuberculosis, although the correlation between these functions in the two 
organisms remains unclear.   
  
  
 110 
 
3.3. The functions of the M. smegmatis ESX-3 secretion system and its substrates 
3.3.1. Introduction 
The ESX-3 secretion system is essential for the in vitro survival of M. tuberculosis,
54, 113
 where its 
expression has been shown to be regulated by IdeR and Zur in response to iron and zinc availability, 
respectively.
50, 114
 ESX-3 is required for iron acquisition via the mycobactin mediated iron uptake system, 
and presumably zinc uptake via an additional pathway.
113
 ESX-3, though non-essential and only 
regulated by iron in M. smegmatis,
115
 is involved in similar pathways in this non-pathogenic, fast growing 
species. We have created an ESX-3 knockout strain of M. smegmatis, ESX-3ms, which serves as a 
useful tool for the investigation of ESX-3 function.  In this study ESX-3ms was used in comparative 
metabolomic, proteomic and secretomic analyses with the wild-type M. smegmatis parental strain, WTms, 
to investigate the role of the ESX-3 secretion system in the biology of the organism. 
3.3.2. Results 
3.3.2.1. Metabolomic analysis of ESX-3 function 
Twelve replicates of WTms and ESX-3ms cultures, grown to mid log phase (OD600= 0.6-0.8) in standard 
Middlebrook 7H9 culture medium, were subjected to GC-MS metabolomic analysis. The PCA scores plot 
of the metabolite data showed that the individual samples from each of the two strains clustered 
independently (Figure 3.3.1). This can be attributed to consistent differences in analysed metabolite 
profiles of the individual samples of each strain.  Due to the natural separation achieved in the PCA, a 
PLS-DA was constructed to confirm and identify additional metabolites to those identified using the PCA, 
possibly supplying additional compound information for explaining ESX-3 gene functionality. The 
important metabolites which best describe the variation between WTms and ESX-3ms, identified using the 
PCA, PLS-DA and univariate statistics, are compounds which are either entirely unique to a particular 
strain, or common to both groups, but exhibit a constant variation in concentration between the two 
strains (Tables 3.3.1a and b; analysis was done by Mr Reinart J. Meissner-Roloff in Prof. du Toit’s 
group). The metabolites which vary most between WTms and ESX-3ms are predominantly amino acids 
and sugars. Histidine, proline, alanine, cysteine, methionine, isoleucine, aspartic acid, tryptophan, valine, 
threonine, phenylalanine, serine, leucine, glucose, galactose and mannose, were all reduced, and lysine, 
oxy-proline, glycine, citrulline, glutamine, glutamate and tyrosine were elevated in ESX-3ms relative to 
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WTms. Although lactic acid, aspartic acid, threonine, tryptophan, serine, phenylalanine and valine were 
not identified as top markers for either the PCA or the PLS-DA analyses, their relative concentrations 
were also determined for all samples, averaged and included in Tables 3.3.1a and b, due to their roles as 
intermediates in the metabolism of the previously mentioned metabolite markers.  
 
Figure 3.3.1.  PCA scores plot of individually cultured ESX-3ms (circles) and WTms (triangles). The 
individual samples from each strain cluster separately.  PC1 and PC2 explain 33.8% of the total variation 
in the data. Separation of the two groups is due to differences in the metabolite profiles in each of the 
sample groups. The PCA plot was generated by Mr Reinart J. Meissner-Roloff in Prof. du Toit’s group. 
 
Table 3.3.1a. Metabolites which occur at higher concentrations in ESX-3ms than in WTms 
Compound name 
Concentration (µg/mg) ±standard deviation  
(% of samples with detected compound) 
Effect sizes 
    WTms ESX-3ms   
Citrulline 0 (0) 0.258 ±0.058 (100) >0.5 
Lysine 0.012±0.096 (100) 0.24+0.096(100) >0.5 
Oxy-proline 28.193±8.998 (100) 33.838±5.3.1 (100) >0.8 
Glycine 0 (0) 0.06±.0.02 (100) >0.8 
Tyrosine 0.098 ±0.125 (75) 1.387 ±0.875 (100) >0.8 
Glutamate 0 (0) 0.0363±0.0318 (100) >0.5 
Acryl glycine 0 (0) 0.044±0.04 (63) >0.8 
Glutamine 0.027±0.025 (83) 0.478±0.081 (100) >0.8 
Parabanic acid 0.014±0.003 (100) 0.051±0.008 (100) >0.8 
Butanal 0 (0) 0.192±0.137 (73) >0.5 
2,4 bispyrimidine 0.113 ±0.145 (83) 4.128 ±0.944 (100) >0.8 
Phosphenodiimidic amine 0 (0) 0.431 ±0.226 (100) >0.5 
Succinic semialdihyde 0.005 ±0.050 (100) 0.016 ±0.181 (100) >0.5 
Hexanedioc acid 0.027±0.02 (75) 0.478±0.177 (100) >0.8 
9H-purine 0 (0) 0.21±0.009 (90) >0.8 
*Lactic acid 0.005±0.004 (75) 0.011±0.008 (82) >0.5 
Xylose 0.293±0,184 (64) 0.634±0.172 (82) >0.5 
Erythro-pentose 0 (0) 0.145±0.033 (100) >0.5 
Myo-inositol 0 (0) 0.145±0.033 (100) >0.8 
* Compounds which were not identified as top markers for either the PCA or the PLS-DA analyses. 
Values in brackets represent the percentage of samples in which the compound was detected.  
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Table  3.3.1b. Metabolites which occur at higher concentrations in WTms than in ESX-3ms  
Compound name 
Concentration (µg/mg) ±standard deviation  
(% of samples with detected compound) 
Effect sizes 
 
WTms ESX-3ms  
Histidine 0.407 ±0.157 (100) 0 (0) >0.8 
Proline 1.452 ±0.594 (100) 0.005 ±0.005 (73) >0.8 
Alanine 8.377 ±1.225 (100) 3.571 ±0.867 (100) >0.8 
Methionine 1.169±0.324 (100) 0.039±0.052 (63) >0.8 
Isoleucine 2.895±0.501 (100) 1.467±0.374 (100) >0.8 
Leucine 1.585±0.721 (100) 0.288±0.032 (100) >0.8 
Cysteine 0.18±0.033 (100) 0.057±0.026 (100) >0.8 
*Aspartic acid 0.44±0.128 (100) 0.379±0.102 (100) >0.8 
*Tryptophane 0.205±0.198 (75) 0.199±0.184 (64) >0.5 
*Valine 0.371±0.099 (83) 0.227±0.132 (90) >0.5 
*Threonine 0.245±0.065 (100) 0.166±0.081 (100) >0.8 
*Phenylalanine 0.127±0.103 (100) 0.076±0.054 (100) >0.8 
*Serine 0.219±0.079 (100) 0.137±0.082 (100) >0.8 
Galactose 0.212 ±0.160 (100) 0 (0) >0.8 
Glucose 10±5.705 (100) 3.373±5.301 (100) >0.8 
Mannose 1.678±0.912 (75) 0.67±1.765 (64) >0.8 
Altro Heptulose 3.427±1.432 (100) 1.825±1.765 (73) >0.5 
Turanose 0.573±0.096 (100) 0.416±0.083 (100) >0.8 
Galactose oxime 7.366±2.405 (100) 3.686±1.603 (100) >0.8 
Ribofuranoside 0.081±0.037 (100) 0 (0) >0.8 
Butanoic acid 0.071 ±0.011 (100) 0.030 ±0.006 (100) >0.8 
Mannonic acid 0.117 ±0.04 (100) 0.0136 ±0.012 (82) >0.8 
Dodecanoic acid 1.378 ±0.228 (75) 0.366 ±0.083 (100) >0.8 
Phosphoric acid 0.515±0.106 (100) 0.337±0.101 (100) >0.5 
Gluconic acid 0.117±0.083 (100) 0.0136±0.0113 (82) >0.5 
2-Piperidone 1.476 ±0.248 (100) 0.405 ±0.109 (100) >0.8 
Bis-thiodiglycol 0.106 ±0.026 (100) 0.021 ±0.014 (73) >0.5 
* Compounds which were not identified as top markers for either the PCA or the PLS-DA analyses. 
Values in brackets represent the percentage of samples in which the compound was detected. 
3.3.2.2. Whole cell lysate proteomic analysis of ESX-3 function 
The proteomes of ESX-3ms and WTms cultures were analysed using LC-MS/MS on the LTQ Orbitrap 
Velos. A combined total of 2845 proteins were identified in the M. smegmatis ESX-3ms and WTms strains 
(Supplementary Table S3.3). Protein abundances were compared and used to investigate the biological 
functions of the ESX-3 secretion system. Almost 95% of the detected proteins showed no significant 
variation between strains. Eight proteins were detected in ESX-3ms but not in WTms, while 63 proteins 
were present in WTms, but not detected in ESX-3ms. A further 38 and 43 proteins were present at a 
significantly greater or lower abundance, respectively, in ESX-3ms relative to WTms (Table 3.3.2). Two of 
the proteins which were completely absent in ESX-3ms, but present in WTms, MSMEG_0615 (EccA3) and 
MSMEG_0626 (EccE3), are encoded by the first and last genes in ESX-3, confirming the deletion of ESX-
3 from ESX-3ms. Two additional ESX-3 encoded proteins, MSMEG_0617 and MSMEG_0623, were 
detected at approximately 5 and 30 times lower levels, respectively, in ESX-3ms than in WTms. The 
detection of these proteins in ESX-3ms may be attributed to the presence of their paralogues encoded in 
ESX-4 and ESX-1, while their greatly reduced abundances support deletion of these genes in ESX-3ms.  
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Table 3.3.2. Proteins with different abundances in ESX-3ms and WTms WCLs, classified according to biological function. 
MSMEG_ Product Differential abundance*  
p 
value 
Biological function 
H37Rv 
ortholog 
0615 ATPase, AAA family protein, EccA3  only WTms 0.007 ESX-3 Rv0282 
0626 hypothetical protein, EccE3  only WTms 0.003 ESX-3 Rv0292 
0617 ftsk/spoiiie family protein, EccC3 -4.9 0.009 ESX-3 Rv0284 
0623 secretion protein Snm4, EccD3 -30.8 0.018 ESX-3 Rv0290 
0454 GntR-family protein transcriptional regulator  only WTms 0.001 Transcriptional regulation Rv0454 
6580 transcriptional regulator family protein  only WTms 0.003 Transcriptional regulation Rv3095 
5566 transcriptional regulator only WTms 0.051 Transcriptional regulation Rv1404 
5422 transcriptional regulator, MazG family protein only WTms 0.001 Transcriptional regulation Rv1021 
5040 transcriptional regulator, TetR family protein  only WTms 0.043 Transcriptional regulation Rv1255c 
3646 transcriptional regulator, MerR family protein 2.1 0.049 Transcriptional regulation Rv1828 
2248 two-component system sensor kinase  only ESX-3ms 0.039 Transcriptional regulation 
 0592/6022 putative rhamnose catabolism operon/ xylose repressor, ROK-family protein 2.4 0.005 Transcriptional regulation 
 
1473 ribosomal protein L30, rpmD  only WTms 0.023 Translation Rv0722 
5432 peptidyl-tRNA hydrolase, pth 3.0 0.001 Translation Rv1014c 
6191 translation initiation inhibitor 2.5 0.016 Translation Rv3678c 
1439 ribosomal protein L2, rplB -2.5 0.048 Translation Rv0704 
1442 ribosomal protein S3, rpsC -2.8 0.035 Translation Rv0707 
1485 methionine aminopeptidase, type I, map -9.6 0.034 Translation Rv0734 
2519 ribosomal protein S2, rpsB -2.7 0.007 Translation Rv2890c 
2649 tRNA pseudouridine synthase B, truB -2.1 0.001 Translation Rv2793c 
4571 ribosomal protein S20, rpsT -4.7 0.013 Translation Rv2413 
4624 ribosomal protein L27, rpmA -2.9 0.004 Translation Rv2441c 
1033/2313 ribonucleoside-diphosphate reductase, beta -2.2 0.019 Translation 
 
0438 periplasmic binding protein (High affinity iron ion transport) only WTms 0.013 Divalent cation homeostasis 
 
2615 chelatase  only WTms 0.000 Divalent cation homeostasis Rv2850c 
2652 iron repressor protein, SirR  only WTms 0.038 Divalent cation homeostasis Rv2788 
5014 copper-translocating P-type ATPase  -2.2 0.002 Divalent cation homeostasis Rv0969 
5006 phosphohistidine phosphatase only WTms 0.005 Amino acid metabolism Rv1276c 
4538 cysteine desulphurase, SufS  only WTms 0.035 Amino acid metabolism 
 1041/2321 phosphoserine phosphatase (glycine biosynthesis/L-serine biosynthesis), SerB 2.0 0.042 Amino acid metabolism 
 3033 3-dehydroquinate synthase, aroB 2.5 0.002 Amino acid metabolism Rv2538c 
3183 
threonine dehydratase (pyruvate family amino acid biosynthesis/isoleucine 
biosynthesis from threonine and pyruvate), ilvA 2.0 0.018 Amino acid metabolism Rv1559 
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3317 
dihydrodipicolinate reductase, N-terminus domain (lysine biosynthesis aspartate 
family amino acid biosynthesis), dapB 2.3 0.041 Amino acid metabolism 
 3648 glycine cleavage system H protein, gcvH 2.0 0.001 Amino acid metabolism Rv1826 
1671 succinate dehydrogenase hydrophobic membrane, sdhD -2.2 0.018 Amino acid metabolism Rv3317 
2111 chorismate mutase  -2.2 0.034 Amino acid metabolism Rv1885c 
5524 succinyl-CoA synthetase, alpha subunit, sucD -2.1 0.014 Amino acid metabolism Rv0952 
2684 dihydrodipicolinate synthase, dapA -2.1 0.021 Amino acid metabolism Rv2753c 
1668 pyridoxamine 5'-phosphate oxidase family only WTms 0.050 Cofactor metabolism 
 
2653 riboflavin biosynthesis protein RibF  only WTms 0.036 Cofactor metabolism Rv2786c 
1822 biotin-[acetyl-CoA-carboxylase] ligase  only WTms 0.007 Cofactor metabolism 
 
0964 pyridoxamine 5'-phosphate oxidase family 2.7 0.010 Cofactor metabolism 
 2201 ZbpA protein, Z-domain biotinylation protein  2.1 0.003 Cofactor metabolism Rv0130 
4829 cytochrome P450  only ESX-3ms 0.013 Reduction/oxidation 
 6858 epoxide hydrolase 1  only ESX-3ms 0.035 Reduction/oxidation 
 4685 oxidoreductase only WTms 0.020 Reduction/oxidation 
 2275 hydrogenase expression/formation protein HypD only WTms 0.011 Reduction/oxidation 
 6031 carveol dehydrogenase only WTms 0.025 Reduction/oxidation 
 0127 oxidoreductase, zinc-binding dehydrogenase 2.2 0.018 Reduction/oxidation Rv0162c 
0835 copper/zinc superoxide dismutase, sodD -2.6 0.014 Reduction/oxidation Rv0432 
1011/2291 short chain dehydrogenase -3.3 0.045 Reduction/oxidation 
 
2351 electron transfer flavoprotein, beta subunit, etfB -2.1 0.036 Reduction/oxidation Rv3029c 
5287 dehydrogenase  2.0 0.025 Reduction/oxidation 
 
4119 3-hydroxybutyryl-CoA dehydratase only WTms 0.039 Reduction/oxidation 
 6239 1,3-propanediol dehydrogenase only WTms 0.015 Reduction/oxidation 
 3422 D-isomer specific 2-hydroxyacid dehydrogenase, 2.1 0.012 Reduction/oxidation 
 1363 glucokinase  only WTms 0.003 Carbohydrate metabolism Rv0650 
1695 phosphoglucomutase/phosphomannomutase  only WTms 0.022 Carbohydrate metabolism Rv3308 
2512 lactate 2-monooxygenase only WTms 0.024 Carbohydrate metabolism 
 0361 glycosyl hydrolase family protein 3  only WTms 0.031 Carbohydrate metabolism Rv0237 
3269 putative sugar ABC transporter ATP-binding only WTms 0.002 Carbohydrate metabolism 
 6804 sugar ABC transporter substrate-binding protein only WTms 0.013 Carbohydrate metabolism 
 0049 pirin domain protein only WTms 0.002 Carbohydrate metabolism 
 
4183 phosphoglycolate phosphatase, chromosomal  only WTms 0.016 Carbohydrate metabolism 
 
3262 L-xylulose reductase only WTms 0.016 Carbohydrate metabolism 
 
6645 2-methylcitrate dehydratase 2  only ESX-3ms 0.000 Carbohydrate metabolism Rv1130 
0947 acyltransferase  only WTms 0.050 Fatty acid metabolism Rv0502 
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1886 fatty acid desaturase only WTms 0.024 Fatty acid metabolism Rv3229c 
3139 enoyl-CoA hydratase/isomerase  only WTms 0.045 Fatty acid metabolism Rv1472 
3812 acyl-CoA thioesterase only WTms 0.019 Fatty acid metabolism 
 
5886 enoyl-CoA hydratase only WTms 0.002 Fatty acid metabolism 
 
4833 putative acyl-CoA dehydrogenase only WTms 0.007 Fatty acid metabolism 
 
4118 acyl-CoA dehydrogenase  2.0 0.031 Fatty acid metabolism 
 5276 enoyl-CoA hydratase  3.1 0.021 Fatty acid metabolism Rv1071c 
2393 NAD-dependent glycerol-3-phosphate, gpsA -4.4 0.020 Fatty acid metabolism Rv2982c 
1284 PIN domain protein, single strand nuclease  only WTms 0.024 DNA/RNA metabolism Rv0624 
2389 DNA-binding protein HU, hup/hlp, stabilisation -2.0 0.038 DNA/RNA metabolism Rv2986c 
2630 DHH family protein  -2.4 0.009 DNA/RNA metabolism 
 
5278 
conserved membrane-spanning protein (biosynthesis and degredation of 
peptidoglycan) only ESX-3ms 0.012 Cell wall synthesis Rv1069c 
6935 N-acetylmuramoyl-L-alanine amidase,  (degradation of peptidoglycan) 2.0 0.035 Cell wall synthesis Rv3915 
1826 dTDP-RhA:a-D-GlcNAc-diphosphoryl polyprenol, -2.5 0.028 Cell wall synthesis Rv3265c 
0380 MmpS4 protein 2.9 0.044 Cell membrane and cell surface  Rv0457c 
0143 probable conserved mce associated membrane 2.2 0.011 Cell membrane and cell surface  
 0640 oligopeptide transport ATP-binding protein OppD -2.7 0.007 Cell membrane and cell surface  
 0919 heparin-binding hemagglutinin -3.0 0.038 Cell membrane and cell surface  Rv0475 
2695 35 kDa protein -2.7 0.000 Cell membrane and cell surface  Rv2744c 
4239 LppM protein  -2.6 0.011 Cell membrane and cell surface  Rv2171 
3887 twin arginine-targeting protein translocase, tatA -6.0 0.048 Cell membrane and cell surface  Rv2094c 
6109 LpqG protein only WTms 0.020 Cell membrane and cell surface  
 4228 cell division protein FtsW only WTms 0.005 Cell division Rv2154c 
1811 septum formation protein Maf only WTms 0.048 Cell division Rv3282 
0095 methyltransferase only ESX-3ms 0.016 Methyltransferase 
 2773 hypothetical RNA methyltransferase WT 0.048 Methyltransferase Rv2689c 
6278 metallo-beta-lactamase superfamily protein, only WTms 0.019 Antibiotic 
 6339 metallo-beta-lactamase family protein only WTms 0.009 Antibiotic Rv3762c 
6086 antibiotic biosynthesis monooxygenase domain 2.2 0.018 Antibiotic Rv3592 
6190 metallo-beta-lactamase family protein  2.8 0.042 Antibiotic Rv3677c 
6575 beta-lactamase  2.2 0.003 Antibiotic Rv3775 
3958 glyoxalase/bleomycin resistance 2.2 0.006 Antibiotic 
 
1134 putative protease HtpX  -5.1 0.011 Stress protein Rv0563 
5733 universal stress protein family protein  2.2 0.013 Stress protein 
 6202 secreted protein  only WTms 0.022 Secreted protein Rv3683 
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6218 secreted protein only WTms 0.007 Secreted protein Rv3691 
5015 secreted protein only WTms 0.019 Secreted protein 
 
5664 binding protein 2.2 0.026 Other 
 
4495 CBS domain protein -5.6 0.025 Other 
 
5162 cinnamoyl ester hydrolase  only WTms 0.013 Other 
 
5436 4-diphosphocytidyl-2C-methyl-D-erythritol, ispE only WTms 0.006 Other Rv1011 
6423 glycerophosphoryl diester phosphodiesterase only WTms 0.008 Other Rv3842 
0884 glyoxalase family protein  3.6 0.018 Other 
 1603 IMP dehydrogenase family protein  2.0 0.007 Other Rv3410 
1835 TobH protein 2.0 0.024 Other Rv3256c 
2042 phosphotransferase enzyme family protein 2.4 0.040 Other Rv3168 
2932 HIT family protein hydrolase  2.2 0.038 Other Rv2613c 
3457 DoxD family protein/pyridine nucleotide-disulfide oxidoreductase 3.3 0.049 Other 
 5680 glyoxalase family protein 2.1 0.012 Other Rv0887c 
3859 glycosyl transferase, group 2 family protein  -2.0 0.010 Other 
 
5182 2-nitropropane dioxygenase  -3.9 0.032 Other 
 
5789 putative thiosulfate sulfurtransferase  -2.3 0.015 Other Rv0815c 
6114 inorganic pyrophosphatase, ppa -2.0 0.026 Other Rv3628 
6554 hypothetical ABC transporter ATP-binding -4.6 0.045 Other Rv1348 
3168 phenolpthIocerol synthesis type-i polyketide ppse only WTms 0.046 Other 
 0074/1865/ 
2824/3433 
/5181 IS1549, transposase  only WTms 0.028 Other 
 2746 conserved hypothetical alanine and leucine rich only ESX-3ms 0.004 Other Rv2714 
3026 hypothetical protein  only ESX-3ms 0.000 Hypothetical protein Rv2554c 
0971 hypothetical protein  only WTms 0.043 Hypothetical protein Rv0526 
1891 hypothetical protein  only WTms 0.028 Hypothetical protein Rv3226c 
2032 hypothetical protein only WTms 0.002 Hypothetical protein 
 2197 hypothetical protein only WTms 0.034 Hypothetical protein 
 
2779 hypothetical protein  only WTms 0.000 Hypothetical protein Rv2680 
3027 hypothetical protein only WTms 0.015 Hypothetical protein Rv2553c 
3229 hypothetical protein  only WTms 0.000 Hypothetical protein 
 6081 hypothetical protein  only WTms 0.010 Hypothetical protein Rv3587c 
6373 hypothetical protein  only WTms 0.003 Hypothetical protein 
 4693 hypothetical protein only WTms 0.019 Hypothetical protein Rv3623 
4141 hypothetical protein only WTms 0.034 Hypothetical protein 
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5279 hypothetical protein only WTms 0.002 Hypothetical protein Rv1066 
6080 hypothetical protein  2.8 0.007 Hypothetical protein Rv3586 
6159 hypothetical protein 2.1 0.035 Hypothetical protein Rv3648c 
1136 hypothetical protein 2.0 0.007 Hypothetical protein 
 
1734 hypothetical protein  2.8 0.004 Hypothetical protein Rv3304 
3004 conserved hypothetical protein  2.7 0.000 Hypothetical protein 
 4284 hypothetical protein  2.0 0.005 Hypothetical protein Rv2216 
0368 hypothetical protein  -2.2 0.016 Hypothetical protein 
 1513 hypothetical protein  -2.2 0.044 Hypothetical protein 
 3081 hypothetical protein -2.0 0.020 Hypothetical protein Rv2569c 
3261 hypothetical protein  -2.7 0.008 Hypothetical protein 
 4199 hypothetical protein  -5.8 0.005 Hypothetical protein Rv2140c 
4322 hypothetical protein  -2.2 0.044 Hypothetical protein Rv2240c 
6129 hypothetical protein  -4.3 0.010 Hypothetical protein 
 
6386 membrane protein  -2.0 0.029 Hypothetical protein Rv3792 
6502 hypothetical protein  -3.7 0.024 Hypothetical protein Rv2366 
*Differential abundances represent the fold change in abundance of a protein in ESX-3ms relative to WTms. Negative values indicate a lower abundance in ESX-
3ms than WTms. Where indicated proteins were detected in only one strain.
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The ESX-3ms and WTms strains exhibit clear differences in protein profiles, indicative that ESX-3 plays a 
biological role in M. smegmatis physiology under these conditions. The differentially expressed proteins 
are involved in multiple cellular functions including amino acid and cofactor metabolism, fatty acid and 
carbohydrate metabolism, redox homeostasis, transcriptional regulation, translation and cell wall 
synthesis. ESX-3 clearly impacts on multiple aspects of the cellular biology of M. smegmatis, some of 
which, including amino acid, carbohydrate and fatty acid metabolism and oxidative stress, correlate with 
the variation detected in the metabolomics experiment. 
3.3.2.3. Culture filtrate proteomic analysis of ESX-3 
Culture filtrate fractions were prepared from WTms and ESX-3ms and the constituent proteins identified 
by LC-MS/MS analysis on the LTQ Orbitrap Velos. One thousand eight hundred and three proteins were 
identified in the two strains (Supplementary table S3.4). Protein abundances were compared to identify 
exported proteins which are influenced by the presence or absence of ESX-3 (Table 3.3.3). No ESX-3 
proteins were detected in the CF fractions of either strain. Similar pathways to those identified in the WCL 
proteome analysis were found to be influenced by the deletion of ESX-3 in the CF fraction, including 
amino acid biosynthesis, vitamin/cofactor biosynthesis, translation and transcriptional regulation and cell 
wall biosynthesis, although most proteins detected in different abundances appear to be cytosolic, and 
not extracellular proteins. 
3.3.2.4. Divalent metal cation regulation of ESX-3 expression 
Regulation of expression of ESX-3 by various divalent metal cations was investigated using a β-
galactoside promoter assay. The activity of the M. smegmatis ESX-3 promoter in the absence and 
presence of various metal cations was determined and compared to that of the M. tuberculosis ESX-3 
promoter (Figure 3.3.2). The M. smegmatis ESX-3 promoter activity is only repressed by the presence of 
iron, while the M. tuberculosis ESX-3 promoter is repressed by zinc, and further repressed in the 
presence of both iron and zinc. Promoter activities were not determined for cobalt in M. smegmatis and 
for copper in M. bovis BCG as these metals had a toxic effect on the respective species. No regulation 
was observed for any other metal cations.  
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Table 3.3.3. Proteins with different abundances in ESX-3ms and WTms culture filtrates, classified according to biological function. 
 
MSMEG_ Product Differential abundance*  
p 
value 
Biological function 
H37Rv 
ortholog 
6077 transcriptional regulator, CarD family protein  only WTms 0.013 Transcriptional regulation Rv3583c 
6451 transcriptional regulator, ArsR family protein  only WTms 0.026 Transcriptional regulation Rv0081 
2916 DNA-binding response regulator, PhoP family only ESX-3ms 0.003 Transcriptional regulation Rv1033c 
4070 transcriptional regulator, TetR family protein, only ESX-3ms 0.022 Transcriptional regulation 
 
4242 transcriptional regulatory protein  -2.3 0.017 Transcriptional regulation Rv2175c 
6628 transcriptional regulator, TetR family protein  -3.6 0.024 Transcriptional regulation 
 1345 transcription antitermination protein NusG  -2.4 0.001 Transcriptional regulation Rv0639 
5774 tRNA-dihydrouridine synthase, putative only ESX-3ms 0.001 Translation Rv0823c 
1365 ribosomal protein L7/L12, rplL  -3.2 0.020 Translation Rv0652 
1657 tryptophanyl-tRNA synthetase, trpS -2.9 0.033 Translation Rv3336c 
3035 translation elongation factor P, efp  -2.3 0.003 Translation Rv2534c 
3792 ribosomal protein L35, rpmI  -3.9 0.009 Translation Rv1642 
6897 ribosomal protein S6 , rpsF -2.5 0.001 Translation Rv0053 
4291 D-tyrosyl-tRNA(Tyr) deacylase, dtd 9.9 0.046 Translation Rv1897c 
0020 periplasmic binding protein - iron ion transporter 2.2 0.002 Divalent cation homeostasis 
 2750 iron-dependent repressor IdeR  -2.2 0.022 Divalent cation homeostasis Rv2711 
3636 ferric iron-binding periplasmic protein of ABC transporter -2.0 0.014 Divalent cation homeostasis 
 3648 glycine cleavage system H protein, gcvH  2.1 0.021 Amino acid metabolism Rv1826 
3173 L-asparaginase (asparagine to aspartate) 4.0 0.006 Amino acid metabolism Rv1538c 
1496 3-hydroxyisobutyrate dehydrogenase , mmsB (valine, leucine, isoleucine degradation) 34.5 0.030 Amino acid metabolism Rv0751c 
4976 isochorismatase hydrolase  -2.9 0.028 Amino acid metabolism 
 3872 precorrin-8X methylmutase only WTms 0.046 Cofactor metabolism Rv2065 
3873 cobalamin biosynthesis protein cobIJ  only ESX-3ms 0.021 Cofactor metabolism Rv2066 
2937 pyridoxine biosynthesis protein  2.0 0.003 Cofactor metabolism Rv2606c 
2198 ThiF family protein  only ESX-3ms 0.039 Cofactor metabolism Rv1355c 
1416 pyridine nucleotide-disulphide oxidoreductase  -2.0 0.013 Reduction/oxidation Rv0688 
3199 quinolinate synthetase complex, A subunit, nad  -3.3 0.001 Reduction/oxidation Rv1594c 
2923 dehydrogenase/reductase SDR family protein only WTms 0.002 Reduction/oxidation 
 5319 alkylhydroperoxidase AhpD core  only WTms 0.001 Reduction/oxidation 
 2566 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase only ESX-3ms 0.025 Reduction/oxidation 
 4305 phosphoglycerate mutase  2.5 0.026 Carbohydrate metabolism Rv2228c 
2119 N-acetylglucosamine-6-phosphate deacetylase, nagA only WTms 0.008 Carbohydrate metabolism Rv3332 
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3598 periplasmic sugar-binding proteins  only ESX-3ms 0.009 Carbohydrate metabolism 
 4696 alpha-amylase family protein only ESX-3ms 0.004 Carbohydrate metabolism Rv2471 
0603 putative acyl-CoA dehydrogenase only ESX-3ms 0.000 Fatty acid metabolism Rv0271c 
6001 enoyl-CoA hydratase  2.1 0.028 Fatty acid metabolism Rv3550 
0986 RemM protein (DNA binding) -2.3 0.007 DNA/RNA metabolism 
 
2399 uracil-DNA glycosylase  only WTms 0.003 DNA/RNA metabolism Rv2976c 
1900 D-alanyl-D-alanine carboxypeptidase family 2.1 0.002 Cell wall synthesis 
 0928 UDP-N-acetylenolpyruvoylglucosamine reductase, murB -3.5 0.049 Cell wall synthesis Rv0482 
6354 serine esterase, cutinase family protein -3.4 0.008 Cell wall synthesis Rv1758 
3790 RNA methyltransferase, TrmH family protein only ESX-3ms 0.003 Methyltransferase Rv1644 
6784 beta-lactamase only ESX-3ms 0.001 Antibiotic 
 6815 secreted protein  -2.1 0.034 Secreted protein 
 5245 universal stress protein family protein  2.1 0.009 Stress  Rv2028c/3134c 
0760 thioesterase family protein only WTms 0.001 Other Rv0356c 
1078 hydrolase only WTms 0.000 Other 
 
1835 TobH protein  only WTms 0.004 Other Rv3256c 
6425 rhodanese-like domain protein 2.1 0.024 Other 
 0865 bacterial membrane flanked domain family 2.5 0.044 Other 
 0408 type I modular polyketide synthase 2.5 0.006 Other 
 2410 putative serine-threonine protein kinase  -2.1 0.035 Other Rv2969c 
2769 155 TrkB protein  -2.1 0.012 Other Rv2692 
6092 Lsr2 protein  -2.1 0.026 Other Rv3597c 
6282 KanY protein  -2.0 0.018 Other Rv3718c 
4999 bacterial extracellular solute-binding protein, -2.2 0.005 Other Rv1280c 
6783 integral membrane protein  -2.3 0.001 Other 
 5224 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, ispH only WTms 0.002 Other Rv1110 
4043 amidohydrolase 2 only ESX-3ms 0.001 Other 
 
5017 lipoprotein only ESX-3ms 0.029 Other 
 
6035 nitrilotriacetate monooxygenase component B only ESX-3ms 0.000 Other Rv3567c 
6788 dihydroxyacetone kinase  only ESX-3ms 0.007 Other 
 5827 glyoxalase family protein only ESX-3ms 0.001 Other Rv0801 
5913 dioxygenase  only ESX-3ms 0.020 Other 
 4114 naphthoate synthase, menB -2.2 0.009 Other 
 0369 hypothetical protein only WTms 0.038 Hypothetical protein 
 1581 hypothetical protein  only WTms 0.009 Hypothetical protein 
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1976 hypothetical protein only WTms 0.000 Hypothetical protein 
 2763 hypothetical protein only WTms 0.003 Hypothetical protein Rv2699c 
2861 hypothetical protein  only WTms 0.011 Hypothetical protein 
 
3024 hypothetical protein only WTms 0.024 Hypothetical protein Rv2556c 
3843 hypothetical protein  only WTms 0.003 Hypothetical protein Rv1628c 
5634 hypothetical protein  only WTms 0.048 Hypothetical protein Rv0910 
6579 hypothetical protein  only WTms 0.014 Hypothetical protein 
 3114 hypothetical protein  only ESX-3ms 0.003 Hypothetical protein 
 3253 hypothetical protein only ESX-3ms 0.013 Hypothetical protein 
 5865 hypothetical protein  only ESX-3ms 0.019 Hypothetical protein Rv0762c 
5932 hypothetical protein  only ESX-3ms 0.012 Hypothetical protein Rv3531c 
0692 hypothetical protein  2.8 0.011 Hypothetical protein 
 2434 hypothetical protein 2.5 0.034 Hypothetical protein Rv2910c 
1042/2322 hypothetical protein  4.2 0.006 Hypothetical protein 
 
0423 hypothetical protein  -2.4 0.001 Hypothetical protein 
 
3171 hypothetical protein  -2.1 0.011 Hypothetical protein 
 
3674 hypothetical protein -2.1 0.009 Hypothetical protein 
 4399 hypothetical protein  -3.7 0.037 Hypothetical protein 
 4689 hypothetical protein  -3.2 0.024 Hypothetical protein Rv1690/3354 
4784 hypothetical protein -2.3 0.005 Hypothetical protein 
 6454 hypothetical protein -2.1 0.034 Hypothetical protein 
 2027 conserved hypothetical protein TIGR00026  -2.2 0.001 Hypothetical protein 
 *Differential abundances represent the fold change in abundance of a protein in ESX-3ms relative to WTms. Negative values indicate a lower abundance in 
ESX-3ms than WTms. Where indicated proteins were detected in only one strain.
 122 
 
  
A. 
 
B. 
 
 
Figure 3.3.2. Metal cation regulation of the M. smegmatis (A) and M. tuberculosis (B) ESX-3 
promoter.  Cultures were grown in chelated Kirchener’s broth and Kirchener’s broth supplemented with 
the metal cations, iron (Fe, 100uM); zinc (Zn, 100uM); iron and zinc (FeZn,100uM ea.); cobalt (Co, 
7.5uM); copper (Cu, 50uM); nickel (Ni, 35uM); manganese (Mn, 0.75uM) and lead (Pb, 10uM) and the 
promoter activities expressed as a percentage of the un-supplemented promoter activity. Promoter 
activities assayed in M. smegmatis are represented by blue bars, and in M. bovis BCG by red bars. The 
M. smegmatis promoter was only regulated by iron, while the M. tuberculosis promoter was regulated by 
zinc, and further repressed by the co-supplementation with iron and zinc. 
 
 
3.3.3. Discussion 
The ESX-3 secretion system has been implicated in divalent metal cation homeostasis, and specifically 
iron and zinc uptake. Iron is essential for all organisms, in which it functions as a cofactor for many 
enzymes and forms structural scaffolds for various proteins. Excessive intracellular iron is, however, toxic 
to cells, and iron levels are tightly regulated by mechanisms which control iron uptake and storage.
161
 
Zinc is also an important cofactor for many enzymes and its uptake is tightly regulated.
162
 The acquisition 
of these metal cations, and the tight regulation thereof is important for M. smegmatis.  The involvement of 
ESX-3 in iron and zinc homeostasis is well established.
50, 113-116
 In this study we have investigated the 
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biological impact of the absence and presence of ESX-3 on the physiology of M. smegmatis by 
investigating the metabolomics and proteomic differences between M. smegmatis wild type and ESX-3 
strains. 
3.3.3.1. The metabolomic analysis of the M. smegmatis ESX-3 knockout strain indicates altered amino 
acid and energy metabolism and increased oxidative stress 
Amongst the compounds which contribute most to the variation between the metabolomes of WTms and 
ESX-3ms are various amino acids, sugars and fatty acids (Figure 3.3.3).  Notably, most amino acids are 
reduced in ESX-3ms, suggesting a general reduction in amino acid synthesis. Of the amino acids which 
are more prevalent in ESX-3ms, several are derived directly from glutamate, which is the only amino acid 
provided directly in the culture medium. Therefore the increased levels of glutamine, citrulline and oxy-
proline may stem from increased uptake of glutamate in response to generalised amino acid depletion. 
Furthermore, influx of glutamate may increase the activity of the glyoxylate shunt, increasing glycine 
production. 
Many of the metabolite differences between WTms and ESX-3ms can be attributed to the involvement of 
ESX-3 in iron and zinc homeostasis. The synthesis of histidine, which was completely absent from ESX-
3ms, is dependent on two enzymes, HisG and HisE, which are coexpressed, but expression of which is 
repressed by IdeR in the presence of iron.
50, 51
 In addition, expression of PheA and TrpE2, which are 
required for the synthesis of phenylalanine and tryptophan, is also regulated by IdeR in response to 
iron,
50, 163, 164
 and synthesis of threonine and isoleucine is upregulated during iron starvation.
165
 
Considering these data, the reduced concentrations of these amino acids in ESX-3ms may indicate an 
increase in iron within ESX-3ms relative to WTms.  
In addition to the glutamate supplied in the culture medium, glutamate synthase activity is dependent on 
iron in many organisms,
165
 therefore increased iron concentrations within ESX-3ms may contribute to the 
increased levels of glutamate and glutamine and additional glutamate-metabolism linked compounds 
such as oxyproline, citrulline, succinic semialdehyde, butanoic acid and the purines and pyrimidines, all of 
which were detected at increased concentrations in ESX-3ms. 
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Figure 3.3.3. The metabolites influenced by the deletion of ESX-3 from M. smegmatis. Metabolites in green are present in increased concentrations in 
 ESX-3ms, and metabolites in orange in reduced concentrations in ESX-3ms, relative to WTms. Solid red circles indicate enzymes which are repressed under high 
iron conditions, interrupted red circles represent enzymes which are iron-dependent and interrupted green circles represent enzymes which are zinc-dependent, 
according to the literature, as described in the text. Metabolic pathways were adapted from KEGG. 
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Several amino acid biosynthesis pathways are also influenced by zinc, which functions as a cofactor for 
many enzymes. MetE and MetH are cobalamin independent and cobalamin dependent methionine 
synthases, respectively, both of which require zinc to enable the biosynthesis of methionine.
166
 
Methionine was detected at significantly reduced levels in ESX-3ms, possibly indicating that activity of 
these enzymes is reduced, pointing to lower zinc levels in this strain. LeuA, responsible for leucine 
synthesis, is also a zinc-dependent enzyme,
167
 and leucine levels are also reduced in ESX-3ms, lending 
support to the theory of reduced zinc levels. 
Disregulation of iron and zinc homeostasis in ESX-3ms may influence other metabolic pathways. Excess 
iron is a significant source of oxidative stress in all organisms, due to the Fenton reactions in which 
ferrous iron and hydrogen peroxide produce ferric iron, hydroxide anions and hydroxide radicals.
168
 The 
oxidative response in M. bovis BCG involves an increase in amino acid transport, increased expression 
of some amino acid synthesis genes, decreased lipid transport and metabolism and increased membrane 
synthesis.
169
 This correlates with the metabolic phenotype of ESX-3ms, which exhibits altered amino acid 
metabolism as well as a reduction in fatty acids and increased lactic acid concentrations. Oxidative stress 
also results in inhibition of the electron transport chain, increasing the catabolism of simple sugars via 
glycolysis and the glyoxylate shunt.
170
 This may account for the reduced levels of simple sugars in ESX-
3ms, as well as the reduced concentrations of valine, alanine and leucine which are derived from 
pyruvate, a substrate of the glyoxylate cycle, and the excess of glycine, a product of the glyoxylate shunt. 
ESX-3 has been implicated in the acquisition of iron and zinc, and as such we anticipated that the 
absence of ESX-3 would result in iron and zinc starvation. However, the metabolic profile of ESX-3ms 
relative to wild type M. smegmatis suggests that in the absence of ESX-3, the organism experiences iron 
excess. It has previously been shown that repression of ESX-3 in M. bovis BCG results in upregulation of 
expression of mycobactin and other iron-uptake genes.
116
 This was ascribed to a greater perceived iron 
starvation, resulting in overcompensation for the repression of ESX-3. M. smegmatis possesses an 
alternative iron acquisition system, the exochelin system which may be induced to acquire additional iron 
in the absence of ESX-3, resulting in the greater iron levels and subsequent metabolic changes observed 
in ESX-3ms. Alternatively, ESX-3 may be involved in the export of excess iron resulting in iron build-up in 
ESX-3ms. ESX-3 has not previously been associated with zinc homeostasis in M. smegmatis where its 
expression is regulated only by iron. However, here we describe metabolic changes which implicate ESX-
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3 in the uptake of zinc, suggesting that in M. smegmatis ESX-3 may play a role in the homeostasis of 
metal cations which do not directly impact on its expression.   
This metabolomic analysis has clearly distinguished the M. smegmatis wildtype and ESX-3 knockout 
strains based on their metabolite profiles. Furthermore, the variation in metabolite concentrations in the 
two strains can be correlated with the role of ESX-3 in iron and zinc uptake and/or homeostasis.  
3.3.3.2. The proteomic profile of the M. smegmatis ESX-3 knockout strain does not indicate altered 
expression of the IdeR and Zur regulons. 
The proteomic variation between ESX-3ms and WTms correlates with the metabolic differences observed. 
Differentially expressed proteins are involved in the pathways and biological processes which influence 
the levels of metabolites which varied in the metabolomics study (Figure 3.3.4). However, the 
abundances of the enzymes which were presumed to be differentially expressed in the two strains, to 
explain the metabolomic variation, remained constant. Furthermore, the protein profiles of ESX-3ms and 
WTms do not show the proposed disregulation of iron and zinc homeostasis; neither the M. smegmatis 
zinc (Zur) regulon
114
 nor the iron (IdeR) regulon,
164
 is varied between the two strains. Although some of 
the same metabolic pathways are implicated in both the metabolomics and proteomic results, differential 
abundance of the specific proteins used to explain the metabolomic variation, was not observed in the 
proteomic study.  
Recently it has been shown that M. smegmatis acquires iron by passive diffusion through the Msp family 
of outer membrane porins and that high-affinity iron acquisition systems (mycobactins and exochelins) 
are obsolete under these conditions.
171
 In iron concentrations of 150uM ferric citrate, as is present in 7H9 
culture medium, the IdeR regulon is repressed, inhibiting expression of the high affinity iron uptake 
systems.
171
 At iron concentrations greater than 5uM, expression of IdeR-regulated genes was minimal, 
suggesting that amongst other genes, ESX-3 is repressed under the conditions of this study. This is 
supported by the promoter activity assay in which expression from the M. smegmatis ESX-3 promoter is 
almost completely repressed in the presence of 100uM Ferric ammonium citrate. This supports the 
proteomic results which show no variation in the IdeR regulon protein abundances. Low levels of some 
ESX-3 proteins were detected in WTms, indicating that these proteins are being expressed, albeit at a low 
level, under these conditions; and the metabolomic and proteomic variation between the WTms and 
ESX-3ms clearly indicate that this expression has significant effects on the physiology of M. smegmatis. 
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Figure 3.3.4. The enzymes influenced by the deletion of ESX-3 from M. smegmatis. Several enzymes involved in energy and amino acid metabolism were 
found to be differentially abundant in WTms and ESX-3ms in this study. Enzymes detected only in WTms are indicated in blue, only in ESX-3ms in pink, and at higher 
levels in WTms than ESX-3ms, in teal. Although these enzymes correlate with the pathways involved in determining the altered levels of metabolites, they do not 
correlate with those which are regulated by IdeR in response to iron levels. Metabolic pathways were adapted from KEGG. 
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We do observe some disregulation of divalent metal cation-associated proteins in the WCLs and CFs of 
the two strains. The four differentially abundant proteins identified in the WCL proteomic analysis include 
a periplasmic binding protein (MSMEG_0438), thought to be involved in iron ion transport, a chelatase 
(MSMEG_2615), and a putative iron repressor protein (SirR, MSMEG_2652) which were only detected in 
WTms; and a copper-translocating P-type ATPase (MSMEG_5014), which is twice as abundant in WTms 
as in ESX-3sm. Two additional periplasmic iron binding proteins are found in different abundances in the 
CFs of the two strains; MSMEG_0020 is twice as abundant in WTms, while MSMEG_3636 is twice as 
abundant in ESX-3sm. IdeR (MSMEG_2750) is also twice as abundant in the CF of WTms than of ESX-
3ms. WTms contains increased abundances of iron-binding proteins, chelatases and Cu-translocators, as 
well as increased amounts of the iron repressor proteins SirR and IdeR. SirR is closely related to IdeR 
and other iron-repressors, but no role has been identified for SirR in iron homeostasis in mycobacteria,
172
 
and this regulator may be involved in the regulation of transcription in response to a different signal, 
potentially that of an additional metal cation. The significance of the increased abundance of IdeR in the 
CF of WTms is also unclear, as there is no difference in the abundance of this protein in the WCLs of the 
two strains. It is important to consider that it is not increased levels of these regulators which elicit a 
response, but the binding of the metal cation to the repressor which results in repression of transcription. 
These proteins provide evidence of some disregulation of divalent metal cation homeostasis in ESX-3ms. 
The reduction in metal-cation-binding and -regulator proteins in ESX-3ms may indicate an increased iron 
concentration relative to WTms, although this variation may be above the threshold for IdeR or may be 
indicative of a disregulation in the homeostasis of other divalent metal cations. 
3.3.3.3. The proteome of ESX-3ms shows signs of disrupted polyamine metabolism 
Polyamines are small, positively charged aliphatic hydrocarbons with quaternary nitrogen groups. 
Putrescine and spermidine are the most common polyamines found in bacteria.
173
 Putrescine is 
synthesised from arginine, via agmatine or ornithine. S-adenosylmethionine, generated from methionine, 
is used in the conversion of putrescine to spermidine (Figure 3.3.5.).
174
 Positively charged polyamines 
interact with negatively charged nucleic acids to stabilise and maintain their optimum conformation, and 
are therefore required for optimal DNA replication, transcription and translation.
175
 They have also been 
linked to outer membrane functionality, physiological stress responses, microbial pathogenicity, biofilm 
formation, cell membrane and cell wall stabilisation and the synthesis of molecules involved in iron 
acquisition.
173, 175, 176
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Figure 3.3.5. Bacterial polyamine biosynthesis. Putrescine is synthesised from arginine and ornithine. 
Spermidine biosynthesis from putrescine is dependent on decarboxylated S-adenosylmethionine which is 
derived from methionine. 
Polyamine metabolism has not been well studied in mycobacteria, however the WCL and CF proteomic 
variation observed in ESX-3ms closely resembles the transcriptomic and proteomic changes seen in 
Plasmodium falciparum when S-adenosylmethionine (SAM) decarboxylase, an essential enzyme in the 
production of spermidine, is inhibited,
177
 and in polyamine deficient mutants of E. coli.
178
 The reduced 
levels of ribosomal proteins, DNA stabilisation proteins and proteins involved in cell division, as well as 
altered levels of transcriptional regulators in ESX-3ms correlate with the functions of polyamines in 
nucleic acid stabilisation and their requirement for optimal DNA replication, transcription and translation. 
The changes in protein levels in ESX-3ms correlate with those observed upon inhibition of SAM 
decarboxylase (in P. falciparum), suggesting that ESX-3ms is deficient in polyamines, specifically 
spermidine and spermine. Methionine was detected at considerably lower levels in ESX-3ms than WTms. 
As methionine is a precursor of SAM, and carboxy-SAM, which is required for the synthesis of 
spermidine, and hence spermine, this may account for the apparent deficiency of polyamines ESX-3ms. 
Variations in abundance of other proteins including methyltransferases, fatty acid metabolism- and 
glycolysis- associated enzymes, proteins involved in oxidation-reduction reactions and enzymes involved 
in the biosynthesis and metabolism of cofactors (pyridoxamine, riboflavin, biotin and cobalamin) also 
correlate with the changes seen under SAM decarboxylase inhibition in P. falciparum. In addition to the 
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effects of polyamines on DNA and RNA regulatory processes they are also involved in oxidative stress 
responses, cell signalling and membrane and cell wall stabilisation, to which they may be integrated or 
attached.
175
 These functions also concur with proteomic changes observed in ESX-3ms.  
Furthermore, polyamines have been implicated in the biosynthesis of siderophores and the intracellular 
transport of chelators, as well as in biofilm formation
173, 175
, which in M. smegmatis, has been shown to be 
dependent on iron.
179
 Due to their positive charge, polyamines can bind to chelators in the cell to prevent 
their association with metal cations during their transport from the cell. Conversely they can compete with 
metal cation binding to chelators, interfering with metal cation uptake and homeostasis. Polyamines have 
also been shown to exert direct effects on several membrane ion channels and outer membrane porins of 
various species, altering their charge and pore size, and thereby affecting the permeability of the 
channels to various molecules, affecting membrane permeability to amongst others, various metal 
cations.
173, 180, 181
 As described earlier, under iron-rich conditions, M. smegmatis relies on passive uptake 
of iron though outer membrane pores, and altered polyamine levels could affect the permeability of the 
membrane to iron, and other metal cations. Therefore, the disturbed polyamine metabolism of ESX-3ms 
can be linked back to the proposed role of ESX-3 in divalent cation homeostasis, in addition to the 
proteomic changes observed in the mutant strain. It is also possible that a reduced zinc availability in 
ESX-3ms results in inhibition of MetE and MetH, preventing sufficient production of methionine, 
preventing polyamine synthesis. Polyamines remain understudied in mycobacteria and this study 
highlights a new avenue of research into the function of ESX-3, which may, in addition to its role in iron 
acquisition under iron-scarce conditions in M. smegmatis be linked to polyamine-regulation and its role in 
mycobacterial physiology.  
3.3.4. Limitations 
The major limitation of this study involves the high iron concentration in the culture medium, which 
represses transcription of ESX-3 in M. smegmatis, reducing the effect of the absence of the secretion 
system in ESX-3ms. The strain variation detected despite this reduced effect highlights a possible 
additional role of ESX-3 beyond its direct role in high affinity iron uptake. Metabolomic and proteomic 
investigations under conditions of iron (and other metal cation) starvation may identify additional 
mechanisms and pathways in which ESX-3 functions and may be more effective in identifying the 
physiological role of ESX in divalent cation homeostasis. 
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3.3.5. Conclusion 
The importance of ESX-3 in divalent metal cation homeostasis in M. smegmatis, and M. tuberculosis, has 
been well established, however its precise biological function remains elusive. In this study we have used 
a metabolomic and proteomic approach to investigate the physiological changes resulting from the 
presence and absence of ESX-3 in M. smegmatis. The variation in cellular metabolite concentrations 
could clearly distinguish between the two strains. The absence of ESX-3 resulted in significant reductions 
in the abundances of amino acids and simple sugars, and increases in fatty acid metabolism. We 
endeavoured to explain these results in the context of ESX-3’s role in iron and zinc uptake/homeostasis 
and subsequent downstream effects on oxidative stress, suggesting that the loss of ESX-3 resulted in 
iron excess and zinc starvation. However, although the proteomic variation between WTms and ESX-3ms 
correlated with pathways contributing to the metabolite changes, there was no proteomic evidence of 
disturbed iron or zinc homeostasis, as neither the IdeR nor the Zur regulon was altered. The proteomic 
variation does, however resemble changes resulting from disturbed polyamine metabolism, affecting DNA 
stability, transcriptional regulation, translation as well as several secondary pathways. The disruption to 
polyamine metabolism may be explained by the substantially lower levels of methionine in ESX-3, as S-
adenosyl-methionine is required for the synthesis of the polyamine, spermidine. Due to their positive 
charge, polyamines can influence the permeability of plasma membranes to various molecules, including 
metal cations, by influencing the charge and size of porins and other membrane channels. Polyamines 
have also been associated with the transport of metal chelators within the cell, with competing with metal 
cations in protein-binding, and in the production of siderophores, once again associating ESX-3 with 
divalent cation homeostasis 
In these experiments M. smegmatis was exposed to high levels of iron, under which conditions it has 
been shown to acquire iron via passive porin mediated uptake, and high affinity iron uptake is repressed. 
Passive iron uptake is sufficient to repress the IdeR regulon, however other mechanisms, possibly the 
influence of disturbed polyamine metabolism on these porins, may influence the iron levels within the 
cells, above the threshold of the IdeR regulon, but still exerting an effect of bacterial metabolism. 
Although ESX-3 is not required for iron acquisition under these conditions, the low level expression of this 
secretion system under these conditions, together with the substantial metabolomic and proteomic effects 
of its deletion suggest that this secretion system performs additional physiological functions. The 
proteome variation highlights polyamine metabolism as a novel avenue of research into ESX-3 function. 
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3.4. The functions of the M. smegmatis ESX-4 secretion system and its substrates 
3.4.1. Introduction 
The ESX-4 gene cluster is the most ancestral ESX,
27
 and is present in the genomes of all mycobacteria, 
with the exception of M. leprae, and in other actinomycetes. Although most ESX-4 component proteins 
have not been detected in proteomic analyses, and it is not essential for in vitro or in vivo growth, the 
maintenance and conservation of this gene cluster suggests that it performs an important biological 
function. Investigation of ESX-4ms in comparison to WTms on a metabolomic and proteomic level may 
highlight pathways or mechanisms in which it may function. 
3.4.2. Results 
3.4.2.1. Metabolomic analysis of ESX-4 function 
Five replicates of WTms and ESX-4ms cultures, grown to mid log phase (OD600= 0.6-0.8) in standard 
Middlebrook 7H9 culture medium, were subjected to GC-MS metabolomic analysis. The two dimensional 
PCA scores plots of the metabolite data, based on combinations of PC1, PC2 and PC3 did not show 
significant separation of the two strains (data not shown), however a three dimensional PCA scores plot 
based on PC1, PC2 and PC3 showed some clustering of the individual samples from each of the two 
strains (Figure 3.4.1). A PLS-DA was constructed and the PCA and PLS-DA analyses combined to 
compile a list of compounds which best represent the variation between ESX-4ms and WTms (Table 
3.4.1; analysis was done by Prof. Loots’s group). The list of variable compounds includes several amino 
acids and fatty acids. However, the variation between individual samples of the same strain is high, with 
no significant variation between strains; as suggested by the poor discrimination between strains in the 
PCA scores plots.  
3.4.2.2. Whole cell lysate proteomic analysis of ESX-4 function 
The whole cell lysate proteomes of ESX-4ms and WTms cultures were analysed using LC-MS/MS on the 
LTQ Orbitrap Velos. A combined total of 2884 proteins were identified in the M. smegmatis ESX-4ms and 
WTms strains (Supplementary Table S3.5). Protein abundances were compared and used to investigate 
the biological functions of the ESX-4 secretion system (Table 3.4.2). Ninety seven percent of the detected 
proteome showed no significant variation in protein abundance. Seven proteins were detected in ESX-
 133 
 
4ms but not in WTms, while 27 proteins were present in WTms, but not detected in ESX-3ms. A further 17 
and 33 proteins were present at a significantly greater or lower abundance, respectively,in ESX-3ms 
relative to WTms. No ESX-4 proteins were detected in either of the strains, however two ESX-3 proteins, 
EccC3 and EccD3, had a two-fold reduction in abundance in ESX-4ms compared to WTms. Two additional 
ESX-3 proteins EccA3 and EccE3 also had reduced abundances in ESX-4ms although this was not 
significant. 
a.      b.  
Figure 3.4.1. Three dimensional PCA scores plot of individually cultured ESX-4ms and WTms 
cultures representing non-parametric (a) and logarithmic (b) scaling. The individual samples from 
the two strains could be separated based on PC1, PC2 and PC3, which explain 81.7% of the variation 
between the two groups. Separation of the two groups is due to differences in the metabolite profiles in 
each of the sample groups. The PCA plot was generated by in Prof. du Loots’s group. 
 
Table 3.4.1. Differential abundance of the metabolites best representing the variation between 
ESX-4ms and WTms 
Compound name Concentration (µg/mg) ±standard deviation 
  
WTms ESX-4ms 
Serine 0.451  0.069 0.633  0.091 
Glycine 0.771  0.403 0.957  0.476 
Threonine 0.417  0.087 0.475  0.086 
Sarcosine 0.020  0.016 0.067  0.021 
Valine 3.406  0.684 4.119  0.746 
Leucine 2.125  0.431 2.795  0.541 
Isoleucine 0.933  0.197 1.122  0.193 
Alanine 0.186  0.233 0.345  0.423 
Phenylalanine 0.018  0.008 0.025  0.005 
Octadecanoic acid 1.741  1.594 4.496  2.257 
Nonadecanoic acid 4.282  2.087 0.680  0.927 
5-oxo-proline 19.690  6.106 14.204  8.383 
Propanoic acid 0.142  0.024 0.331  0.360 
Benzoic acid 0.033  0.013 0.055  0.019 
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Proteins that were differentially expressed in the two strains include multiple transcriptional regulators, 
proteins involved in cofactor metabolism, specifically folate and molybdopterin synthesis, amino acid and 
carbohydrate metabolism and several hypotheticals. However, these differentially abundant proteins only 
reflect a very small proportion of the proteome and therefore this minor variation may have little or no 
physiological effect. 
3.4.2.3. Culture filtrate proteomic analysis of ESX-4 
Culture filtrate fractions were prepared from WTms and ESX-4ms and the constituent proteins identified 
by LC-MS/MS analysis on the LTQ Orbitrap Velos. One thousand eight hundred and nine proteins were 
identified in the two strains (Supplementary Table S3.6). Protein abundances were compared and 
proteins with a minimum of 2-fold variance with a statistical significance of p<0.05, as well as proteins 
which were present only in the culture filtrate fractions of one strain (p<0.05) were considered to be 
influenced by the presence or absence of ESX-4. Six proteins were detected only in WTms and another 
six only in ESX-4ms, while 29 and 25 proteins were present in higher and lower abundances in ESX-4ms 
than WTms. 
No ESX proteins were detected in the CF fractions. Most proteins identified in the culture filtrates appear 
to be cytosolic proteins, many involved in transcriptional regulation, DNA metabolism, redox metabolism 
and pathways implicated in the WCL proteome analysis (Table 3.4.3). 
3.4.3. Discussion 
Our understanding of the ancestral ESX-4 secretion system is poor, and this study used comparative 
whole metabolomic and proteomic analyses to investigate the influence of the absence and presence of 
ESX-4 on the physiology of M. smegmatis in an attempt to identify potential functions or cellular 
processes in which it may be involved. ESX-4 is found throughout the most of the mycobacteria and the 
components and arrangement of ESX-4 in M. smegmatis and M. tuberculosis are conserved, making 
ESX-4ms a useful tool in the investigation of this secretion system. 
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Table 3.4.2. Proteins with different abundances in ESX-4ms and WTms WCLs, classified according to biological function. 
MSMEG_ Product Differential abundance*  p value Biological function 
H37Rv 
ortholog 
0617 ftsk/spoiiie family protein, EccC3  -2.2 0.003 ESX-3 Rv0284 
0623 secretion protein Snm4, EccD3  -2.0 0.011 ESX-3 Rv0290 
1015/2295 transcriptional regulator, TetR family protein  only ESX-4ms 0.024 Transcriptional regulation Rv3055 
2476 MarR family protein transcriptional regulatory only ESX-4ms 0.017 Transcriptional regulation  
6829 transcriptional regulatory protein only ESX-4ms 0.036 Transcriptional regulation  
1842 transcriptional regulator, TetR family protein only WTms 0.016 Transcriptional regulation Rv3248c 
4517 TetR-type transcriptional regulator of sulfur only WTms 0.028 Transcriptional regulation  
6139 putative HTH-type transcriptional regulator only WTms 0.022 Transcriptional regulation Rv2912c 
1831 Transcription factor WhiB 
+ 
 
 
4.3 0.037 Transcriptional regulation  
0663 TetR-family protein transcriptional regulator  -2.3 0.034 Transcriptional regulation  
1915 anti-sigma factor, family protein  -3.2 0.017 Transcriptional regulation Rv3221A 
3628 ComA operon protein 2  2.1 0.027 Transcriptional regulation Rv1847 
5696 ‘cold-shock' DNA-binding domain protein -2.2 0.016 Transcriptional regulation Rv0871 
2426 nitrogen regulatory protein P-II  -2.5 0.042 Transcriptional regulation Rv2919c 
2793 sensor-type histidine kinase PrrB  -2.4 0.012 Transcriptional regulation  
1445  30S ribosomal protein S17 -2.1 0.001 Translation Rv0710 
2400  ribosomal protein L28, rpmB  -2.3 0.038 Translation  
3483 mosc domain protein (molybdenum ion binding) only WTms 0.042 Divalent cation homeostasis Rv1864c 
4903 glutamate racemase, MurI only WTms 0.048 Amino acid metabolism Rv1338 
5536 chorismate mutase only WTms 0.003 Amino acid metabolism Rv0948c 
2726 glutamate permease -2.2 0.016 Amino acid metabolism  
6307 glutamine-binding periplasmic protein/glutamine transport system permease -2.2 0.002 Amino acid metabolism  
6911 ABC transporter, ATP-binding protein GluA  -2.0 0.036 Amino acid metabolism  
5085 dihydropteroate synthase, FolP  only WTms 0.036 Cofactor metabolism Rv1207 
5470 molybdopterin biosynthesis protein MoeA 1  only WTms 0.022 Cofactor metabolism Rv0994 
5703 molybdenum cofactor biosynthesis protein C, MoaC 2.0 0.010 Cofactor metabolism Rv0864 
0974 cytochrome c-type biogenesis protein CcsB  only WTms 0.007 Reduction/oxidation Rv0529 
4263 ubiquinol-cytochrome c reductase cytochrome b -2.0 0.002 Reduction/oxidation Rv2196 
2201 ZbpA protein 2.1 0.001 Reduction/oxidation Rv0130 
0086 1-phosphofructokinase  only WTms 0.031 Carbohydrate metabolism  
0655 glucose 1-dehydrogenase, putative only WTms 0.003 Carbohydrate metabolism  
0452 inner membrane permease YgbN (gluconate transport) only WTms 0.031 Carbohydrate metabolism  
4183 phosphoglycolate phosphatase, chromosomal  only WTms 0.007 Carbohydrate metabolism  
0784 acetate kinase  2.3 0.034 Carbohydrate metabolism Rv0409 
6021 xylose isomerase, XylA  3.2 0.017 Carbohydrate metabolism  
1671 succinate dehydrogenase hydrophobic membrane, SdhD -3.2 0.023 Carbohydrate metabolism Rv3317 
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0389 glycosyl transferase  -2.9 0.050 Carbohydrate metabolism 
 
6367 glycosyl transferase, group 2 family protein  -2.1 0.049 Carbohydrate metabolism Rv3782 
3739 cytidylate kinase  only WTms 0.047 DNA/RNA metabolism Rv1712 
3473 uracil phosphoribosyltransferase  only ESX-4ms 0.044 DNA/RNA metabolism  
2683 thymidylate synthase, flavin-dependent, ThyX 2.4 0.015 DNA/RNA metabolism Rv2754c 
6276 mur ligase family protein only WTms 0.011 Cell wall biosynthesis Rv3712 
4236 MraZ protein (cell division/cell wall biosynth) only WTms 0.048 Cell wall biosynthesis Rv2166c 
1661 D-alanyl-D-alanine carboxypeptidase  -2.9 0.001 Cell wall biosynthesis Rv3330 
0928 UDP-N-acetylenolpyruvoylglucosamine reductase, murB only ESX-4ms 0.038 Cell wall biosynthesis Rv0482 
4228 cell division protein FtsW  only WTms 0.003 Cell division Rv2154c 
4236 MraZ protein (cell division/cell wall biosynth) only WTms 0.048 Cell division Rv2166c 
2688 antibiotic biosynthesis monooxygenase domain 12.2 0.000 Antibiotic Rv2749 
3848 para-nitrobenzyl esterase  2.1 0.006 Antibiotic Rv2045c 
6202 secreted protein only WTms 0.001 Secreted protein 
Secreted protein 
Rv3683 
5412 immunogenic protein MPT63  -2.3 0.007 Secreted protein 
  2377 P49 protein  only WTms 0.024 Other Rv2997 
0203/0398 IS1096, tnpR protein only WTms 0.009 Other 
 2490 decarboxylase only WTms 0.005 Other 
 2579 zinc metalloprotease  only WTms 0.041 Other Rv2869c 
2696 putative conserved membrane alanine rich only WTms 0.001 Other Rv2743c 
3280 polyamine-binding lipoprotein  only WTms 0.036 Other 
 4908 endo-type 6-aminohexanoate oligomer hydrolase only WTms 0.014 Other Rv1333 
5162 cinnamoyl ester hydrolase only WTms 0.012 Other 
 6710 hydrolase, alpha/beta fold family protein  only WTms 0.025 Other   
0884 glyoxalase family protein  3.1 0.005 Other 
 1640 ATP/GTP-binding protein  2.0 0.011 Other Rv3362c 
2409 alpha/beta hydrolase fold family protein 2.1 0.005 Other Rv2970c 
6386 membrane protein -2.3 0.030 Other Rv3792 
0403 integral membrane protein  -2.4 0.048 Other 
 2100 peptidase family protein M20/M25/M40  -3.2 0.037 Other 
 2441 signal peptidase I, LepB  -2.9 0.032 Other Rv2903c 
4250 putative membrane transport ATPase  -3.8 0.036 Other Rv2184c 
5257 channel protein, hemolysin III family protein  -2.0 0.000 Other Rv1085 
5368 ectoine/hydroxyectoine ABC transporter binding protein, EhuB -2.2 0.036 Other 
 5827 glyoxalase family protein -2.7 0.015 Other Rv0801 
6239 1,3-propanediol dehydrogenase -3.6 0.010 Other   
3026 hypothetical protein  only ESX-4ms 0.039 Hypothetical protein Rv2554c 
6601 hypothetical protein  only ESX-4ms 0.004 Hypothetical protein 
 1434 hypothetical protein  only WTms 0.003 Hypothetical protein 
 0971 hypothetical protein  only WTms 0.033 Hypothetical protein Rv0526 
3514 hypothetical protein only WTms 0.027 Hypothetical protein 
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4569 hypothetical protein  only WTms 0.000 Hypothetical protein Rv2410c 
1734 hypothetical protein  2.6 0.007 Hypothetical protein Rv3304 
4324 hypothetical protein  2.7 0.004 Hypothetical protein Rv2242 
5614 hypothetical protein  2.0 0.031 Hypothetical protein 
 6159 hypothetical protein 2.3 0.015 Hypothetical protein Rv3648c 
6280 hypothetical protein 8.2 0.014 Hypothetical protein Rv3716c 
0368 hypothetical protein  -2.2 0.017 Hypothetical protein 
 0833 hypothetical protein  -3.0 0.047 Hypothetical protein 
 1076 hypothetical protein  -2.0 0.008 Hypothetical protein 
 1243 hypothetical protein  -2.0 0.005 Hypothetical protein 
 1981 hypothetical protein -2.1 0.031 Hypothetical protein 
 5223 hypothetical protein  -2.8 0.004 Hypothetical protein Rv1111c 
*Differential abundances represent the fold change in abundance of a protein in ESX-4ms relative to WTms. Negative values indicate a lower abundance in ESX-
4ms than WTms. Where indicated proteins were detected in only one strain. 
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Table 3.4.3. Proteins with different abundances in ESX-4ms and WTms culture filtrates, classified according to biological function. 
MSMEG_ Product Differential abundance*  p value Biological function H37Rv ortholog 
3319  repressor protein only ESX-4ms 0.009 Transcriptional regulation   
1305  TetR family protein regulatory protein -2.2 0.024 Transcriptional regulation   
1611  transcriptional regulator, TetR family protein, -14.2 0.028 Transcriptional regulation   
3980  transcriptional regulator, GntR family protein  -2.1 0.032 Transcriptional regulation   
1364  50S ribosomal protein L10  -2.4 0.010 Translation Rv0651 
1444  ribosomal protein L29 -2.2 0.048 Translation Rv0709 
5432  peptidyl-tRNA hydrolase 3.1 0.029 Translation Rv1014c 
2768  OB-fold nucleic acid binding domain protein only WTms 0.000 DNA/RNA metabolism Rv2694c 
3078  excinuclease ABC, C subunit 2.1 0.003 DNA/RNA metabolism Rv1420 
1901  DNA-binding HTH domain containing protein 28.4 0.016 DNA/RNA metabolism   
6941  R3H domain-containing protein  2.3 0.023 DNA/RNA metabolism Rv3920c 
4724  oligoribonuclease  -2.2 0.044 DNA/RNA metabolism Rv2511 
5243  helix-turn-helix motif  -4.2 0.044 DNA/RNA metabolism   
2724  regulatory protein RecX  -4.0 0.050 DNA/RNA metabolism Rv2736c 
1182 imidazolonepropionase only ESX-4ms 0.003 Amino acid metabolism   
1496 3-hydroxyisobutyrate dehydrogenase  8.0 0.001 Amino acid metabolism Rv0751c 
4905 cysteine synthase B  2.0 0.008 Amino acid metabolism Rv1336 
3397 acetylornithine deacetylase 4.3 0.044 Amino acid metabolism   
2937 pyridoxine biosynthesis protein  2.4 0.005 Cofactor metabolism Rv2606c 
2787 putative riboflavin biosynthesis protein RibD  4.2 0.044 Cofactor metabolism Rv2671 
5319 alkylhydroperoxidase AhpD core only WTms 0.002 Reduction/oxidation   
6362 quinone oxidoreductase  2.5 0.000 Reduction/oxidation Rv3777 
0408 type I modular polyketide synthase  2.4 0.009 Reduction/oxidation   
0604 glyoxylate reductase  4.7 0.028 Reduction/oxidation Rv0728c 
2536 3-oxoacyl-[acyl-carrier-protein] reductase -2.0 0.017 Reduction/oxidation   
6636 [Mn] superoxide dismutase  -2.0 0.017 Reduction/oxidation Rv3846 
0502 glucosidase  6.4 0.014 Carbohydrate metabolism   
4305 phosphoglycerate mutase  2.6 0.050 Carbohydrate metabolism Rv2228 
2512 lactate 2-monooxygenase  -2.6 0.030 Carbohydrate metabolism   
1820 phosphoribosylaminoimidazole carboxylase -2.6 0.039 Carbohydrate metabolism Rv3275c 
1952 ATP-dependent DNA helicase -2.2 0.041 Carbohydrate metabolism Rv3198c 
2349 glycosyl hydrolase, family protein 57 -2.8 0.044 Carbohydrate metabolism Rv3031 
2070 acyl-CoA dehydrogenase family protein  3.1 0.009 Fatty acid metabolism   
6388 probable arabinosyltransferase B  only WTms 0.001 Cell wall biosynthesis Rv3794 
2395 D-alanine--D-alanine ligase  2.3 0.002 Cell wall biosynthesis Rv2891c 
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1580 O-sialoglycoprotein endopeptidase  only ESX-4ms 0.002 Other Rv3419c 
1703 amidohydrolase only ESX-4ms 0.002 Other Rv3305c 
0939 Ppx/GppA phosphatase family protein  only ESX-4ms 0.003 Other Rv0496 
4362 universal stress protein family protein  only ESX-4ms 0.013 Other   
4939 ATP synthase delta chain  3.5 0.014 Other Rv1307 
1835 TobH protein  3.4 0.026 Other Rv3256c 
4043 amidohydrolase 2  4.7 0.028 Other   
5017 lipoprotein  3.0 0.031 Other   
0270 aminoglycoside phosphotransferase  4.5 0.033 Other   
0518 ABC transporter, nucleotide binding/ATPase 4.3 0.036 Other   
5118 nudix hydrolase  4.1 0.049 Other   
4672 Clp protease  -2.0 0.014 Other Rv2460c 
0241 MmpL11 protein -4.6 0.015 Other Rv0202c 
4975 flavin-nucleotide-binding protein  -2.3 0.018 Other   
5198 carnitinyl-CoA dehydratase -2.1 0.018 Other   
1976 hypothetical protein  only WTms 0.000 Hypothetical protein   
2763 hypothetical protein  only WTms 0.001 Hypothetical protein Rv2699c 
6579 hypothetical protein  only WTms 0.001 Hypothetical protein   
1356 hypothetical protein  only ESX-4ms 0.002 Hypothetical protein   
3910 hypothetical protein  only ESX-4ms 0.005 Hypothetical protein   
1210 hypothetical protein  only ESX-4ms 0.031 Hypothetical protein   
4365 hypothetical protein  6.4 0.000 Hypothetical protein   
1176 hypothetical protein  4.2 0.019 Hypothetical protein   
4128 hypothetical protein  5.1 0.019 Hypothetical protein   
2037 hypothetical protein  3.1 0.036 Hypothetical protein   
3661 hypothetical protein  2.7 0.049 Hypothetical protein Rv1815 
2679 hypothetical protein  2.5 0.050 Hypothetical protein   
4399 hypothetical protein  -14.0 0.000 Hypothetical protein   
5614 hypothetical protein  -2.8 0.000 Hypothetical protein   
3026 hypothetical protein  -2.2 0.006 Hypothetical protein Rv2554c 
2436 hypothetical protein  -3.4 0.007 Hypothetical protein Rv2908c 
1680 hypothetical protein  -2.1 0.012 Hypothetical protein   
3843 hypothetical protein  -4.7 0.026 Hypothetical protein Rv1628c 
3016 hypothetical protein  -4.2 0.044 Hypothetical protein Rv2566 
*Differential abundances represent the fold change in abundance of a protein in ESX-4ms relative to WTms. Negative values indicate a lower abundance in ESX-
4ms than WTms. Where indicated proteins were detected in only one strain. 
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3.4.3.1. Expression of ESX-4 is repressed under standard culture conditions in M. smegmatis. 
The whole cell lysate and culture filtrate proteomic analyses were unable to identify any of the ESX-4 
proteins in any of the WTms replicates. This apparent lack of expression is supported by the absence of 
significant metabolomic variation between WTms and ESX-4ms. These results correlate with several in 
vitro studies which have failed to identify ESX-4 proteins in various cellular fractions,
120, 182, 183
 although 
EccC4 and MycP4 have been detected in the cell membrane and cytosolic fractions of M. tuberculosis 
respectively, grown in an alternate culture medium under different conditions.
184
 On a protein level, 
however, significant variation in protein abundances was detected in the whole cell lysate and culture 
filtrate fractions. This may be attributed to very low level, undetectable, expression of ESX-4 which none-
the-less influences cellular biology of the mycobacterium. These influences may result in insignificant 
changes to the metabolite profiles of the two strains, or influence processes which do not influence the 
metabolite levels. The lack of significant variation in metabolite concentrations might also be attributed to 
the small sample numbers in the metabolomic analyses, which influence statistical significance. It 
appears that under the conditions of this study expression of ESX-4 is repressed, but that low level, 
undetectable expression impacts various cellular processes leading to substantial proteomic variation, 
but no significant metabolomic distinction, between WTms and ESX-4ms. 
3.4.3.2. The absence of ESX-4 influences the expression of ESX-3 
Interestingly, two ESX-3 proteins, EccC3 and EccD3, were only half as abundant in ESX-4ms as in WTms. 
Two additional ESX-3 proteins, EccA3 and EccE3, were also underrepresented in ESX-4ms, although not 
significantly so. Therefore it appears that the presence or absence of ESX-4 influences the expression of 
ESX-3 in M. smegmatis. Cross-talk between different ESX secretion systems has previously been shown 
for ESX-1 and ESX-5, where deletion of esxA-esxB results in increased secretion of PPE41 (ESX-5),
59
 
while deletion of ESX-5 increases the secretion of ESX-1 substrates.
30
 Although the five ESX secretion 
systems are unable to complement one another, it has been suggested that partial complementation by 
some proteins may be possible.
30
 Alternatively, the functions of one ESX secretion system may influence 
those of another. 
Several pathways which were influenced by the deletion of ESX-3 also show variations in protein 
abundances in ESX-3ms. These include proteins involved in carbohydrate and amino acid metabolism, 
redox homeostasis, cell wall biosynthesis, translation, secreted proteins and hypotheticals. The variations 
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in these proteins might be attributed to the reduced expression of ESX-3 rather than directly to the 
absence of ESX-4. 
3.4.3.3. ESX-4 and cell division 
The absence of ESX-4 resulted in the disregulation of numerous transcription factors, most of which are 
of unknown function, but which likely result in the other changes in protein expression. Notably, a WhiB 
transcriptional regulator, encoded by MSMEG_1831, is more than four times more abundant in ESX-4ms 
than in WTms. MSMEG_1831 encodes WhmD, the M. smegmatis ortholog of M. tuberculosis WhiB2. The 
gene whmD is essential, and is involved in cell division, specifically in ensuring proper septum 
formation.
185, 186
 Under-expression of WhmD results in filamentation with multiple arrested septa 
distributed unevenly thoughout the length, but does not affect biomass accumulation. Overexpression of 
WhmD resulted in small colony size, but only slightly reduced growth rate in liquid culture and a frequent 
occurrence of multiseptate bacteria. WhiB2 is expressed throughout log phase, but greatly reduced in 
late stationary phase,
187
 indicating its requirement for active growth. WhiB2 expression is also 
upregulated when exposed to various antibiotics which inhibit cell wall biosynthesis.
187
 Therefore it 
appears that WhmD may be involved in cell division by regulating the expression of proteins directly 
involved in septum formation or in cell division-associated cell wall biosynthesis. 
EccC4 was classified as a FtsK/SpoIIIE protein, proteins which are typically involved in cell division and 
peptidoglycan synthesis and modification, and have been shown to assist in the transfer of DNA through 
the septum.
188, 189
 Rv3447c (M. tuberculosis EccC4) was found to be upregulated when FtsI, a protein 
involved in peptide crosslinking at the septum, is inhibited.
121
 Furthermore, inhibition of FtsI results in a 
similar filamentous phenotype as caused by WhmD underexpression. Therefore it appears that WhmD, 
FtsI and ESX-4 may all be linked to cell division and septum formation. There are several other proteins 
involved in cell division and cell wall biosynthesis which were found to be differentially abundant in WTms 
and ESX4ms, including FtsW (involved in Z-ring stabilisation and septal peptidoglycan synthesis), MrzA 
(involved in cell wall synthesis and cell division) and some Mur family proteins (involved in cell wall 
biosynthesis), suggesting that these processes may be influenced by ESX-4. 
Interestingly, ESX-4 expression has been shown to be induced by WhiB5, another WhiB transcriptional 
regulator, during reactivation of M. tuberculosis following dormancy and starvation.
112
 Reactivation 
involves increased cell growth and division, further associating ESX-4 with the processes of cell division, 
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septum formation, or cell division-related cell wall biosynthesis. It is possible that ESX-4 is responsible for 
secreting specific proteins involved in these processes, and possibly the transport of DNA at the septum, 
as indicated by the FtsK/SpoIIIE motif in EccC4. The involvement of ESX-4 in these processes may be 
limited to reactivation, during which its expression is induced, allowing normal cell growth and cell division 
of ESX-4ms during standard in vitro culture. 
3.4.3.4. ESX-4 and molybdenum metabolism 
Interestingly three proteins which are involved in molybdopterin metabolism were differentially abundant 
in WTms and ESX-4ms. Molybdopterin is a molybdenum containing cofactor which is required by various 
enzymes. MoeA and MoaC are involved in the biosynthesis of molybdopterin,
190
 while the mosc domain 
protein requires a molybdopterin cofactor. Molybdenum is a transition metal and altered molybdopterin 
metabolism may be indicative that ESX-4 is involved in the homeostasis of molybdenum levels in the cell, 
and possibly the uptake thereof, as described for iron and zinc and ESX-3.  
3.4.4. Conclusion 
In this study we have attempted to define the metabolomic and proteomic changes resulting from the 
absence or presence of the ancestral ESX-4 secretion system in M. smegmatis, in order to identify 
possible functions and cellular processes in which it may be involved. Although the inability to detect any 
of the ESX-4 proteins in the wild-type M. smegmatis samples, and the lack of significant metabolomic 
differences between WTms and ESX-4ms suggest that ESX-4 is not expressed under these conditions, 
significant differences were observed between the whole cell lysate and culture filtrate fractions from the 
two strains. This suggests that ESX-4 may rather be expressed at undetectable levels under these 
conditions. A reduced abundance of ESX-3 proteins was detected in ESX-4ms relative to WTms, 
suggesting that ESX-4 influences the expression of ESX-3, and that their functions may be somehow 
linked. We have identified two pathways in which ESX-4 may be involved, namely cell division or cell 
division-associated cell wall biosynthesis and molybdopterin homeostasis. The functions of this 
inessential, but highly conserved, ESX-4 secretion system have remained elusive, and this study has 
identified novel directions for investigation of its functional role in mycobacterial physiology. 
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3.5. General conclusion 
This study has used has used a “systems biology” approach, incorporating whole proteomic and 
metabolomic analyses to investigate the global biological changes resulting from a specific genomic 
modification. The effects on multiple cellular pathways and their impact on one another can be detected 
simultaneously, allowing for the identification of pathways affected by such a genomic modification. 
These global analyses provide a unique way of understanding bacterial physiology in response to various 
stimuli and stresses in addition to specific genome modifications and may be hugely beneficial in 
expanding our understanding of mycobacteria and their mechanisms of pathogenicity. 
Individual ESX knockout strains of M. smegmatis were used to investigate the effect of the presence or 
absence of each of the M. smegmatis ESX gene clusters on the metabolomes and proteomes of the 
bacteria, in order to identify possible biological functions of the associated ESX secretion systems. No 
pathways were considerably altered by the deletion of ESX-1, despite the detection of most of the ESX-1 
components in the WCL of WTms. The numbers of proteins which vary between ESX-1ms and WTms on 
both a proteomic and secretomic level are much lower than those obtained in the ESX-3 and ESX-4 
studies, despite the far higher expression level of ESX-1 under these conditions, suggesting that the 
function of ESX-1 may be more independent of general cellular functions. Deletion of ESX-3 resulted in 
major changes on a proteomic and metabolomic level, including altered amino acid and carbohydrate 
metabolism, translational processes and redox metabolism which might be ascribed to polyamine 
metabolism. No significant metabolomic variation resulted from the deletion of ESX-4. However, although 
no ESX-4 component proteins were detected in WTms, the proteome of ESX-4ms was altered, possibly 
linking ESX-4 to cell division or molybdenum homeostasis. Interestingly the deletion of ESX-4 resulted in 
reduced the abundance of ESX-3 components, possibly linking the functions of these two secretion 
systems. The identification of pathways influenced by the absence or presence of the ESX gene clusters 
provides new directions for research into their functions and role in mycobacterial pathogenicity. 
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Supplementary Tables S3.1 to S3.6. The detected WCL and CF proteomes of ESX-1ms, ESX-3ms 
and ESX-4ms with abundances relative to the detected WTms proteome. 
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4. The substrates of the M. smegmatis ESX secretion systems 
4.1. Introduction 
The mycobacterial ESX secretion systems are predicted to secrete the Esx, PE and PPE proteins 
encoded within them.
30
 In M. tuberculosis, some ESX have further been shown to secrete additional 
proteins, including Esx, PE and PPE proteins which were duplicated from these gene clusters and 
situated in other parts of the genome, and various other proteins encoded within the ESX gene clusters 
and at other genome locations. Recently a YxxxD/E amino acid motif has been found to be a general 
ESX (Type-VII) secretion signal for M. tuberculosis ESX substrates.
72
 The non-ESX encoded Esx, PE 
and PPE duplications and various other M. tuberculosis ESX substrates are not present in M. smegmatis 
and additional ESX substrates have not been identified in this organism. This study aimed to use the 
secretomic analyses (as described in section 3) to identify novel substrates of the M. smegmatis ESX-1, 
ESX-3 and ESX-4 secretion systems. 
4.2.  Results 
The secretomes of ESX-1ms, ESX-3ms and ESX-4ms were analysed and compared to that of WTms. 
Proteins which were detected in WTms but not in a specific ESXms strain are potential secreted 
substrates of that ESX secretion system (Tables 4.1 to 4.3). Proteins with a minimum of 4 times greater 
abundance in WTms than in the ESX strain were included to account for cell leakage or cell lysis which 
may result in some proteins in the culture filtrate.  
The general Type-VII secretion signal, YxxxD/E was identified using M. tuberculosis and M. marinum 
proteins, 
72
 therefore to investigate the appropriateness of using the YxxxD/E motif for the confirmation of 
ESX substrates in M. smegmatis, the Esx and PE protein sequences from the three M. smegmatis ESX 
gene clusters were analysed. The CFP-10-like Esx proteins and the PE proteins from ESX-3 and ESX-1 
in M. smegmatis contain conserved YxxxD motifs near their C-termini (Figure 4.1.a). This correlates with 
previous findings that these proteins contain the signal to allow secretion of the Esx-Esx and PE-PPE 
complexes. The motif was not identified at the C-terminal of EsxU or EsxT from ESX-4, however a YxxxE 
is present near the N-terminal of EsxT, and may substitute for the secretion signal.  
The amino acid sequence of each possible M. smegmatis ESX substrate protein was analysed to identify 
a YxxxD/E motif. Five proteins containing this motif were identified for ESX-4, six for ESX-3 and one for 
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ESX-1 (Figure 4.1.b). Two proteins, MSMEG_5319 and MSMEG_1976, were common for both ESX-4 
and ESX-3. No previously assumed or identified ESX substrates were identified, and only a single ESX-
encoded protein, EccA1, was identified in the culture filtrates. 
Table 4.1. Possible M. smegmatis ESX-1 secreted proteins.  
MSMEG_ Product 
Differential 
abundance p value 
YxxxD/E 
motif 
H37Rv 
ortholog 
ESX-1ms : WTms 
0059 ATPase, AAA family protein large subunit only WT 0.008 YspdE Rv3868 
3142 HTH-type transcriptional repressor AcnR only WT 0.000  Rv1474c 
1573 carbohydrate kinase family protein  only WT 0.012  Rv3433c 
3778 phenylalanyl-tRNA synthetase, alpha subunit  only WT 0.002  Rv1649 
6278 metallo-beta-lactamase superfamily protein only WT 0.013  
 1108 hydrolase, alpha/beta fold family protein  only WT 0.049  Rv0554 
3016 hypothetical protein only WT 0.014  Rv2566 
 
Table 4.2. Possible M. smegmatis ESX-3 secreted proteins.  
MSMEG_ Product 
Differential 
abundance 
ESX-3ms: WTms 
p value 
YxxxD/E 
motif 
H37Rv 
ortholog 
3872 precorrin-8X methylmutase only WT 0.046  Rv2065 
2119 N-acetylglucosamine-6-phosphate deacetylase, nagA only WT 0.008  Rv3332 
2923 dehydrogenase/reductase SDR family protein only WT 0.002 YgitD 
 5319* alkylhydroperoxidase AhpD core  only WT 0.001 YftdE 
 6077 transcriptional regulator, CarD family protein  only WT 0.013  Rv3583c 
6451 transcriptional regulator, ArsR family protein  only WT 0.026  Rv0081 
2399 uracil-DNA glycosylase  only WT 0.003  Rv2976c 
0369 hypothetical protein only WT 0.038  
 1581 hypothetical protein  only WT 0.009 YryaE 
 1976* hypothetical protein only WT 0.000 YsddE 
 2763 hypothetical protein only WT 0.003  Rv2699c 
2861 hypothetical protein  only WT 0.011  
 3024 hypothetical protein only WT 0.024  Rv2556c 
3843 hypothetical protein  only WT 0.003  Rv1628c 
5634 hypothetical protein  only WT 0.048  Rv0910 
6579 hypothetical protein  only WT 0.014  
 0760 thioesterase family protein only WT 0.001 YeagE Rv0356c 
1078 hydrolase only WT 0.000  
 1835 TobH protein  only WT 0.004  Rv3256c 
5224 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, ispH only WT 0.002 YurhE Rv1110 
* absent in both ESX-3ms and ESX-4ms culture filtrates. 
 
Table 4.3. Possible M. smegmatis ESX-4 secreted proteins.  
MSMEG_ Product 
Differential 
abundance  
ESX-4ms: WTms 
p value 
YxxxD/E 
motif 
H37Rv 
ortholog 
2768 OB-fold nucleic acid binding domain protein only WT 0.000  Rv2694c 
5319* alkylhydroperoxidase AhpD core only WT 0.002 YftdE   
6388 probable arabinosyltransferase B  only WT 0.001 YlrdD Rv3794 
1976* hypothetical protein  only WT 0.000 YsddE   
2763 hypothetical protein  only WT 0.001  Rv2699c 
6579 hypothetical protein  only WT 0.001    
1611 transcriptional regulator, TetR family protein, -14.2 0.028    
4399 hypothetical protein  -14.0 0.000    
3843 hypothetical protein  -4.7 0.026 YtddD Rv1628c 
0241 MmpL11 protein -4.6 0.015 YcgrD Rv0202c 
5243 helix-turn-helix motif  -4.2 0.044    
3016 hypothetical protein  -4.2 0.044  Rv2566 
2724 regulatory protein RecX  -4.0 0.050  Rv2736c 
* absent in both ESX-3ms and ESX-4ms culture filtrates. 
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EsxB ESX-1 MAAMNTDAAVLAKEAANFERISGELKGVIAQVESTGSALAAQMVGQAGTAAQAALARFHEAAAKQVQELNEISANIHTSGTQYTSTDEDQAGTLASSMNI 
EsxG ESX-3 MSLLDAHIPQLIASEANFGAKAALMRSTIAQAEQAAMSSQAFHMGEASAAFQAAHARFVEVSAKVNALLDIAQLNIGDAASSYVAQDAAAASTYTGI 
EsxU ESX-4 MSTPLGADFDVMTTVAGQIDVRNDDIRSMLQTFIGRMNTVPPTVWGGVAATRFRDVVERWNAESLTLHTTLQRIAETIRHNERTLREAADGHAQRLGGVGETL 
EsxT ESX-4 MSQLLSYDFGEIEYTVRQEIHATHSRFNAALEELRAQIAPLQQVWTREAAAAYQVEQARWNQAAAALNEILFSLGNAVRDGSDEVAATDRSAANAWGV 
PE35 ESX-1 MQPMTHNPGAEAVAAQVIANAARGLAGGTTASAAVTALVPAGADEVSALAAVAFASEGVEALAANAFAQEELTRAGAAFAEIAGIYNAVDAANAATM 
PE5 ESX-3 MTLRVVPEGLTAASSAVEALTARLAAAHAAAAPMISTVLPPAADAVSLQTAAGFSANGAQQSAVAAQGVEELGRSGVGVGESGVSYATGDAQAAASYLTARGL 
    a) 
MSMEG_0059 ESX-1 413-PFGAEALDTLLARMENDRDRLVVIIAGYSNDIDRLLEVNDGLRSRFATRIEFDSYSPDEIVEISKVIATANDSRLDDTAAKRVLEA-500 (574) 
   MSMEG_2923 ESX-3 187-FAGNPEALAETAKHAETPEFTGRLIDALYRDPQLGELSGQTVIGAELATRYGITDEGGRIPPSHREMLGAPRVAHPAVVR-266 (266) 
MSMEG_5319 ESX-3/4 69-STDRIAVIPAWRETAYFTDEERAALAIAEEITDISNPPRASDAELLTALSTQQVAVLRWLAVTINAFNRIAISSHYKVGP-148 (148) 
MSMEG_1581 ESX-3 1-MNLERLAHTLQITELLYRYAELVDAGDFDGVGQLLGRGAFMGVTGADAIAALFAATTRRFPEHGNRPRTRHLVLNPIIDI-80 (149) 
MSMEG_1976 ESX-3/4 168-RRRFTIGLSNCPNSKVLVDDEGKPVAPEAVPMRLRFARSVRISMEGNSHFCRGLLATRYSDDEPAGALPVVTDTRTRRSR-247 (247) 
MSMEG_0760 ESX-3 1-MSADFGLDPRRTDPKYHSEHGGFPVFEAAEPGPGFGRFLTAMRRAQDLAVSADPDAATWDKAADLVEELVALLDPYEAGEGVGPA-85 (216) 
MSMEG_5224 ESX-3 1-MSGKRVLLAEPRGYCAGVDRAVETVERALEKHGAPVYVRHEIVHNRHVVETLAKAGAIFVDETDEVPEGAIVVFSAHGVAPT-82 (314) 
   
MSMEG_6388 ESX-4 1001-VVSSNQWQSAADGGPFLFIQALLRTEAIPTYLRDDWYRDWGSIERYIRVVPQEQAPTAAIEEGSTRVFGWSRGGPIRALP-1080 (1080) 
MSMEG_3843 ESX-4 71-SYTENRYAPPPPYPSPDPFEPFAVAAVELADEGLIVLGKVVEGTLAADLKVGMEMELTTMPLYTDDDGVERLTYAWRIA-150 (150) 
MSMEG_0241 ESX-4 875-LVDLMDSHTAALVLASMDRYYCGRDPSNRWVATQLVRRLADPQPSDEHDVRMSGPDAAEDWEKVRQRCLSVAVAMLEEAK-954 (954) 
       b) 
Figure 4.1 ESX secreted substrates contain a general mycobacterial Type VII secretion motif. a) The prototype substrates of ESX-1 and ESX-3 contain C-
terminal YxxxD motifs, while the ESX-4 Esx substrate contains a YxxxE motif toward the N-terminal. b) Ten of the possible ESX secreted substrates contain 
YxxxD/E motifs. The region of the protein sequence shown is indicated, total amino acid length of each protein is in brackets and the YxxxD/E motifs are in bold. 
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4.3. Discussion 
The ESX gene clusters encode dedicated Type-VII protein secretion systems, responsible for the 
export of specific proteins into the extracellular milieu. The secretion of Esx, PE and PPE proteins has 
been linked to their associated ESX secretion systems, and several additional secreted substrates 
have been identified in M. tuberculosis, predominantly for the ESX-1 and ESX-5 secretion systems. 
However, additional substrates of the M. smegmatis ESX have not been identified. Here we have used 
a comparative whole secretomic analysis to identify novel M. smegmatis ESX substrates by 
comparing the protein constituents of the culture filtrates of WTms with those of ESX-1ms, ESX-3ms 
and ESX-4ms. The absence of each specific secretion system prevents the secretion of the correlating 
protein substrates allowing their identification only from WTms. Several proteins were identified which 
were secreted in WTms but not in a ESXms strain, or had greatly reduced abundances in the ESXms 
strain than in WTms, and were defined as possible ESX substrates.  
Protein concentrations in the culture filtrate fractions may be influenced directly by ESX secretion, by 
increased expression levels and by additional biological processes which are influenced by the 
presence or absence of the ESX secretion systems. Therefore not all proteins which are only detected 
in the culture filtrates of WTms can be directly associated with ESX secretion. A recently identified 
general secretion signal for mycobacterial ESX secretion, YxxxD/E,
72
 was used to screen the possible 
substrates. Ten differentially secreted proteins, containing YxxxD/E motifs, were identified for all three 
ESXms strains, two of which were absent in both ESX-4 and ESX-3. This correlates with the 
proteomic findings which showed that ESX-3 abundance was lower in the absence of ESX-4, and 
suggests that these proteins are substrates of ESX-3, rather than ESX-4.  
Only one possible protein substrate containing a YxxxD/E motif was identified for ESX-1, namely 
EccA1, encoded by MSMEG_0059. EccA1 is generally considered to be a cytosolic protein, although it 
has been detected in the membrane fraction of M. tuberculosis.
159
 Recently EccA1 has been 
associated with mycolic acid synthesis,
109
 and this may link it functionally to the cell membrane or 
periplasmic space. However, our study shows that it does contain an ESX secretion system motif, 
indicating that it might, in fact, be a true ESX secreted protein. 
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Of the six possible secreted substrates with the general Type-VII secretion signal identified for ESX-3, 
four are involved in redox metabolism, and two are conserved hypotheticals. The metabolomic 
analysis of ESX-3ms indicated that the organism experiences increased levels of oxidative stress, 
therefore the redox-related proteins in the culture filtrate of WTms may contribute to the reduction of 
this stress. Two of the proteins, MSMEG_2923 and MSMEG_1976, contain the YxxxD/E motif near to 
their C-termini, resembling those of the know substrates, while in the remaining four the motif occurs 
closer to the N-terminus. 
The possible substrates of ESX-4, MSMEG_6388, MSMEG_3843 and MSMEG_0241, encode an 
arabinosyltransferase, a conserved hypothetical and a MmpL11 protein respectively, the homologs of 
which have all been detected in the membrane of M. tuberculosis.
159
 Arabinosyltransferases are 
involved in cell wall synthesis, while the MmpL proteins are predicted to export mycolic acids and 
other lipids for cell wall and membrane synthesis.
191
 This correlates with a possible involvement of 
ESX-4 in cell division-related cell wall synthesis. MSMEG_6388 and MSMEG_0241 are large proteins 
with a YxxxD/E motif toward the C-terminus, while MSMEG_3843 is a smaller protein which contains a 
secretion motif within 17 amino acids of the C-terminus, possibly presenting a better prospect as an 
ESX substrate (which are usually around 100 amino acids in length).  
Proteins which contain a general Type-VII secretion signal which is not located at the N-terminus may 
still be substrates of an ESX secretion system, as some proteins have a YxxxD/E motif within an N-
terminal domain of the protein which is cleaved from a functional C-terminus domain after secretion.
72
 
Furthermore, because most identified ESX substrates appear to be secreted as heterodimers, proteins 
without the YxxxD/E motif may be co-secreted with a Type-VII secretion motif-containing protein. 
However, while the presence of the YxxxD/E motif suggests that these proteins are exported through 
the membrane using the ESX secretion machinery, it is possible that the increased abundance of 
these proteins is rather indicative of another alteration to the bacterial metabolism resulting from the 
absence of the ESX.  
None of the ESX-4 component proteins were detected in the WCL or CF of M. smegmatis and only a 
few of the ESX-3 component proteins were detected at low levels in the WCL. Furthermore, although 
ESX-1 was significantly expressed, only two of the prototype substrates, EsxA and PPE68 were 
detected in the WCL, and none in the CF. EsxA and PPE68 rely on EsxB and PE35 to provide the 
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signal for secretion.
72
 Therefore low expression levels, export rates or inefficient concentration of the 
culture filtrate may preclude effective identification of known and novel substrates in this study. In 
addition, cytosolic proteins were abundant in the CF fraction, suggesting that culture filtrate 
fractionation was not sufficiently precise. Several of the possible substrates which were identified and 
contain secretion motifs are localised to the cell membrane and it remains unclear whether they are 
genuine substrates which are integrated into the membrane via the ESX secretion system, as has 
been seen for some PPE proteins, or whether their detection is due to a lack of specificity of the 
sample fractionation. Developing new methods for the fractionation of mycobacteria to improve 
specificity, and increasing expression and export by using more appropriate culture conditions will 
advance our ability to identify novel substrates. 
4.4. Conclusion 
In this study we have attempted to use comparative proteomic analyses of the culture filtrates of M. 
smegmatis wild type and ESX1ms, ESX-3ms and ESX-4ms strains to identify novel secreted protein 
substrates of each M. smegmatis ESX secretion system. The secretome of a bacterium, containing 
the exported proteins, is predicted to contain approximately 10% of the annotated proteins, however, 
in our culture filtrate analysis, we identified approximately 1800 proteins. Although care was taken to 
prevent excessive lysis of the cells during culture, due to the low abundance of secreted proteins 
relative to cytosolic proteins, the levels of cytosolic protein contamination in the culture filtrates was 
high (data not shown). None of the prototype Esx, PE and PPE secreted substrates were identified in 
the culture filtrate of wild type M. smegmatis. Ten possible substrates of the M. smegmatis ESX 
secretions systems were identified at high confidence, using the presence of the YxxxD/E general 
mycobacterial Type-VII secretion signal as a validation. This study may serve as a fishing tool to 
highlight proteins to validate as substrates of the M. smegmatis ESX secretion systems. 
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Tuberculosis, caused by M. tuberculosis, continues to infect and kill millions of people annually,
16
 
despite the development and implementation of the BCG vaccine and several anti-tuberculosis drugs. 
Improving our understanding of the biology and mechanisms of pathogenicity of M. tuberculosis will 
enhance our ability to develop novel drugs and vaccines to eradicate the disease. The mycobacterial 
ESX secretion systems, recently defined as a novel Type-VII secretion machinery, have been linked to 
mycobacterial virulence and survival and as such present a promising subject for research in the field 
of tuberculosis. This study aimed to investigate the evolution, regulation, functions and substrates of 
the mycobacterial ESX secretion systems.  
The evolutionary history of the ESX gene cluster was investigated using in silico methods and 
determined through phylogenetic analyses of sequences obtained from all mycobacterial species 
which have been sequenced, as well as several closely related actinomycetes and the WXG-FtsK 
clusters of other bacterial species. The ESX-4 gene cluster is the ancestral ESX which appears to 
have evolved from the WXG-FtsK cluster along with the evolution of the mycomembrane. ESX-4 
incorporates several additional genes which may be involved in mycomembrane transport. ESX-3 was 
the first duplication from ESX-4, and marks the evolution of the genus Mycobacterium. An ancestral 
ESX-3 was identified in N. farcinica, which seems to have evolved divergently from the mycobacterial 
ESX-3. The ESX-1 duplication appears to have occurred next, followed by ESX-2 and ESX-5, which 
occur only in the slow growers. An ancestral ESX-2 was identified in M. tusciae, a slow-growing 
mycobacterium which clusters phylogenetically with the fast growers, and this may be an evolutionary 
link between the fast- and slow- growing mycobacteria. Five additional, previously unidentified, ESX 
gene clusters were identified in the mycobacteria. These were identified, or predicted to be located, on 
plasmid DNA, and were named ESX-P1 to -P5. The plasmid ESX appear to be evolutionary 
precursors of the genomic ESX-3, -1 and -5, suggesting that the duplication and evolution of the ESX 
gene clusters may have been, at least partly, plasmid-mediated.  
Promoter-containing intergenic regions of the M. tuberculosis ESX gene clusters were identified using 
a promoter-probe assay. Promoters driving expression of ESX-3, -1, -2 and -5 were identified and 
promoter motifs proposed using in silico promoter prediction programs and sequence conservation. 
No promoters were identified for ESX-4. Identification of the promoters of the ESX, and the availability 
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of the promoter probes, will facilitate the investigation of the conditions and regulation of expression of 
the ESX secretion systems. 
M. smegmatis, a fast growing non-pathogenic model organism used for M. tuberculosis research, 
contains three ESX gene clusters, ESX-4, -3 and -1, which are similar to those of M. tuberculosis. A 
library of ESX knockout strains of M. smegmatis was generated by allelic exchange, and includes 
strains from which each ESX gene cluster has been deleted individually, and in combination to create 
double and triple ESX knockouts. The ESX-4ms, ESX-3ms and ESX-1ms strains were used in 
comparative proteomic, secretomic and metabolomic analyses, with wild type M. smegmatis, to 
investigate the functions and substrates of the M. smegmatis ESX secretion systems. This is a novel 
approach which aimed to identify global changes related to the functions of the ESX secretion 
systems. 
The ESX-3 knockout showed significant variation from wild-type M. smegmatis on a metabolite level. 
The levels of most amino acids and sugars were reduced, while increases were detected in oxidative 
stress markers. The proteomic variation correlated with these results, with substantial variation in 
proteins involved in amino acid, carbohydrate and fatty acid metabolism and oxidative stress. 
However, although the metabolomic variation could be ascribed to perturbed iron and zinc 
homeostasis, the proteomic variation did not corroborate this, as no variation in the iron and zinc 
regulons was detected. ESX-3 promoter activity in M. smegmatis was shown to be repressed in high 
iron conditions, correlating with low levels of the ESX-3 protein components detected. Therefore ESX-
3 is likely not involved in iron uptake in the presence of high iron concentrations. Rather, the proteomic 
variation indicated possible disturbed polyamine metabolism in the absence of ESX-3. Spermidine 
synthesis requires methionine, which was almost completely absent in ESX-3ms, supporting this 
theory. Polyamines influence multiple cellular processes as indicated by the variation in the proteomic 
and metabolomic profiles of the two M. smegmatis strains. 
No ESX-4 component proteins were detected in wild type M. smegmatis, and no significant variation 
was observed in the metabolomic analysis. This correlates with the lack of promoter activity obtained 
for ESX-4. The proteomes of ESX-4ms and WTms, however, showed substantial variation. ESX-3 
component proteins were found to be half as abundant in ESX-4ms as WTms, suggesting that ESX-4 
expression influences the expression of ESX-3, and that their functions might be linked. Much of the 
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proteomic variation correlated with pathways which were altered in ESX-3ms, and could be ascribed 
to the reduced expression of ESX-3. WhmD, a WhiB2 global transcriptional regulator of cell division, 
was 4 times more abundant in ESX-4ms, reaffirming a previous link between ESX-4 and cell division. 
Furthermore, some other cell division and cell-division related cell wall biosynthetic proteins were 
undetected in the absence of ESX-4. Molybdopterin metabolism was also influenced by the absence 
of ESX-4, suggesting that ESX-4 may be involved in molybdenum homeostasis, linking ESX-3 and 
ESX-4 to metal cation homeostasis. 
ESX-1 was the most highly expressed ESX in M. smegmatis under the conditions of this study. 
However, although most ESX-1 component proteins were detected in WTms and not in ESX-1ms, the 
ESX-1ms proteome showed the least variation relative to wild type M. smegmatis. Proteins with 
altered abundances are involved in a variety of functions and pathways, and no specific pathways 
showed substantial variation, suggesting that ESX-1 functions independently of many other cellular 
processes. ESX-1 has been linked to conjugal DNA transfer in M. smegmatis and mycolic acid 
synthesis in M. tuberculosis; however the proteomic variation does not correlate with these functions. 
The involvement of ESX-1 in conjugative DNA transfer, in light of the association of the ESX with 
plasmids, identified in this study, is intriguing, suggesting that the ESX may originally have facilitated 
conjugal transfer of plasmid DNA between mycobacterial cells. The absence of ESX-1 does result in 
changes in the abundance of several transcriptional regulators. This was also observed for ESX-3 and 
ESX-4, suggesting that the ESX secretion systems influence the regulome of the bacterium, in 
different ways, in order to maintain cellular homeostasis.  
Proteins which were secreted in WTms, but not in any of the ESXms strains, were investigated as 
possible secreted substrates of the associated ESX secretion system. Several of the proteins contain 
a YxxxD/E general mycobacterial type-VII ESX secretion motif, and may be secreted substrates of 
these secretion systems. However, many of these proteins are membrane localised, and it is unclear 
whether these proteins are integrated into the membrane via the ESX, or if the altered abundance in 
the culture filtrate is a result of other cellular processes. Other possible substrates are hypothetical 
proteins, and no functional relevance could be determined. None of the prototype ESX secreted 
substrate proteins were detected in the culture filtrates. The current techniques for fractionation of 
mycobacterial cells are not specific, and proteins from other fractions are frequently found. Numerous 
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cytosolic and membrane proteins were detected in the culture filtrates, therefore improved 
fractionation methods will facilitate the identification of novel secreted substrates. The low expression 
levels of ESX-3 and ESX-4, under the conditions of this study, may also prevent the identification of 
novel substrates. Although multiple substrates of the ESX secretion systems have been identified for 
M. tuberculosis and M. marinum, homologs of these proteins are not present in M. smegmatis. 
Secretion of these additional substrates may be responsible for the functional variation in some ESX 
secretion systems between M. tuberculosis and M. smegmatis. 
This study has described the evolutionary history of the mycobacterial ESX secretion systems, 
identified promoters driving their expression, identified novel pathways in which the M. smegmatis 
ESX secretion systems are involved, and highlighted possible substrates of the secretion systems. 
This study sets the groundwork for future work in understanding the functional roles and expression 
patterns of these ESX secretion systems and in using global proteomic and metabolomic analyses to 
understand cellular changes in response to specific signals or genomic changes. The ESX secretion 
systems are essential for virulence and survival in M. tuberculosis, and improved understanding of 
their expression, functions and mechanisms may lead to improved treatment and prevention strategies 
for tuberculosis. 
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In this study, we have investigated the evolutionary history of the mycobacterial ESX secretion 
systems, based on sequenced genomes. Evolutionary analyses of unsequenced mycobacteria, by 
PCR-sequencing and Southern-blotting, as well as future in silico analysis of the rapidly growing 
collection of mycobacterial whole genome sequences will fill in gaps in the evolutionary history of the 
ESX secretion systems. 
The proteomic, secretomic and metabolomic variation between M. smegmatis wild type and ESX-1ms, 
ESX-3ms and ESX-4ms strains was investigated under standard 7H9 culture conditions. No ESX-4 
proteins and only low levels of some ESX-3 proteins were detected under these conditions. Similar 
studies investigating ESX-3 under conditions of iron and zinc deprivation may provide better insight 
into the role of ESX-3 in divalent metal cation homeostasis, and provide more marked differences 
between the strains (metabolomic analyses of WTms and ESX-3ms in media containing different iron 
concentrations are currently underway, in collaboration with Prof. Loots at North West University, 
South Africa). The ESX-4 expression patterns should be determined, possibly by assaying promoter 
activity under various conditions, to determine the optimal conditions for expression. WhiB5 and SigM 
dependent expression has recently been shown for ESX-4, suggesting that ESX-4 may be expressed 
under starvation or reactivation. Similar studies under conditions in which ESX-4 is more abundantly 
expressed, will enhance the identification of changes resulting from its absence or presence. 
Metabolomic analyses of WTms and ESX-1ms are currently underway, in collaboration with Prof. Loots 
at North West University, South Africa. 
Identification of novel secreted substrates of the ESX secretion systems was hampered by inefficient 
fractionation and purification of the culture supernatant. Alternative culture conditions and fractionation 
methods should be investigated to optimise this process to prevent contamination with cytosolic and 
membrane proteins. The use of solid media has been investigated, but resulted in similar amounts of 
cytosolic contamination (Z. Fang, unpublished results). Increasing the expression of the ESX secretion 
systems, and thereby the rate of secretion, will also assist in the detection of the associated secreted 
substrates. 
Transcriptomic analyses of the ESXms strains will further establish the functional role of the ESX 
secretion systems in M. smegmatis. Linking the transcriptomic, proteomic, secretomic and 
 158 
 
metabolomic effects of the presence or absence of each ESX secretion system will generate a 
complete “systems biology” view of ESX functionality.  
Complementation of the ESX deletions and whole genome sequencing of the ESXms strains will 
assist in confirming which changes are directly associated with the ESX deletion, and which may 
result from other genomic mutations or adaptive changes resulting from the allelic exchange process 
used to generate the ESXms strains. 
Investigation of the transcriptomes, proteomes, secretomes and metabolomes of the double- and triple 
ESXms strains will help to further establish the functional roles of the M. smegmatis ESX secretion 
systems, the overall cellular function of ESX secretion and as well as the interactions between 
different ESX secretion systems. 
Similar proteomic, secretomic and metabolomic analyses could be done on M. tuberculosis or the non-
pathogenic M. bovis BCG to investigate the functions and substrates of these secretion systems in 
slow growing mycobacteria. This will help to identify functions and substrates of ESX-2, which remains 
largely unstudied, and of ESX-5. The promoter probe vectors could be utilised to identify optimal 
expression conditions for these analyses. 
This study identified novel pathways associated with the ESX-3 and ESX-4 secretion systems. The 
involvement of the ESX secretion systems in these processes must be verified and the mechanisms 
involved established. The possible secreted substrates can be confirmed by tagged protein expression 
and western blotting detection. 
In vivo studies, using proteomics and secretomics in infected THP-1 cell lines or macrophages, will 
investigate the roles of the ESX secretion systems during infection and establish host-pathogen 
interactions influenced by ESX secretion.  
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